![]() | Essential Drugs -Practical Guidelines (MSF, 1993, 286 p.) |
By Mcins Sans Frontis
- intended for doctors, nurses, medical auxiliaries and
pharmacists
- use and management of drugs and medical supplies, in
dispensaries, health centres and refugee camps
NOTE FROM THE CD-ROM EDITORS: THIS MANUAL SHOULD BE USED BY MEDICALLY TRAINED PERSONS ONLY. THE GREATEST CARE HAS BEEN GIVEN TO ACCURATE REPORT BUT IT CAN NOT BE TOTALLY EXCLUDED SOMETIMES A TYPESETTING OR SCANNING ERROR HAS OCCURED (ON AVERAGE 1 OUT OF 2000 TO 3000 CHARATERS IN TEXT AND 1 OUT OF 200 DIGITS IN TABLES).
ALL DOSES OR MEDICAL ACTIONS MENTIONED HERE SHOULD BE CHECKED WITH THE COMMON MEDICAL SCIENTIFIC AND PHARMACEUTICAL KNOWLEDGE AND WITH THE PARTICULAR LOCAL CONDITIONS, AND PERFORMED OR PRESCRIBED UNDER THE SOLE RESPONSABILITY OF A MEDICALLY TRAINED PERSON.
1st edition
Essential drugs
Practical guidelines
PREPARATION OF THIS GUIDE COORDINATED BY
Jacques PINEL (Ph)
WITH ASSISTANCE OF
Annie FOURRIER (Ph)
Jeanne MARITOUX (Ph)
Frans MOUNIS
(O)
Contributions (in alphabetical order):
Ph. Authier (MD), J. Combreau (MW), J.C. Desenclos (MD), H. Grandguillot (N), M. Henkens (MD), Ph. Malfait (MD), B. Morini (MD), B. Renchon (Ph), J. Rigal (MD), C. Sla (MD), A. Stragiotti (Ph), F. Van Loon (MD).
FRENCH-ENGLISH TRANSLATION COORDINATED BY
Mcins Sans Frontis Holland
Egbert SONDORP (MD),
Elisabeth VANDOORNE (N),
Sharon
CAMPBELL (Lab)
(MD) Medical doctor, (MW) Midwife, (N) Nurse, (O) Osteopath, (Ph) Pharmacist, (Lab) Lab technician
This book would not have been possible without Ms Evelyne LAISSU who was responsible for the design and layout.
This guide is not a pharmacological dictionary, it is a practical manual. It is meant for health professionals, physicians, nurses, pharmacists and health auxiliaries whether they are working in curative care, or the use and management of drugs and medical equipment.
We have tried to answer as simply as possible the problems and questions that confront health staff with solutions practiced and tested on the field by Mcins Sans Frontis. We have taken into account the recommendations of reference organisations such as the World Health Organization (WHO) and the advice of specialized publications (see bibliography page 255).
Some of the medicines listed are not on the essential drug list of the WHO, but are still frequently used in certain countries and, although their use is sometimes not advised, we have chosen to include them in this guide.
The level of information on the drug sheets is adapted to the level of training of the health worker:
- the sheets marked "Health post" give simple information for community health workers;
- the sheets marked "Health clinic" and "District hospital" are more detailed and are meant for qualified auxiliaries, nurses and doctors.;
- the sheets marked "Special department"are included for specialized health services (obstetrics, surgery, anaesthesia) and for programmes for the major endemic diseases (tuberculosis, leprosy, trypanosomiasis.).
Obviously the level of health care training and health workers varies from country to country.
The drug sheets are classified in terms of administration, and within each class, in alphabetical order. This classification is an integral part of the whole proposed drug management system (see chapter "Organization and management of a pharmacy", page 179).
Only the main side-effects, contra-indications and precautions are mentioned in this book. For more complete information, we refer to specialized literature.
We would like those who use this book to send us their comments and criticisms so that it remains adapted to the realities of the field.
Please send to:
Mcins sans Frontis - Service mcal
8 rue Saint-Sabin
- 75544 Paris Cedex 11 - FRANCE
Tel. (33) 1- 40.21.29.29 - Fax (33) 1-
48.06.68.68 - Tlx 214360 MSF F
GENERAL RECOMMENDATIONS FOR THE PRESCRIPTION OF DRUGS
(see also "Prescription, cost, compliance", page 199)
When patients are hospitalized, the administration of drugs is controlled, so in general they are used well.
With prescriptions for out-patients, however, it is important to adopt certain rules to encourage proper use of the prescribed treatments:
1° Limit the number of drugs prescribed at any one time:
maximum two.
2° Limit the duration of treatment (should be maximum five
days).
Whenever possible, the patient should preferably take his/her medication daily in the health clinic.
3° Give the patient all the necessary information or' how to take the treatment:
- when,
- how (preparation on an oral rehydration salt
solution.).
Dispensing staff must be trained to do this and the drugs should be labelled with adequate instructions.
Use of the guide
General organization
Three easy ways to find information:
- A summary in the beginning of the guide lists the chapters and their corresponding pages.
- Two indexes of essential drugs in the final pages:
· a pharmaco-therapeutical index with the international generic names, integrated in the essential drug list of the WHO,
· an alphabetical index with double entry with international generic and commercial names.
Every sheet has a table showing an average dose by weight and age. The dosage is given in the unit of the drug (tablet, ampoule.).
With malnourished patients one has to bear in mind the weight and adapt the dose of the prescription accordingly in mg/kg.
Designation of drugs
The international nonproprietary names (INN) classification is used in this guide. Some frequently used commercial names, followed by the symbol (R), are given.
E.g.: ampicillin (Amfipen(R), Penbritin(R)
Drugs on sheets marked with a grey diagonal line are:
- either potentially dangerous and forbidden in certain
countries;
- or obsolete, ineffective or capable to produce resistant
bacterial strains.
These drugs are still widely used, therefore we draw attention to the risk and unnecessary cost of the prescription.
Symbols used
Health post - Community health worker level
Health clinic - Nurse and auxiliary staff level
District hospital - Doctor and medical assistant level
Special department - For the major endemic diseases or in specialised services (surgery, obstetrics, anaesthesia)
PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
This box is found on certain sheets at District hospital level to show that the nurse or medical assistant working at the hospital will not be authorized to prescribe this drug in absence of a doctor.
FIGURE
Abbreviations used
Unit
kg = kilogram
g = gram
mg = milligram (1 g = 1,000
mg)
IU = international unit
mEq= milliequivalent
mmol= millimol
ml =
millilitre (1 cc = 1ml)
tsp= teaspoon (=5ml)
Route of drug administration
P.O. = per os - orally
IM = intramuscular
IV =
intravenous
SC = subcutaneous
Presentation
tab = tablet
cap =capsule
vl = vial
amp =
ampoule
susp = suspension
Duration
x. d = during. days
Example: 300 mg/d divided in 3 doses x 5 d
(three hundred milligrams per day to be divided in three doses of one hundred milligrams to be taken during five days)
Acetaminophen
Acetyl salicylic acid =
ASA
Albendazole
Albuterol
Aluminium
hydroxide
Aminophylline
Amoxicillin
Ampicillin
Aneurin
Ascorbic
acid
Atropine sulphate
B
Complex
Butylscopolamine
Charcoal
Chloramphenicol
Chloroquine
Chlorpheniramine
=
Chlorphenamine
Chlorpromazine
Cimetidine
Clofazimine
Cloxacillin
Cotrimoxazole
= SMX +
TMP
Dapsone
Dexamethasone
Dexchlorpheniramine
Diazepam
Diethylcarbamazine
Digoxin
Dihydralazine
Dipyrone*
Doxycycline
Erythromycin
Ethambutol
Ferrous
salts = Ferrous sulphate
Ferrous sulphate + Folic
acid
Flubendazole
Folic acid
Furosemide =
Frusemide
Griseofulvin
Halofantrine*
Hydralazine
Hydrochlorothiazide
Hyoscine
butylbromide
Ibuprofen
Indometacin
Iron salts
Isoniazid =
INH
Isoniazid +
Thiacetazone
Ivermectin
Levamisole
Loperamide
Mebendazole
Mefloquine
Metamizol*
Methyldopa
Methylprednisolone
Metoclopramide
Metrifonate
Metronidazole
Multivitamins
Niclosamide
Nitrofurantoin
Noramidopyrine*
Noscapine
Nystatin
Oral
rehydration salt =
O.R.S.
Oxamniquine
Oxytetracycline
Paracetamol
Phenobarbitone =
Phenobarbital
Phenoxymethyl penicillin = Penicillin
V
Phenylbutazone*
Phenytoin
Piperazine
Potassium
chloride
Praziquantel
Prednisolone-
Prednisone
Probenecid
Proguanil
Promethazine
Propanthelin
Propranolol
Pyrantel
Pyrazinamide
Pyridoxine
Quinine
salts
Reserpine
Retinol
Rifampicin
Salbutamol
Sulfadimidine
Sulfadoxine
+
Pyrimethamine
Sulfaguanidine*
Tetracycline
Theophylline
Thiabendazole
Thiamine
Tolbutamide
Vitamin
A
Vitamin B1
Vitamin B6
Vitamin C
Vitamin B Complex
* The use of this drug is not advised.
ACETYL SALICYLIC ACID = A.S.A.
(Aspirin)
Health post
Therapeutic action
- Analgesic
- Antipyretic
- Anti-inflammatory
Indications
- Headache, toothache
- Fever
- Joint or muscular pain
Preparation
- Tablets of 75 mg, 100 mg, 300 mg and 500mg
Dosage
- Child: 50 mg/kg/d divided in 3 doses
- Adult: 1-3 g/d
divided in 3 doses
- In case of joint pain, double the dose.
FIGURE
Duration: depending on clinical progress, 1-3 days
Contra-indications, side-effects, precautions
- Do not administer:
· in cases of heartburn, alcoholism, haemorrhage,
asthma.
· children under one year (preferably use paracetamol when
available).
- If heartburn or allergic reaction, stop treatment and give
paracetamol.
- Do not combine with probenecid.
- Pregnancy: avoid if
possible (preferably use paracetamol especially in the third trimester of
pregnancy)
- Lactation: avoid if possible (preferably use paracetamol)
Remarks
- Take during meals, preferably",with a lot of water.
-
Storage: keep cool if possible
- Do not use if the tablets have a strong
unusual smell (acid or vinegar). A slight acetic acid smell is always present.
ALUMINIUM HYDROXIDE [with or without magnesium salts]
Health post
Therapeutic action
- Antacid
- Protects digestive mucosa
Indications
- Heartburn after or during meals (gastritis)
- Stomach ulcer
Preparation
- Tablet of 500 mg There are numerous preparations on the base of aluminium and/or magnesium hydroxide in varying dosages. Adapt dosage accordingly.
Dosage
- Child: rarely indicated. When necessary: 75 mg/kg/d
-
Adult: 1.5 to 3 g/d divided in 3 doses after meals or at the time of extreme
pain
FIGURE
Duration :5 days (longer if necessary)
Contra-indications, side-effects, precautions
- Frequent constipation (except when the tablets contain
magnesium salts).
- Decreases the absorption of many drugs so avoid
simultaneous administration especially with tetracycline. Separate the different
drugs by one or two hours.
- Chew tablets.
- Besides this treatment, the
patient should avoid taking alcohol, coffee, tea, coca-cola, carbonated drinks,
spices and tobacco.
- Pregnancy: no contra-indication
- Lactation: no
contra-indication
Remarks
- Storage: no special precautions
AMINOPHYLLINE (Euphyllin(R), Theodrox(R).) and THEOPHYLLINE (Nuelin(R).)
District hospital
Therapeutic action
- Bronchodilator
Indications PRESCRIPT/ONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Asthma
- Severe respiratory problems combined with
bronchopneumonia
Preparation
- Tablets of 100 mg and 200 mg
Dosage
- Child and adult:
· Aminophylline: 13 to 15 mg/kg/d divided in 3
doses
· Theophylline : 10 to 13 mg/kg/d divided in 3 doses
- For smokers, it is sometimes necessary to increase the dosage
to 20 mg/kg/d.
- Aminophylline contains 85% of theophylline.
FIGURE
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Paediatrics:
· do not combine with erythromycin.
· the
therapeutic dose is near the toxic dose.
- Toxic in case of overdose:
· early signs: vomiting, hyperthermia.
· signs of
intoxication: convulsions.
When these symptoms appear, stop treatment and refer to a doctor as soon as possible.
- Lower the dosage in case of heart failure.
- Administer
with care to children under one year.
- Avoid combination with
phenobarbitone.
- Pregnancy: avoid (especially in the third trimester of
pregnancy)
- Lactation :avoid
Remarks
- Storage: keep below 30°C
AMOXICILLIN (Amoxil(R), Clamoxyl(R).)
Health clinic
Therapeutic action
- Antibacterial (antibiotic) of the penicillin group
Indications
- Respiratory infections with fever in children under 5
years
- Prevention and treatment of secondary infections of whooping cough
and measles
- Genito-urinary infections, especially in pregnant women
Preparation
- Tablets or capsules of 500 mg and 250 mg
- Syrup of 125
mg/5 ml = 1 teaspoon (tsp)
Dosage
- Child : 50 mg/kg/d divided in 2 doses
- Adult: 1 to 2 g/d
divided in 2 doses
- In case of severe infections, use the maximum dosage in
3 doses/day.
- Treatment of genito-urinary infections in pregnant women: 1
g/d divided in 2 or 3 doses for 10 days.
FIGURE
Duration
- Minimum 5 days
- 10 days in case of genito-urinary
infections in pregnant women
Contra-indications, side-effects, precautions
- Do not administer if known allergy to penicillin.
- If
allergic reaction, stop treatment and refer to a doctor.
- Do not combine
with other antibiotics without medical advice.
- Pregnancy: no
contra-indication
- Lactation: no contra-indication
Remarks
- Amoxicillin is used for the same indications as ampicillin
but, because of its better intestinal absorption, only half the dose is required
by oral administration.
- Storage: keep cool if possible.
Once prepared,
the syrup should be kept cool, and will only last for 1 week.
AMPICILLIN (Amfipen(R), Penbritin(R).)
Health clinic
Therapeutic action
- Antibacterial (antibiotic) of the penicillin group
Indications
- Respiratory infections with fever in children under 5
years
- Prevention and treatment of secondary infections of whooping cough
and measles
- Genito-urinary infections, especially in pregnant women
Preparation
- Tablets or capsules of 500 mg and 250 mg - Syrup of 125 mg/5 ml = 1 teaspoon (tsp)
Dosage
- Child: 100 mg/kg/d divided in 2 doses
- Adult: 2 to 4 g/d
divided in 2 doses
- In case of severe infections, use the maximum dosage in
3 doses/day.
- Treatment of genito-urinary infections in pregnant women: 1
g/d divided in 2 or 3 doses for 10 days.
FIGURE
Duration
- Minimum 5 days
- 10 days in case of genito-urinary
infections in pregnant women
Contra-indications, side-effects, precautions
- Do not administer if known allergy to penicillin.
- If
allergic reaction, stop treatment and refer to a doctor.
- Do not combine
with other antibiotics without medical advice.
- Pregnancy: no
contra-indication
- Lactation: no contra-indication
Remarks
- Avoid to take ampicillin during meals.
- Amoxicillin is
used for the same indications as ampicillin but, because of its better
intestinal absorption, only half the dose is required by oral
administration.
- Storage: keep cool if possible.
Once prepared, the syrup should be kept cool, and will only last for 1 week.
ASCORBIC ACID = VITAMIN C (Redoxon(R).)
District hospital
Therapeutic action
- Vitamin
Indications
- Treatment and prevention of scurvy
Preparation
- Tablets of 50 mg and 250 mg
There are also tablets of 500 mg and 1 g. Adapt dosage accordingly.
Dosage
- Treatment:
child: 100 to 300 mg/d divided in 3 doses
adult: 500 mg to 1
g/d divided in 3 doses
- Prevention:
child: 50 to 100 mg/d
adult: 50 to 100 mg/d
FIGURE
Duration
- Treatment: 1 to 2 weeks until symptoms improve, followed by a
maintenance dose for 2 weeks (preventive dose).
- Prevention: as long as the
situation requires (e.g. insufficient supply in the food rations of displaced
population).
Contra-indications, side-effects, precautions
- Well tolerated.
- Pregnancy: no contra-indication
-
Lactation: no contra-indication
Remarks
- High doses of vitamin C can interfere with the measurement of
glucose in urine.
- This supplement is rarely necessary when the food intake
contains enough fruit and vegetables.
- Storage: keep below 30°C
ATROPINE Sulphate
HYOSCINE BUTYLBROMIDE = BUTYLSCOPOLAMINE
(Buscopan(R).) PROPANTHELIN (Probanthine(R).)
District hospital
Therapeutic action
- Antispasmodic
Indications
- Spasms of the digestive and uro-genital tract
Preparation
- Atropine sulphate : tablet of 1 mg
- Hyoscine butylbromide:
tablet of 10 mg
- Propanthelin : tablet of 15 mg
Dosage
- Child: avoid
- Adult:
atropine sulphate : 3 mg/d divided
in 3 doses
hyoscine butylbromide: 30 to 60 mg/d divided in 3
doses
propanthelin : 45 to 90 mg/d divided in 3 doses
- Butylhyoscine or
propanthelin are to be preferred since their side-effects are less pronounced
than those of atropine.
FIGURE
Duration: depending on clinical progress, maximum 1 to 4 days
Contra-indications, side-effects, precautions
- Do not administer in cases of:
· urinary retention,
· cardiac problems,
·
glaucoma.
- May cause:
· dry mouth,
· constipation,
· dizziness,
headache.
- Do not combine with chlorpromazine or promethazine.
-
Pregnancy: avoid, particularly in the third trimester of pregnancy, NO PROLONGED
TREATMENTS
- Lactation: avoid, NO PROLONGED TREATMENTS
Remarks
- Do not use for convenience.
- Storage:
CHARCOAL
District hospital
Therapeutic action
- Absorbent
Absorbs toxic substances of certain plants and drugs and those produced by some microbes.
Indications
- Intoxication after taking drugs in higher doses than normal
(A.S.A., paracetamol, chloroquine, quinine, barbiturates, indometacin,
phenytoine, digoxine, tolbutamide, theophylline...)
- Poisoning by plants
Preparation
- Tablet of 125 mg
There are different strengths. Adapt dosage accordingly.
Dosage
- Child and adult: 6 to 24 tablets in a single dose
- In case
of severe overdose: 30 tablets in a single dose.
FIGURE
Duration: single dose; repeat if necessary.
Contra-indications, side-effects, precautions
- Do not administer after ingestion of caustic products.
-
Constipation possible after treatment.
- Black colouring of faeces.
- Do
not administer with other drugs, because of its absorbing properties.
-
Pregnancy: no contra-indication (avoid prolonged use)
- Lactation: no
contra-indication
Remarks
- Charcoal DOES NOT CURE DIARRHOEA. It does not correct
dehydration. It can only relieve a blown up stomach.
- To make this drug
easier to take, crush the tablets.
- Storage: no special temperature
requirements
CHLORAMPHENICOL (Chloromycetin(R), Tifomycine(R).)
District hospital
Therapeutic action
- Antibacterial (antibiotic)
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Typhoid fever
- Meningitis
- Bronchopneumonia
Preparation
- Tablet or capsule of 250 mg
- Syrup of 125 mg/5 ml
Dosage
- Child under 2 months: 25 mg/kg/d divided in 3 doses
- Child
above 2 months: 50 to 100 mg/kg/d divided in 3 doses
- Adult :1 to 3 g/d
divided in 3 doses
FIGURE
- Typhoid: refer to national protocol. In other cases, start the
first day with a half dose and increase gradually.
- For indications other
than typhoid, do not exceed the total dose of 26 g for adults.
- Can be used
for immediate treatment of gonorrhoea: 2 to 3 g once daily for 2 days.
Duration
- 5 days minimum
- Typhoid fever: continue the antibiotic
therapy 15 days after the fever has gone.
Contra-indications, side-effects, precautio- In newborn babies, administer only for cases of typhoid or meningitis.
- If treatment causes anaemia, stop treatment and refer to a
doctor.
- Do not combine with other antibiotics without medical advice.
-
As far as possible, limit the use of chloramphcol to serious infections.
-
Pregnancy: CONTRA-INDICATED
- Lactation: CONTRA-INDICATED
Remarks
- In spite of a rare severe haematological toxicity, the use of
chloramphenicol is justified because of its effective treatment of the above
mentioned severe infections. Another advantage is the low price.
- The oral
treatment is more effective than the injected (I.M.), as the blood- and tissue
concentrations are better.
- Storage: keep below 30°C if possible-
Once prepared, the syrup should be kept cool, and will only last for 1 week.
CHLOROQUINE Phosphate or Sulphate (Nivaquine(R), Resochin(R).)
Health post
Therapeutic action
- Antimalarial
Indications
- Malaria
· Treatment of a malaria attack (in areas without
chloroquine resistance)
· Prophylaxis for pregnant women, malnourished
children and non-immune individuals in areas without chloroquine resistance
Preparation
- Tablet of 100 mg of chloroquine base
- Tablet of 150 mg of
chloroquine base
IMPORTANT: THE DOSE WRITTEN ON THE LABELS IS SOMETIMES IN CHLOROQUINE SALT AND SOMETIMES IN CHLOROQUINE BASE WHICH LEADS TO FREQUENT CONFUSION. WHO RECOMMENDS PRESCRIPTIONS AND LABELS IN CHLOROQUINE BASE.
Equivalence for salt and base: 130 mg sulphate = 150 mg phosphate or diphosphate = 100 mg base 200 mg sulphate = 250 mg phosphate or diphosphate = 150 mg base
Dosage
PREVENTIVE TREATMENT
When there is no national protocol, apply one of the following schemes, depending on local practice:
FIGURE
CURATIVE TREATMENT
When there is no national protocol, administer in the following way:
- Child and adult: 10 mg base/kg, D1 and D2 5 mg base/kg, D3, D4
and D5
- When treatment schedule must be very simple, it is possible to give
10 mg base/kg/d for 3 days.
- When using injectable chloroquine, never forget
that the therapeutic oral dose is equivalent to a toxic dose when injected.
FIGURE
Duration: curative treatment: 5 or 3 days
Contra-indications, side-effects, precautions
- Vomiting and frequent headaches.
- Pruritis, cutaneous
eruptions possible, most of them occurring in areas of endemic filariasis. These
are not allergic reactions and treatment should not be stopped.
- Do not come
near the toxic dose:
· child: 25 mg base/kg in one dose 2 g base in one dose
· adult: 2 g base in one dose
Intoxication is severe.
- Pregnancy: no contra-indication
- Lactation: no
contra-indication
Remarks
PREVENTIVE TREATMENT
- The prevention of malaria in areas with high prevalence of
chloroquine resistance is often debated. In this case, chloroquine has to be
combined with proguanil or replaced by a different drug.
- Travellers only
have to start treatment on the day of their arrival in affected areas. Treatment
must be continued for 6 weeks after leaving the area.
CURATIVE TREATMENT
- When it is not possible to take two doses on the first day,
give the total dose of the first day at once, 15 mg base/kg.
- If the patient
vomits within one hour of medication being given, repeat the dose.
- Some
national guidelines recommend to give only the first dose of treatment
(conservation of natural immunity of population).
- It is advisable to use
tablets of 150 mg base (= 250 mg of phosphate) in english speaking countries and
100 mg base (= 150 mg of phosphate) in french speaking countries to mountain
local practice and to avoid mistakes in dosage.
- Storage: no special
temperature requirements -
CHLORPHENIRAMINE = CHLORPHENAMINE (Teldvin(R).)
District hospital
Therapeutic action
- Antihistamic
Indications
- Allergic reactions due to:
· contact, seasons.
· drugs, insect bites, food.
- Dry cough of allergic origin
Preparation
- Tablet of 4 mg
Dosage
- Child (above 2 years): 1 to 4 mg/d divided in 2 or 3
doses
- Adult: 8 to 12 mg/d divided in 2 or 3 doses
FIGURE
Duration: single dose or 1 to 3 days depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer to children under 2 years.
- Risk of
drowsiness, use with care when driving.
- Risk of increased sedation when
combined with alcohol and other drugs that act on the central nervous system:
diazepam (Valium(R)), phenobarbitone (Gardenal(R)) and chlorpromazine
(Largactil(R)).
- Avoid alcoholic drink during the treatment.
- Pregnancy:
avoid
- Lactation : avoid
Remarks
- Dexchlorpheniramine (Polaramine(R) has the same indications
but: 2 mg of dexchlorpheniramine has the same effect as 4 mg of
chlorpheniramine.
- Storage: keep below 30°C
CHLORPROMAZINE (Largactil(R).)
District hospital
Therapeutic action
- Sedative neuroleptic
- Major tranquillizer
Indications PRESCRIPTIONS AND FOLLOW-UP TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Acute psychosis with agitation
- Chronic psychosis,
hallucinations and schizophrenia
Preparation
- Tablet of 25 mg
There are also tablets of 50 and 100 mg. Adapt dosage accordingly.
Dosage
Varies from one person to another, doses have to be progressive.
- Child: 1.5 mg/kg/d divided in 3 doses
- Adult: 50 to 100
mg/d divided in 3 doses
FIGURE
- Do not exceed indicated doses.
- Lower the dose for elderly
patients.
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer in cases of:
· barbiturate or alcoholic coma,
· Parkinson's
disease,
· renal or liver failure (risk of overdose).
- If patient becomes febrile, interrupt the treatment. It could
be a case of malicious neuroleptic syndrome.
- Risk of extrapyramidal
manifestations, orthostatic hypotension and photosensitization to the sun.
-
Refer in case of acute intoxication.
- If prolonged treatment, check blood
regularly (risk of agranulocytosis).
- Risk of sedation when combined with
alcohol and other drugs that act on the central nervous system: diazepam
(Valium(R)), phenobarbitone (Gardenal(R) and chlorpheniramine (Teldvin(R)).
-
Pregnancy: CONTRA-INDICATED (in case of psychosis, stop treatment one week
before delivery if possible)
- Lactation: avoid
Remarks
- Storage: keep below 30°C
CIMETIDINE (Tagamet(R).)
District hospital
Therapeutic action
- Healing of ulcers
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Active duodenal and gastric ulcers and prevention of
relapses.
- esophagitis caused by gastro-esophageal reflux unresponsive to
other treatments.
Preparation
- Tablets of 200 mg, 400 mg and 800 mg
Dosage
- Newborn and child: 10 to 20 mg/kg/d divided in 4 to 6
doses
- Adult :800 mg/d once daily (evening)
FIGURE
Duration :4 to 6 weeks
Contra-indications, side-effects, precautions
- Do not administer treatments over long periods.
- Do not
administer an antacid (aluminium hydroxide) for 2 hours before or after taking
cimetidine.
- May cause: diarrhoea, dizziness, rash, fever.
- Association
with other drugs not advised (phenytoine), or to be monitored (propanolol
theophylline...).
- Reduce dosage in case of severe hepatic or renal
failure.
- Pregnancy: CONTRA-INDICATED
- Lactation: CONTRA-INDICATED
Remarks
- To prevent relapses of duodenal ulcers, reduce the dosage by
half.
- Expensive treatment.
- Storage: keep below 30°C
CLOFAZIMINE (Lamprene(R).)
Special department
Therapeutic action
- Antibacterial, active against the leprosy bacillus
Indications
- Multibacillary leprosy, in association to other "anti-leprosy"
medication
- Leprotic reaction: erythema nodosum leprosum
Preparation
- Capsules of 50 mg and 100 mg
Dosage
According to national protocol. For information:
- Multibacillary leprosy: 300 mg once a month under surveillance
and 50 mg/d taken by patient at home. Must be combined with rifampicin and
dapsone.
- Leprotic reaction: 100 to 300 mg/d
Duration
- 6 months or 2 years depending on the type of leprosy.
-
Leprotic reaction :3 months, then decrease dosage progressively.
Contra-indications, side-effects, precautions
- Do not administer doses of 300 mg/d or over for more than 3
months.
- Administer with care in cases of liver or renal failure.
-
Occasionally causes nausea and/or abdominal cramps.
- Orange red colouring of
the skin, mucosa and skin lesions, which continues a long time after the end of
treatment.
- Orange colouring of the urine, faeces and secretions.
-
Should be combined with other "antileprotics".
- Pregnancy: avoid (if
necessary may be used under medical supervision)
- Lactation: avoid (if
necessary may be used under medical supervision)
Remarks
- The action on the tuberculoid type is quite slow, about 2 to 6
weeks.
- Only prescribe "anti-leprotics" in the content of an organised
leprosy program.
- Storage: no special precautions.
CLOXACILLIN (Orbenin(R).)
District hospital
Therapeutic action
- Antibacterial (antibiotic) of the penicillin group, acting specifically against penicillinase producing staphylococci
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE
UNDER MEDICAL SUPERVISION
- Staphylococci infections resistant to other antibiotics: chronic osteomyelitis, pulmonary staphylococci of the newborn.
Preparation - Capsules of 250 mg and 500 mg
Dosage
- Child: 50 mg/kg/d divided in 3 doses
- Adult: 1 to 2 g/d
divided in 3 doses
- In case of a severe infection, the dose can be doubled.
FIGURE
Duration: minimum 7 days
Contra-indications, side-effects, precautions
- Do not administer if known allergy to penicillin.
- If
allergic reactions, stop treatment and refer to a doctor.
- Pregnancy: no
contra-indication
- Lactation: no contra-indication
Remarks
- Cloxacillin, oxacillin and dicloxacillin are equivalent
products: same indications and same doses, except for dicloxacillin (25
mg/kg/day).
- Storage: keep cool if possible
COTRIMOXAZOLE = Sulfamethoxazole (SMX) + Trimethoprim (TMP) (Bactrim(R), Cotrim(R), Eusaprim(R), Septrim(R).)
Health post
Therapeutic action
- Combination of 2 antibacterials including a sulfonamide (active during maximum 12 hours)
Indications
- Respiratory infections with fever
- Urinary infections
-
Bacillary dysentery
- Otitis
- Gonorrhoea
Preparation
- Tablet of 400 mg sulfamethoxazole (SMX) + 80 mg trimethoprim
(TMP)
- Syrup of 200 mg SMX + 40 mg TMP / 5 ml = 1 teaspoon
There are also tablets of 800 mg SMX + 160 mg TMP (named cotrimoxazole "forte") and paediatric tablets of 100 mg SMX + 20 mg TMP. Adapt dose accordingly.
Dosage
- Child : 1/2 to 2 tab of 400 mg + 80 mg/kg/d divided in 2
doses
- Adult: 4 tab of 400 mg + 80 mg/d divided in 2 doses
FIGURE
- To treat:
· gonorrhoea: 10 tabs of 400 mg + 80 mg/d once daily for 3
days
· urinary infections: 4 tabs of 400 mg + 80 mg in a single dose
- In case of acute respiratory infections in children under 5 years, double the dose:
· from 2 months to 1 year: 1/2 tab x 2
· from 1 to
5 years : 1 tab x 2
Duration: minimum 5 days
Contra-indications, side-effects, precautions
- Do not administer to children under 2 months.
- Frequent
digestive problems.
- Allergic reactions mostly benign but sometimes severe
(generalised bullous eruptions, agranulocytosis). In this case, stop treatment
and refer to a doctor.
- Do not combine with other antibacterials.
- Drink
a lot of liquid during treatment.
- Pregnancy: CONTRA-INDICATED
-
Lactation: CONTRA-INDICATED
Remarks
- Storage: no special precautions.
Once prepared, the syrup can be kept for up to 1 week if kept cool.
DAPSONE (Avlosulfon(R).)
Special department
Therapeutic action
- Antibacterial, active against the leprosy bacillus
Indications
- Leprosy, in association to other "anti-leprosy" medication
Preparation
- Tablets of 50 mg and 100 mg
There are different strengths. Adapt dosage accordingly.
Dosage
According to national protocol.
For information:
- Child : 1 to 2 mg/kg/d once daily
- Adult: 100 mg/d once
daily
FIGURE
Duration
- Multibacillary leprosy: 2 years or more, depending on the
progress
- Paucibacillary leprosy: 6 months
Contra-indications, side-effects, precautions
- Do not administer if allergy or intolerance to
sulfonamides.
- Avoid in case of liver failure.
- If severe anaemia or
leucopenia develops, stop treatment and replace dapsone with another
"antileprotic".
- Pregnancy: avoid (if necessary may be used under medical
supervision)
- Lactation: avoid (if necessary may be used under medical
supervision)
Remarks
- Warning: antileprotic treatment should only be prescribed in
the context of an organised program.
- Dapsone should not be used alone, but
in combination with other "antileprotic" drugs to avoid development of
resistance.
- Storage: keep below 30°C
DIAZEPAM (Tensium(R), Valium(R).)
District hospital
Therapeutic action
- Anxiolytic
- Anticonvulsive, muscle relaxant
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Muscular contractions
- Agitation and anxiety
Preparation
-Tablet of 5 mg
There are also tablets of 2 mg and 10 mg. Adapt dosage accordingly.
Dosage
- Child: 0.5 mg/kg/d divided in 3 doses
- Adult: 5 to 15 mg/d
divided in 3 doses
FIGURE
- Do not exceed indicated doses.
- Signs of overdose:
muscular weakness, ataxia.
- Signs of intoxication (5 times the therapeutic
dose): hypothermic coma.
- The dose should be halved for elderly
patients.
- Should only be used exceptionally and with great care for
children.
Duration: depending on clinical progress
Contra-indications, side-effects, precautions.
- Do not administer in cases of respiratory depression.
-
Risk of drowsiness, use with care when driving.
- Addiction will occur in
case of prolonged use (average 12 days). Reduce the dosage gradually to wean the
patient off the drug.
- Risk of causing sedation when combined with alcohol
and other drugs that act on the central nervous system: chlorpromazine
(Largactil(R)), phenobarbitone (Gardenal(R)) and chlorpheniramine
(Teldvin(R)).
- Pregnancy: avoid
- Lactation :avoid
Remarks
- Do not use as an easy remedy.
- Storage: no special
precautions
DIETHYLCARBAMAZINE (Banacide(R), Hetrazan(R), Notezine(R).)
Special department
Therapeutic action
- Filaricide
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Lymphatic filariasis (Wuchereria bancrofti)
-
Onchocerciasis (Onchocerca volvulus)
- Loiasis (Loa-loa)
Preparation
- Tablets of 50 mg and 100 mg
Dosage
According to national protocol.
For information:
- Lymphatic filariasis and onchocerciasis
· Child : build up dose progressively (over 4 days) 6
mg/kg/d divided in 2 doses
· Adult: build up dose progressively (over 4
days) 400 mg/d divided in 2 doses start the first day with 25 to 50 mg divided
in 2 doses
- Loiasis
Adapt dosage to the parasite-load of the patient
· Child and adult: build up progressively (over 5 to 8 days) to 6 mg/kg/d divided in 2 doses start the first day with 3 mg/kg/d divided in 2 doses
- In West Africa, every treatment should start with 3 mg/d because of the risk of possible combination of loiasis with other filariasis.
Duration: 21 days
Contra-indications, side-effects, precautions
- Allergic reactions: pruritus, Iymphangitis, risk of shock due
to the microfilaria lysis
(loiasis and onchocerciasis).
- Risk of lethal
encephalitis; reactions are the most severe when the progressive protocol is not
respected.
- Drowsiness, malaise, headache, nausea, vomiting.
- To prevent
or decrease allergic reactions, administration of antihistamines is
recommended.
- Pregnancy: avoid (in most cases, the treatment can wait until
the end of the pregnancy)
- Lactation: avoid
Remarks - To treat onchocerciasis: ivermectin (Mectizan(R)), a single dose medication which is better tolerated, replaces diethylcarbamazine.
- An individual chemoprophylaxis against Loa-Loa is possible
:100 mg once weekly.
- Storage: keep below 30°C
DIGOXIN (Lanoxin(R).)
District hospital
Therapeutic action
- Cardiotonic (reinforces the cardiac contraction, slows down and regulates the cardiac rhythm)
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Congestive heart failure, sinus arrhythmia (fibrillation, flutter, paroxysmal tachycardia) DIAGNOSED BY A DOCTOR.
Preparation
- Tablet of 0.25 mg (= 250 microgram = 250 mcg = 250 ug)
Dosage
- Child
· initial dose : 0.015 mg/kg (= 15 mcg/kg) x 3 to 4 doses
the first day
· maintenance dose: 0.015 mg/kg/d once daily, 5 days in
every 7
- Adult
· initial dose : 0.5 to 1 mg/d divided in 3 or 4 doses the
first day
· maintenance dose: 0.25 mg/d divided in 1 or 2 doses, 5 days
in every 7
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer in cases of:
· bradycardia
· ill-defined heart rhythm disorders
- The surveillance of the pulse is vital at the beginning of the
treatment.
- The therapeutic dose is near the toxic dose.
- Signs of
overdose: digestive problems, visual problems, disorientation or confusion,
arrythmia and problems of the atrio-ventricular conduction. In this case, reduce
dosage or stop treatment. Nausea or vomiting are early signs of overdose.
-
Higher risk of intoxication in cases of hypokalemia, especially if combined with
a diuretic.
- Administer with care in cases of renal failure.
- Pregnancy:
no contra-indication
- Lactation: no contra-indication
Remarks
- Storage: no special temperature requirements
ERYTHROMYCIN (Erythrocin(R), Ilotycin(R).)
District hospital
Therapeutic action
- Antibacterial (antibiotic)
Indications
- For upper and lower respiratory infections as a second choice and in case of allergy or resistance to penicillin
Preparation
- Tablets of 250 mg and 500 mg erythromycin (base)
Dosage
- Child : 30 to 50 mg/kg/d divided in 2 doses
- Adult: 1 to 3
g/d divided in 2 doses depending on the degree of infection
- In case of
severe infections, it is recommended to give the dosage in 3 doses/day.
FIGURE
Duration: minimum 5 days
Contra-indications, side-effects, precautions
- Do not combine with ergotamine or aminophylline, especially in
pediatrics.
- Allergic reactions, digestive problems possible.
-
Administer with care in cases of liver failure.
- Transitory deafness at high
doses.
- Pregnancy: no contra-indicafion
- Lactation: no contra-indication
Remarks
- Take before meals.
- Storage: no special precautions
ETHAMBUTOL (Myambutol(R).)
Special department
Therapeutic action
- "Antituberculous" antibacterial
Indications
- Only for tuberculosis, bacteriologically proven if possible
Preparation
- Tablets of 100 mg and 400 mg
There are also tablets of 250 mg and 500 mg. Adapt dosage accordingly.
Dosage
According to national protocol.
For information:
- Child above 5 years and adult: 20 mg/kg/d once daily
FIGURE
Duration: according to national protocol
Contra-indications, side-effects, precautions
- Do not administer in cases of severe renal failure or ocular
disease.
- In case of inflammation of the optic nerve (problems of vision:
colour and acuity), stop treatment and refer to a doctor.
- Pregnancy: no
contra-indication
- Lactation: no contra-indication
Remarks
- Not recommended for children as the visual problems are hard
to identify.
- Take in the morning before meal.
- Warning: antituberculous
treatment should only be prescribed in the context of an organised program (well
established protocol, regular patient checks and the possibility of laboratory
examination).
- Ethambutol should not be used alone, but in combination with
other "antituberculous" drugs to avoid development of resistance.
- Storage:
no special precautions
Iron salts = FERROUS salts, fumarate, ascorbate, sulphate= FERROUS sulphate
Health post
Therapeutic action
- Essential to produce red blood cells
Indications
- Prevention of anaemia during pregnancy
- Treatment of
anaemia due to lack of iron: insufficient intake, intestinal parasitic disease,
blood loss
Preparation
- Tablet of 200 mg ferrous sulphate (containing 60 mg of the
element iron)
Also available in different strengths. Adapt dosage
accordingly.
Dosage (unit is ferrous salts)
- Prevention:
Child :6 mg/kg/d once daily
Pregnant women: 100 to 200 mg/d
once daily
- Treatment :
Child: 15 to 30 mg/kg/d divided in 3 doses
Adult: 800 mg to
1.2 g/d divided in 3 doses
FIGURE
- Do not exceed indicated doses. Toxic dose: 100 mg/kg ferrous
sulphate (= 30 mg/kg element iron).
- Signs of overdose: diarrhoea with
blood, heart failure.
Duration
- Prevention: throughout the risk period (pregnancy,
malnutrition)
- Treatment: 2 months minimum
Contra-indications, side-effects, precautions
- Do not combine with tetracycline as each drug prevents the
other from being absorbed properly.
- Do not administer in cases of sickle
cell anaemia.
- Can cause gastro-intestinal problems: gastric burning,
diarrhoea or constipation.
- Black colouring of the stools.
- Do not
exceed the recommended dose, especially in children.
- Pregnancy: no
contra-indication (recommended to avoid anaemia)
- Lactation: no
contra-indication
Remarks
- Take during meals to avoid digestive problems.
- If
treatment requires the administration of ferrous salts, tablets containing both
ferrous salts and folic acid are recommended.
- All ferrous salts are to be
used in the same dose, e.g. ferrous fumarate, ascorbate
- Storage: no special
precautions
FOLIC ACID
District hospital
Therapeutic action
- Vitamin necessary to produce red blood cells
Indications
- Anaemia caused by lack of folic acid: severe malnutrition, repeated attacks of malaria, intestinal parasites
Preparation
- Tablet of 5 mg. There are also tablets of 1 mg. Adapt dosage accordingly.
Dosage
- Child : 5 to 15 mg/d once daily
- Adult: 10 to 20 mg/d once
daily
- In case of severe anaemia, it is recommended to double.
FIGURE
Duration :15 to 30 days
Contra-indications, side-effects, precautions
- Well tolerated.
- Pregnancy: no contra-indication
-
Lactation: no contra-indication
Remarks
- Storage: no special temperature requirements
FERROUS Salt + FOLIC ACID (Fegal(R).)
Indications
- Prevention of lack of iron and folic acid, mainly during pregnancy
Preparation
- Tablet of 200 mg ferrous sulphate and 0.25 mg folic acid
Dosage
- Child: 1 tab/d
- Adult: 1 to 2 tab/d
Remarks
- This combination is not suitable for the treatment of folic
acid deficiency because of its low dose (0.25 mg).
- Storage: keep below
30°C
FUROSEMIDE = FRUSEMIDE (Frusid(R)), Lasix(R).)
District hospital
Therapeutic action
- Diuretic
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Oedema caused by renal, heart or liver failure, DIAGNOSED BY A DOCTOR
Preparation
- Tablet of 40 mg
Dosage
- Child: 0.5 to 1 mg/kg/d once daily
- Adult: 20 to 80 mg/d
once daily
FIGURE
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Never administer for other types of oedema, particularly not
for kwashiorkor.
- Risk of hypokalemia (increases the toxicity of digoxin
when used together).
- Pregnancy:avoid
- Lactation: no contra-indication
(but can reduce the milk production)
Remarks
- A lot of fruit should be eaten during the treatment (dates,
bananas, tomatoes, mangos, oranges.), in order to supply additional potassium.
Use potassium tablets as well if available.
- Storage: no special temperature
requirements
GRISEOFULVIN (Fulcin(R), Grisavin(R).)
District hospital
Therapeutic action
- Antifungal
Indications
- Dermatophytosis: fungal infections of skin, scalp and nails (tinea)
Preparation
- Tablets of 125 mg and 500 mg
Dosage
- Child : 10 mg/kg/d divided in 2 doses
- Adult : 500 mg to 1
g/d divided in 2 doses
For scalp infection, there is a single dose treatment
- Child and adult :1.5 g in a single dose (3 tabs of 500 mg or 12 tabs of 125 mg). In this case, the administration of a spoonful of oil improves the effectiveness of the treatment.
FIGURE
Duration - Depending on clinical progress, minimum 10 days. Often needs to be extended over 1 month.
Contra-indications, side-effects, precautions
- Do not administer in cases of liver failure.
- May cause:
frequent vomiting, diarrhea, stomach-ache, headache, dizziness, skin allergy and
photosensitization, especially with the single dose treatment.
- Do not drink
alcohol during treatment.
- Pregnancy: CONTRA-INDICATED
- Lactation:
CONTRA-INDICATED
Remarks
- Use gentian violet to dry the lesions.
- Has no effect on
candidiasis or pityriasis versicolor.
- Storage: no special temperature
requirements.
HALOFANTRINE (Halfan(R).)
The use of this drug is not advised:
- it is potentially dangerous; these severe adverse effects
concerning the cardiac conductions are unforeseable even if an ECG has been done
previously;
- it is not included in the WHO essential drug list;
- it is
expensive.
Therapeutic action
- Antimalarial
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Curative treatment of a malaria attack with Plasmodium falciparum resistant to chloroquine.
Preparation
- Tablet of 250 mg
- Oral suspension 45 ml to 20 mg/ml (1
measuring spoon=1 m.s. = 5 ml = 100 mg)
Dosage
- Child and adult: 24 mg/kg divided in 3 doses to be taken every
6 hours
- Do not exceed indicated doses
FIGURE
Duration: 3 doses, taken every 6 hours
Contra-indications, side-effects, precautions
- Do not administer in case of congenital or acquired prolonged
QT interval of the electrocardiogram.
- Avoid in case of severe electrolytic
disorders and in thiamin (vitamin B1) deficiency.
- Do not associate with
drugs predisposing to the occurrence of "torsades de pointes": antiarrhythmic
drugs (quinidine, disopyramide, sotalol), drugs inducing hypokaliemia
(diuretics, glucocorticoids).
- May induce arrhythmias: prolongation of QT
interval and severe, eventually fatal, ventricular arrhythmias ("torsades de
pointes").
- May cause diarrhoea (occasionally), abdominal pain, nausea and
vomiting.
- Do an ECG before giving the treatment in case of history of
unexplained syncope or malaise.
- Pregnancy: CONTRA-INDICATED
- Lactancy:
CONTRA-INDICATED
Remarks
- Administer away from the meals.
- The QT prolongation is
more marqued in case of recent treatment with mefloquine.
- Do not use as a
preventive treatment because of rapid elimination.
- If the patient has not
had a previous malaria attack repeat the treatment after one week.
- Since
this treatment is expensive, and to avoid emergence of resistant strains, use,
instead sulfadoxine-pyrimethamine or quinine if possible, depending on the local
situation and protocol.
- Storage:
HYDRALAZINE (Apresoline(R).) and DIHYDRALAZINE (Nepressol(R).)
District hospital
Therapeutic action
- Antihypertensive drug with vasodilatory action
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Moderate or severe arterial hypertension when thiazide diuretics or beta-blockers on their own are ineffective
Preparation
- Tablets of 25 mg and 50 mg
Dosage
- Initial dose: adult: 25 to 50 mg/d divided in 2 or 3
doses
- Raise the dose progressively over 2 weeks until the optimal dose of
100 mg/d in 2 or 3 doses is reached.
- When the hypertension is under
control, decrease the dose progressively. Stopping suddenly can provoke a
hypertensive crisis.
- Do not exceed indicated doses. Maximum dose : 200
mg/d.
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer in cases of coronary insufficiency or a
recent myocardial infarction.
- Administer with care to elderly patients or
those with a history of cerebrovascular accidents.
- Tachycardia reflex,
headache.
- Pregnancy: no contra-indication
- Lactation: no
contra-indication
Remarks
- Hydralazine and dihydralazine are used for the same
indications at the same dosage.
- Storage: keep below 30°C
HYDROCHLOROTHIAZIDE (Dochlotride(R), Esidrex(R), HydroSaluric(R).)
District hospital
Therapeutic action
- Diuretic
Indications
- Moderate or severe arterial hypertension
- Oedema caused by
renal, heart or liver failure, DIAGNOSED BY A DOCTOR
Preparation
- Tablet of 50 mg
There are also tablets of 25 mg. Adapt dosage accordingly.
Dosage
- dema
· Child : 1 mg/kg/d divided in 2 doses
· Adult: 50
to 100 mg in the morning, every 2 days
- Hypertension
· Adult: 25 to 50 mg/d divided in 2 doses
FIGURE
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer in cases of severe renal failure, allergy to
sulfonamides or kwashiorkor oedema.
- May cause: orthostatic hypotension,
photosensitization, disturbance of electrolytes, skin allergies.
- Pregnancy:
CONTRA-INDICATED
- Lactation: CONTRA-INDICATED
Remarks
- Often used in association with other antihypertensive
drugs.
- A lot of fruit should be eaten during the treatment (dates, bananas,
tomatoes, mangos, oranges.), in order to supply additional potassium. Use
potassium tablets as well if available.
- Storage: no special temperature
requirements
IBUPROFEN (Brufen(R), Fenbid(R), Motrin(R).)
District hospital
Therapeutic action
- Non-steroidal anti-inflammatory
- Analgesic, antipyretic
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISlON
- Rheumatic diseases
Preparation
- Tablets of 200 mg and 400 mg
Dosage
- Adult: 1200 mg/d divided in 3 doses
- A dose of 2400 mg/d
may be used at the beginning of treatment of rheumatoid arthritis.
FIGURE
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer in cases of gastroduodenal ulcer and severe
renal or liver failure.
- Do not prescribe for children.
- May cause:
gastrointestinal problems, allergic reactions.
- Do not combine with other
anti-inflammatory drugs (aspirin, indometacin).
- Use with care for
infectious diseases: can mask the usual symptoms of the infection.
-
Pregnancy: CONTRA-INDICATED
- Lactation: CONTRA-INDICATED
Remarks
- Take with meals.
- Ibuprofen has less anti-inflammatory
activity than indometacin, but is better tolerated in the long term.
- Only
prescribe for severe cases which do not improve by ASA (aspirin).
- Storage:
no special precautions
INDOMETACIN (Artracin(R), Indocid(R).)
District hospital
Therapeutic action
- Non-steroidal anti-inflammatory drug
- Analgesic,
antipyretic
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Rheumatic diseases
- Gout
Preparation
- Tablet of 25 mg
Dosage
- Adult :50 to 150 mg/d divided in 3 doses
FIGURE
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer in cases of:
· gastroduodenal ulcer,
· severe renal or hepatic
failure,
· asthma.
- Do not prescribe for children.
- May cause: headache,
dizziness, digestive problems, gastric ulcer.
- Use with care for elderly
patients.
- Do not combine with ASA (aspirin) and corticosteroids.
-
Pregnancy :avoid
- Lactation :avoid
Remarks
- Take with meals.
- Only prescribe for severe cases which
are not improving with ASA (aspirin).
- Storage: no special temperature
requirements.
ISONIAZID = INH (Rimifon(R).)
Special department
Therapeutic action
- "Antituberculous" antibacterial
Indications
- Only for tuberculosis, bacteriologically proven if possible
Preparation
- Tablets of 100 mg, 150 mg and 300 mg
There are also tablets of isoniazide + rifampicine.
Dosage
According to national protocol.
For information:
- Child: 10 to 20 mg/kg/d once daily
- Adult: 5 mg/kg/d once
daily
FIGURE
Duration: according to national protocol
Contra-indications, side-effects, precautions
- Do not administer in cases of liver failure or epilepsy.
-
Do not combine with niridazole: severe mental problems.
- If the patient
complains about a prickling feeling in the fingers and toes, or presents signs
of liver intoxication (jaundice), stop the treatment and refer to a doctor.
-
To avoid polyneuritis, give vitamin B6 with this treatment :10 to 25 mg/d.
-
Pregnancy: no contra-indication
- Lactation: no contra-indication
Remarks
- Take in the morning before eating.
- Warning:
antituberculous treatment should only be prescribed in the context of an
organised program (well established protocol, regular patient checks and the
possibility of laboratory examination).
- Isoniazid should not be used alone,
but in combination with other "antituberculous" drugs to avoid development of
resistance.
- Storage: no special temperature requirements
ISONIAZID + THIACETAZONE = INH + THIACETAZONE (Thiazine(R).)
Special department
Therapeutic action
- Combination of two "antituberculous" antibacterial drugs
Indications
- Only for tuberculosis, bacteriologically proven if possible
Preparation
- Tablets of 100 mg INH + 50 mg thiacetazone and 300 mg INH + 150 mg thiacetazone
Dosage
According to national protocol.
For information:
- Child: 10 to 20 mg/kg/d INH + 50 to 100 mg/d thiacetazone,
once daily
- Adult: 5 mg/kg/d INH + 150 mg/d thiacetazone, once daily
FIGURE
Duration: according to national protocol.
Contra-indications, side-effects, precautions
- Do not administer in cases of liver failure or epilepsy.
-
Do not combine with niridazole: severe mental problems.
- If the patient
complains about a prickling feeling in the fingers and toes, or presents signs
of liver intoxication (jaundice), stop the treatment and refer to a doctor.
-
In case of intolerance to thiacetazone: skin reactions, haematological
disorders, signs of haemolysis, reduction of polynuclear cells or cerebral
oedema, stop treatment and refer to a doctor, even if reaction is only
moderate.
- If available, give vitamin B6 with this treatment :10 to 25
mg/d.
- Pregnancy: no contra-indication
- Lactation: no contra-indication
Remarks
- Take in the morning before eating.
- Warning:
antituberculous treatment should only be prescribed in the context of an
organised program (well established protocol, regular patient checks and the
possibility of laboratory examination).
- Intolerance to thiacetazone varies
genetically, and is notably more common in Asia.
- Warning: thiacetazone is
not vitamin B1.
- At the beginning of treatment, INH + thiacetazone should be
accompanied by another "antituberculous" drug.
- Storage: no special
temperature requirements.
IVERMECTIN (Mectizan(R).)
Special department
Therapeutic action
- Antifilaria
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Onchocerciasis with O. volvulus
Preparation
- Divisible tablet of 6 mg
Dosage
- Child and adult :150 to 200 microgrammes/kg (= 0.200 mg/kg), single dose, to be taken on an empty stomach
FIGURE
Duration: single dose
Contra-indications, side-effects, precautions
- Do not administer to children under 5 years.
- May cause
passing allergic reactions: pruritus, lymphangitis, fever, dema,
tachycardia, drowsiness.
- Mild, passing digestive problems.
- Benign
ophthalmic effects.
- Do not eat within 2 hours after taking the
medicine.
- Pregnancy: avoid during first trimester
- Lactation: avoid
until the breastfed infant is 3 months of age.
Remarks
- Ivermectin is much better tolerated than diethylcarbamazine in
the treatment of onchocerciasis.
- Ivermectin is given free of charge by the
manufacturer as part of the campaign against onchocerciasis.
- Storage: no
special precaution
LEVAMISOLE (Tramisol(R).)
Health clinic
Therapeutic action
- Anthelminthic
Indications
- Ascariasis
- Hookworm (ankylostomiasis)
Preparation
- Tablet of 40 mg and 150 mg levamisole (base)
Dosage
Child and adult: 2.5 mg/kg
FIGURE
Duration
- Ascariasis : single dose
- Hookworm: repeat treatment after
7 days
Contra-indications, side-effects, precautions
- May cause: nausea, vomiting.
- Pregnancy: no
contra-indication
- Lactation: no contra-indication
Remarks
- Effectiveness in treatment of hookworm is 75 to 95%.
-
Advice on sanitation should be given with the treatment.
- Storage: no
special precautions
LOPERAMIDE (Imodium(R), Inosec(R).)
District hospital
Therapeutic action
- Antidiarrhoeal
Indications
- Symptomatic treatment of persistent diarrhoeas, primarily for adults with AIDS, with rehydration.
Preparation
- Capsule of 2 mg
Dosage
- Adult: 2 cap at once, then 1 cap 1 to 3 times per day
-
Maximum dosage :8 cap/d
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer to children.
- Risk of constipation.
-
Pregnancy: no contra-indication
- Lactation: no contra-indication
Remarks
- The classical treatment of diarrhoea is based on oral
rehydration. It is also possible to associate a treatment with traditional herbs
(for example infusions of guava leaves.). Loperamide is necessary only for
AIDS-patients.
- Storage: keep below 30°C
MEBENDAZOLE (Vermox(R).)
Health post
Therapeutic action
- Anthelminthic
Indications
- Hookworm (ankylostomiasis)
- Ascariasis
- Enterobiasis
(pinworm)
- (Tapeworms and strongyloidiasis: second choice)
Preparation
- Tablet of 100 mg
There are also tablets of 500 mg. Adapt dosage accordingly.
Dosage
- Child above 2 years and adult
· Hookworm : 200 mg/d divided in 2 doses for 3
days
· Ascariasis : 500 mg in a single dose
· Enterobiasis 100
mg in a single dose, repeat after 2 or 3 weeks
FIGURE
Duration
- Hookworm : 3 days
- Ascariasis : single dose
-
Enterobiasis: single dose, repeat treatment after 2 or 3 weeks
Contra-indications, side-effects, precautions
- Do not administer to children under 2 years.
- Pregnancy:
avoid (in most cases, the treatment can wait until the end of the
pregnancy)
- Lactation: no contra-indication
Remarks
- In cases of endemic hookworm, it is recommended to prescribe
at the same time an antianaemic treatment with ferrous sulphate (if possible
combined with folic acid).
- For the systematic elimination of parasites, a
single dose scheme of 600 mg can be used.
- Flubendazole has the same
indications and dosage.
- Albendazole (Zentel(R)) has the same indications
and dosage as mebendazole: 400 mg (2 tab of 200 mg), single dose.
- Advice on
sanitation should be given with the treatment.
- Storage: no special
precautions
MEFLOQUINE (Lariam(R).)
District hospital
Therapeutic action
- Antimalarial
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Curative treatment of a malaria attack with Plasmodium falciparum resistant to chloroquine.
Preparation
- Divisible tablet of 250 mg
- Tablet of 50 mg
FIGURE
Dosage
- Curative treatment :25 mg/kg (person with no immunity)
-
Preventive treatment for travellers with no immunity in areas with resistance to
chloroquine: 4 mg/kg/week
A weekly dose is necessary: start 1 week before departure and continue for one month after return. Do not take during more than 15 weeks.
Contra-indications, side-effects, precautions
- Not advised for children under 15 kg.
- Digestive problems,
dizziness, headache.
- May cause neuropsychopathic problems at curative
dosage.
- Bedrest under medical supervision for 24 hours after
treatment.
- Do not use at the same time as quinine.
- Pregnancy:
CONTRA-INDICATED
- Lactation: avoid
Remarks
- Because of the secondary reactions, the cost of the treatment,
and to avoid the spread of resistance, treatment with mefloquine is prescribed
as a last resort. Use, instead, sulfadoxine-pyrimethamine or quinine, depending
on the local situation and protocol.
- Storage: keep below 30°C
METAMIZOL = DIPYRONE = NORAMIDOPYRINE (Nolotil(R), Novalgin(R), Novaminsulfon(R).)
The use of this drug is not advised:
- it is potentially dangerous;
- it is not included in the
WHO essential drug list;
- its marketing is forbidden in several
countries;
- its use is never justified as a first-line treatment.
Therapeutic action
- Analgesic
- Antipyretic
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Severe pains
- High fever
Preparation
- Tablet of 500 mg
Dosage
- Child (above 5 years): 250 mg to 1 g/d divided in 3 doses
-
Adult: 500 mg to 3 g/d divided in 3 doses
FIGURE
Duration: depending on clinical progress, 1 to 3 days
Contra-indications, side-effects, precautions
- Do not administer in cases of gastric ulcer.
- Severe and
lethal cases of agranulocytosis have been found. Use only when other
antipyretics and analgesics (e.g. acetyl salicylic acid and paracetamol) are not
effective.
- Pregnancy: avoid
- Lactation: avoid
Remarks
- Storage: no special precautions
METHYLDOPA (Aldomet(R), Medomet(R).)
District hospital
Therapeutic action
- Central acting antihypertensive drug without a diuretic effect
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Arterial hypertension if no improvement is seen using only diuretics or if beta-blockers are contra-indicated
Preparation
- Tablet of 250 mg
Dosage
- Child: 10 mg/kg/d divided in 3 doses
- Adult: 750 mg/d
divided in 3 doses; may be increased progressively up to 1,500 mg/d
- Maximum
dosage :2.5 g/d (10 tab)
FIGURE
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer in cases of:
· angina pectoris,
· renal or liver
failure,
· depression.
- May cause: orthostatic hypotension, dry mouth, sedation,
mental or hormonal problems.
- Don't stop the treatment suddenly; reduce the
daily doses progressively.
- Pregnancy: no contra-indication
- Lactation:
avoid
Remarks
- Storage: keep below 30°C
METOCLOPRAMIDE (Anausin(R), Maxolon(R), Primperan(R), Reglan(R).)
District hospital
Therapeutic action
- Anti-emetic
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Vomiting
- Nausea
- Hiccups
Preparation
- Tablet of 10 mg
Dosage
- Newborn: 0.5 mg/kg/d divided in 3 doses
- Child : 0.3 to
0.4 mg/kg/d divided in 3 doses
- Adult : 5 to 10 mg/kg/d divided in 3 doses
FIGURE
Duration: depending on clinical progress, as short as possible
Contra-indications, side-effects, precautions
- Contra-indicated in case of haemorrhage, gastro-intestinal
obstruction or perforation.
- When elevated doses are given or when
treatments are prolonged, extrapyramidal disorder can occur (agitation and
spasms), specially in young patients.
- Increased risk of crisis with
epileptics and those suffering from Parkinson's disease.
- Reversible
methaemoglobinemia in newborns.
- Association with propantheline, hyoscine,
atropine and chlorpromazine is not advised.
- Risk of drowsiness.
-
Pregnancy: no contra-indication
- Lactation: avoid
Remarks
- It is most important to treat the cause of vomiting; look for
bowel obstruction or malaria.
- Storage: keep below 30°C
METRIFONATE (Bilarcil(R))
Special department
Therapeutic action
- Schistosomicide
Indications
- Urinary bilharzia (Schistosoma haematobium)
Preparation
- Tablet of 100 mg
Dosage
- Child : 10 mg/kg in a single dose
- Adult: 400 mg in a
single dose; if the weight of the patient is known, adapt dosage (10 mg/kg)
-
Do not exceed indicated doses.
FIGURE
Duration: single dose
Contra-indications, side-effects, precautions
- Risk of overdose: abdominal cramps, bronchospasms, sweating,
salivation. In this case, inject an ampoule of atropine SC or inject slowly
intravenously.
- Pregnancy: avoid (in most cases the treatment can wait until
the end of the pregnancy)
- Lactation: avoid
Remarks
- Repeat treatment after 15 days if the patient leaves the
endemic area.
- This drug should be preferred to niridazole (Ambilhar(R)).
Niridazole is more expensive and less well tolerated.
- In an endemic area,
antibilharzia treatment will only be effective if preventive measures exist to
avoid continuous reinfection.
- Advice on sanitation should be given with the
treatment.
- Storage: keep below 30°C
METRONIDAZOLE (Flagyl(R)), Metrolyl(R), Zadstat(R).)
Health clinic
Therapeutic action
- Anti-protozoal, antibacterial
Indications
- Amoebiasis, trichomoniasis, giardiasis (= lambliasis)
-
Certain anaerobic infections (Bacteroides fragilis, Clostridium perfringens)
Preparation
- Tablet of 250 mg
There are also tablets of 200 mg. Adapt dosage accordingly.
Dosage
- Amoebic dysentery:
Child: 30 to 50 mg/kg/d divided in 3 doses
Adult: 1.5 g/d
divided in 3 doses
- Giardiasis:
Child : 15 mg/kg/d divided in 3 doses
Adult: 750 mg/d divided
in 3 doses
- Trichomoniasis :
Adult: 2 g in a single dose
- Metronidazole can be used as an antibiotic, under medical supervision, with the same dose used for amoebiasis treatment and combined with penicillin or ampicillin for 6 to 10 days.
FIGURE
Duration
- Amoebic dysentery: 7 days
- Giardiasis : 7 days; repeat
treatment after one week
- Trichomoniasis : single dose
Contra-indications, side-effects, precautions
- May cause digestive problems.
- Do not drink alcohol during
treatment.
- Pregnancy: a teratogenic effect is not proven, Metronidazole
treatment is possible in pregnant woman and it is justified to treat amoebiasis
with clinical signs. Nevertheless, try to avoid in the first trimester of
pregnancy.
- Lactation: avoid (passes into the breast milk)
Remarks
- In case of trichomoniasis, the partner has to receive oral
treatment as well.
- The metronidazole pessaries are not recommended for
vaginal trichomoniasis. Treatment should be oral.
- The mere presence of
amoeba cysts in the stools is not a sufficient reason to administer
metronidazole.
- In mass-treatment of amoebiasis, single dose treatment can
be used:
· child: 4 tab from 5 to 15 years; 2 tabs from 1 to 5
years; 1 tab from 1 month to 1 year
· adult: 8 tab (in case of vomiting,
give in 2 doses/day)
- Storage: keep below 30°C
MULTIVITAMINS VITAMIN B COMPLEX
Health post
Therapeutic action
- Vitamin supplement
Indications
- Only a few indications: this drug has no effect in cases of real vitamin deficiency, but it will help prevent deficiency in people at risk (pregnant women, malnourished persons).
Preparation
- Tablet and syrup
Composition of tablets varies in quality and quantity, depending on the manufacturer.
Example of composition per tablet(1):
|
Multivitamins |
B complex |
Daily needs - adult |
Vitamin A |
2.500 IU |
/ |
2.500 IU |
Vitamin B1 |
1 mg |
2 mg |
0.9 to 1.3 mg |
Vitamin B2 |
0.5 mg |
1 mg |
1.5 to 1.8 mg |
Vitamin B3 (= PP) |
7.5 mg |
15 mg |
1.5 to 20 mg |
Vitamin C |
15 mg |
/ |
10 mg |
Vitamin D3 |
300 IU |
/ |
100 to 200 IU |
(1) IDA catalogue, 1991
Dosage
- Child and adult: see table below
FIGURE
Duration: depending on situation
Contra-indications, side-effects, precautions
- Pregnancy: no contra-indicafion
- Lactation: no
contra-indication
Remarks
- This drug has no impact on sexual activity.
- Multivitamins
can be used as a placebo as they are both safe and inexpensive. Their
composition is generally similar to the preventive treatment of avitaminoses and
has no contra-indication.
- It is not included in the WHO Essential drug
list.
- Storage: keep cool if posible.
NICLOSAMIDE (Tredemine(R), Yomesan(R).)
Health clinic
Therapeutic action
- Anthelminthic
Indications
- Tapeworms: Taenia saginata (beef), Taenia solium (pork), Hymenolepsis nana
Preparation
- Tablet of 500 mg
Dosage
- Taenia saginata and Taenia solium
· Child: 30 mg/kg in a single dose, on an empty
stomach
· Adult: 2 g in a single dose, on an empty stomach
- Hymenolepsis nana
· Child: 30 mg/kg once daily for 5 days
· Adult: 2
g once daily the first day, then 1 g/d for 6 days
FIGURE
Duration
- Taenia saginata and Taenia solium: single dose
-
Hymenolepsis nana : 7 days
Contra-indications, side-effects, precautions
- Frequent digestive problems (stomach pain).
- Pregnancy: no
contra-indication
- Lactation: no contra-indication
Remarks
- The evening before, take a liquid meal. Take the drug in the
morning before eating. CHEW THE TABLETS WELL. WAIT TWO HOURS BEFORE TAKING
FOOD.
- In case of vomiting, the single dose treatment should be split into
two doses, taken with an interval of one hour.
- Niclosamide kills the worm.
You do not have to wait to see the worm complete in the stools because it is
killed and partially digested.
- Advice on sanitation should be given with
the treatment.
- Storage: no special temperature requirements.
NITROFURANTOIN (Furandantin(R), Urantoin(R).)
District hospital
Therapeutic action
- Antibacterial
Indications
- Infections without complications of the lower urinary tract (without fever or lumbar pain).
Do not confuse with gonorrhea (urethral discharge in the morning)
Preparation
- Tablets of 50 mg and 100 mg
Dosage
- Child (above one year): 5 mg/kg/d divided in 3 doses
-
Adult: 300 mg/d divided in 3 doses
FIGURE
Duration: minimum 10 days
Contra-indications, side-effects, precautions
- Do not administer to children under 1 year.
- Do not
administer in cases of renal failure.
- Dizziness can be a side-effect: stop
treatment immediately and refer to a doctor.
- Do not drink alcohol during
the treatment.
- Pregnancy: CONTRA-INDICATED at the end of the pregnancy
-
Lactation :avoid
Remarks
- If possible, take with meals.
- Cotrimoxazole is generally
more active in cases of urinary infections.
- Storage: no special temperature
requirements.
NOSCAPINE
District hospital
Therapeutic action
- Antitussive
Indications
- Dry cough
Preparation
- Tablet of 15 mg
- Syrup of 15 mg/5 ml = 1 teaspoon
Dosage
- Child (above 30 months): 4 mg/kg/d divided in 3 doses
-
Adult :45 to 90 mg/d divided in 3 doses
- Do not exceed indicated doses.
FIGURE
Duration: maximum 5 days
Contra-indications, side-effects, precautions
- Do not administer in cases of productive cough (sputum).
-
Avoid using in children under 30 months.
- May cause: headache,
constipation.
- Pregnancy:avoid
- Lactation: avoid
Remarks
- Using traditional anti-cough plants in the form of an infusion
or syrup is often recommended.
- Codeine is a similar product with the same
indications, but taken in smaller doses.
- Storage: no special precautions.
NYSTATIN (Mycostatin(R), Nystan(R).)
District hospital
Therapeutic action
- Antifungal: candidiasis
Indications
- Digestive candidiasis
- Candidiasis of the mucosa of the
mouth and vagina
Preparation
- Tablet of 100,000 IU; for oral and gynaecological use
There are also tablets of 500,000 IU. Adapt dosage accordingly.
Dosage
- Digestive candidiasis Child and adult :4 to 5 tab/d to be
sucked
- Candidiasis of the mouth. Child and adult: 1 to 2 tab/d to be sucked
or put in the mouth after being crushed
- Vaginal candidiasis. Adult: 1 to 2
tab/d (wet the tablet before introducing it into the vagina)
Duration
- Candidiasis of the mouth: 8 to 10 days
- Vaginal
candidiasis : 10 to 20 days
Contra-indications, side-effects, precautions
- The drug is well tolerated.
- Pregnancy: no
contra-indication
- Lactation: no contra-indication
Remarks
- Has no effect on other types of fungi.
- Oral candidiasis
can also be treated with the application of gentian violet or mouth washes with
a base of lemon juice or sodium bicarbonate.
- THE GYNAECOLOGICAL TABLETS CAN
ALSO BE USED FOR TREATMENT OF ORAL CANDIDIASIS.
- The tablets of 500,000 IU
are meant to be swallowed (candidiasis of the digestive tube), but they can be
sucked in case of oral candidiasis.
- For vaginal candidiasis, administer
orally at the same time as vaginal applications. Do not interrupt treatment
during menstruation. Sexual activity is not a contra-indication.
- Storage:
keep below 30°C.
ORAL REHYDRATION SALT = ORS (Oralit(R).)
Health post
Therapeutic action
- Provide salts and sugar
Indications
- Prevention and treatment of dehydration in case of diarrhoea and/or vomiting
Preparation
- Sachet of powder to be diluted in one litre of clean, cooled boiled water
Composition:
· sodium chloride (NaCl) 3.5 g
· potassium chloride
(KCl) 1.5 g total = 27.9 g
· trisodium citrate 2.9 g
· glucose
(dextrose) 20.0 g
Dosage
According to national protocol.
For information:
- Child : 1 to 2 sachets/d given during the whole day = 1 to 2
litres
- Adult: 3 to 4 sachets/d given during the whole day = 3 to 4
litres
- Do not exceed indicated doses.
FIGURE
Duration: as long as the diarrhoea and signs of dehydration continue
Contra-indications, side-effects, precautions
- If oedema develops, reduce the quantities.
- In case of
vomiting, give the liquid frequently in very small amounts; do not stop the
rehydration.
- Pregnancy: no contra-indication
- Lactation: no
contra-indication
Remarks
- If the child cannot swallow, use a (naso-) gastric tube if
necessary.
- Signs of improvement: the patient begins to urinate again.
-
When the patient improves, you can give ORS and clean water alternately.
- If
no ORS is available, you can use a sugar and salt solution: 2 pinches of salt (3
g), 4 tablespoons of sugar (40 go), added to some fruit juice, diluted in one
litre of clean, cooled boiled water.
- Storage: no special temperature
requirements. Do not use the powder if it has turned into a yellow-brown sticky
substance.
ONCE MADE UP, THE SOLUTION MUST BE USED THE SAME DAY.
OXAMNIQUINE (Mansil(R), Vansil(R).)
Special department
Therapeutic action
- Schistosomicide
Indications
- Intestinal bilharzia (Schistosomia mansoni)
Preparation
- Tablet of 250 mg
Dosage
- Child : 20 to 40 mg/kg in a single dose
- Adult: 1 g in a
single dose
FIGURE
Duration: single dose
Contra-indications, side-effects, precautions
- Do not administer in cases of renal or heart failure, or
epilepsy.
- May cause: nausea, some dizziness, drowsiness, headache.
-
Colours the urine red.
- Pregnancy: avoid (in most cases, treatment can wait
until the end of the pregnancy)
- Lactation: avoid
Remarks
- Take with evening meal to avoid side-effects.
- Treatment
with praziquantel, which is just as effective and well tolerated, and 3 times as
cheap (IDA 1991).
- This drug is less dangerous than niridazole
(Ambilhar(R)).
- The impact of the antibilharziosis treatment will be
negligible if there are no parallel preventive measures to avoid the recurrence
of the disease in endemic areas.
- Advice on sanitation should be given with
the treatment.
- Storage: no special precautions
PARACETAMOL=ACETAMINOPHEN (Doliprane(R), Panadol(R), Tylenol(R).)
Health post
Therapeutic action
- Analgesic
- Antipyretic
Indications
- Headache, toothache or joint pain
- Fever
Preparation
- Tablets of 100 mg and 500 mg
Dosage
- Child : 20 to 30 mg/kg/d divided in 3 doses
- Adult: 2 to 3
g/d divided in 3 doses
FIGURE
Maximum doses: |
Child: 50 mg/kg/d |
|
Adult: 4 g/d |
Duration
- Depending on clinical progress, 1 to 3 days.
- Do not
continue treatment for an extended period without medical advice.
Contra-indications, side-effects, precautions
- Do not administer in cases of liver disease (hepatitis) or
alcoholism.
- Pregnancy: no contra-indication
- Lactation: no
contra-indication
Remarks
- Paracetamol is recommended for patients who are allergic to
A.S.A. (aspirin), those with stomach problems and for children under one
year.
- IT HAS NO ANTI-INFLAMMATORY PROPERTIES.
- Storage: keep below
30°C.
PHENOBARBITONE = PHENOBARBITAL (Gardenal(R), Luminal(R).)
District hospital
Therapeutic action
- Anticonvulsive, sedative and hypnotic
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Epilepsy: tonic-clonic ("grand mal") and partial (focal) seizures
Preparation
- Tablets of 30 mg, 50 mg and 100 mg
Dosage
According to national protocol.
For information:
- Child : 3 to 5 mg/kg/d once daily or divided in 2 to 3
doses
- Adult: 150 to 200 mg/d once daily or divided in 2 to 3 doses
FIGURE
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer in cases of respiratory depression or
porphyria.
- Risk of drowsiness and depression of the central nervous
system.
- Do not stop the treatment suddenly.
- Risk of sedation when
combined with alcohol and other drugs that act on the central nervous system:
diazepam (Valium(R), chlorpheniramine (Teldvin(R)) and chlorpromazine
(Largactil(R)).
- Pregnancy:avoid
- Lactation: avoid
Remarks
- For convulsions, in cases of extreme agitation and in
emergencies, it is better to use diazepam (Valium(R)).
-
Plasma-concentrations are stable after 2 to 3 weeks. Beware of
accumulation.
- If necessary, a treatment with phenytoin may be used with
this treatment.
- Storage: no special precautions.
PHENOXYMETHYL PENICILLIN=PENICILLIN V (Crystapen V(R), Stabillin V-K(R), V-Cil-K(R).)
Health clinic
Therapeutic action
- Antibacterial (antibiotic)
Indications
- Tonsillitis
- Pneumopathy
- Dental abscess
-
Extensive impetigo with or without general signs
Preparation
- Tablets of 125 mg (200,000 IU) and 250 mg (400,000 IU)
-
Syrup of 125 mg/5 ml (200,000 IU/5 ml) = 1 teaspoon (1 tsp)
There are also other presentations and strengths. Adapt dosage accordingly.
Dosage
- Child: 150,000 IU/kg/d divided in 3 doses
- Adult: 1.5 to 3
MIU/d divided in 3 doses
4 doses/day are more effective, but to ensure that the treatment is likely to be followed correctly, we recommend 3 doses/day.
FIGURE
Duration :5 to 8 days
Contra-indications, side-effects, precautions
- Do not administer in cases of known allergy to
penicillin.
- If allergic reactions: stop treatment and refer to a
doctor.
- Do not combine with other antibiotics.
- Pregnancy: no
contra-indication
- Lactation: no contra-indication
Remarks
- Do not use orally in case of:
· meningitis or gonorrhoea (use injections of procaine
penicillin or PPF);
· syphilis (use injections of benzathine
penicillin).
- Storage: keep below 30°C.
Once prepared, the syrup must be kept cool and will only last for one week.
PHENYLBUTAZONE (Butazolidin(R).)
The use of this drug is not advised:
- it is potentially dangerous;
- it is not included in the
WHO essential drug list;
- its marketing is forbidden in several countries.
Therapeutic action
- Non steroidal anti-inflammatory
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Ankylosing spondilitis, gout, resistant to other anti-inflammatory drugs
Preparation
- Tablet of 200 mg
Dosage
- Adult: 300 to 600 ma/d divided in 3 doses
FIGURE
Duration: as short as possible, depending on clinical progress
Contra-indications, side-efects, precautions
- Do not administer in case of:
· peptic ulcer,
· liver failure,
· known
allergy to phenylbutazone.
- Risk of severe sometimes fatal agranulocytosis.
- Should
only be used as an analgesic if all other analgesics are ineffective.
- Do
not combine with anticoagulants, digitalis, phenytoin or other anti-inflammatory
drugs (including aspirin).
- Pregnancy: avoid
- Lactation: avoid
Remarks
- Take with meals.
- Storage: keep below 30°C
PHENYTOIN (Di-hydan(R), Dilantin(R), Epanutin(R).)
District hospital
Therapeutic action
- Anticonvulsive
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Epilepsy, except absence seizure (petit mal)
Preparation
- Tablet of 100 mg
There are also tablets of 25 mg and 50 mg. Adapt the dosage accordingly.
Dosage
- Child : 3 to 8 mg/kg/d divided in 2 or 3 doses
- Adult: 2
to 6 mg/kg/d divided in 2 or 3 doses
FIGURE
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer in case of known allergy.
- Risk of
digestive problems: gingival hypertrophy, nausea, vomiting.
- If prolonged
usage, risk of haematologic problems. Monitor peripheric blood count if possible
and administer folic acid.
- Risk of neurological problems: dizziness, visual
problems, mental confusion.
- Allergic reactions: cutaneous eruptions, fever,
adenopathy.
- Pregnancy: avoid
- Lactation: avoid
Remarks
- It is not advised to associate phenytoin with oral
contraceptives, sulfamides, or chloramphenicol. Combination with other drugs
must be closely monitored (diazepam, phenobarbital, barbiturates, digoxin,
corticosteroids.).
- Storage: keep below 30°C.
Never use expired phenytoin (risk of under dosage).
PIPERAZINE (Antepar(R), Pripsen(R).)
District hospital
Therapeutic action
- Anthelminthic
Indications
- Ascariasis
- Enterobiasis (pinworm)
Preparation
- Tablets of 300 mg and 500 mg
- Syrup of 750 mg/5 ml = 1
teaspoon
Dosage (expressed in piperazine hydrate)
- Ascariasis : Child: 75 mg/kg, in a single dose Adult :3 to 4
g, in a single dose
- Enterobiasis: Child: 50 mg/kg/d for 5 days Adult: 3 to
4 g/d for 5 days
- Do not exceed indicated doses.
FIGURE
Duration
- Ascariasis : single dose
- Enterobiasis: 1 course of 5 days
Contra-indications, side-effects, precautions
- Do not administer in case of epilepsy, renal or liver
failure.
- Risk of overdose and neurological toxicity: dizziness, problems of
vision and/or consciousness.
- Pregnancy: no contra-indication
-
Lactation: no contra-indication
Remarks
- This drug is still frequently used but considering its
ineffectiveness on hookworm and its side-effects, it is often replaced by more
broad-spectrum anthelmintic drugs (mebendazole), which are more effective for
general deworming.
- 100 mg piperazine hydrate = 120 mg adipate = 125 mg
citrata = 104 mg phosphate.
- Advice on sanitation should be given with the
treatment.
- Storage: no special temperature requirements.
POTASSIUM Chloride
District hospital
Therapeutic action
- Potassium supplement
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Hypokalemia:
· following diuretic treatment with thiazides
· of
other origin (dehydration.)
Preparation
- Tablet of 8 mmol (mEq) of K+ = 600 mg
- Tablet of 6.7 mmol
(mEq) of K+ = 500 mg
WARNING, DOSES VARY DEPENDING ON SUPPLIER. Adapt dosage accordingly.
Dosage
- Adult: 7 to 15 mmol/d or 0.5 to 1 g/d
- Do not exceed
indicated doses.
- Use slow release tablets.
FIGURE
Duration: depending on clinical progress and duration of diuretic treatment
Contra-indications, side-effects, precautions
- May cause: nausea, vomiting.
- Risk of intestinal ulcers
and heartburn, in particular when using quick dissolving tablets.
- Do not
combine with spironolactone and other similar diuretics.
- Pregnancy: no
contra-indication
- Lactation: no contra-indication
Remarks
- If tablets are not available, a lack of potassium can be
corrected by a diet rich in dates, bananas, mangos, oranges, tomatoes.
- One
ORS sachet contains 1,5 g of potassium chloride.
- Storage:
PRAZIQUANTEL (Biltricide(R).)
Special department
Therapeutic action
- Schistosomicide, also active on distomiasis
Indications
- Bilharziasis:
· S. haematobium (urinary bilharzia)
· S. mansoni
and S. intercalatum (intestinal bilharzia)
· S. japonicum and S. mekongi
(hepato-splenic bilharzia)
- Distomiasis: Opisturchis felinus, Clonorchis sinensis, Paragonimum westermani, Fasciola hepatica
Preparation
- Tablet of 600 mg
Dosage
- Bilharziasis S. haematobium, S. mansoni, S.
intercalatum
Child and adult :40 mg/kg in a single dose
- Bilharziasis S.
japonicum, S. mekongi
Child and adult :60 mg/kg divided in 3 doses in 1
day
- Distomiasis
Child and adult: 75 mg/kg/d divided in 3 doses
FIGURE
Duration
- Bilharziasis S. haematobium, S. mansoni, S. intercalatum:
single dose
- Bilharziasis S. japonicum, S. mekongi :3 doses, 1 day
-
Distomiasis: Opisturchis felinus, Clonorchis sinensis, Paragonimum westermani :2
to 3 days
Fasciola hepatica :5 to 7 days
Contra-indications, side-effects, precautions
- Risk of allergy.
- May cause: nausea, vomiting,
headache.
- Pregnancy: avoid (in most cases, treatment can wait until the end
of the pregnancy)
- Lactation :avoid
Remarks
- In an endemic area, antibilharzia treatment will only be
effective if preventive measures exist to avoid continuous reinfection.
-
Advice on sanitation should be given with the treatment.
- Storage:
PREDNISOLONE (Codelsol(R), Deltastab(R), Prednesol(R).) and PREDNISONE (Decortisyl(R), Econosone(R).)
District hospital
Therapeutic action
- Corticosteroid
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Symptomatic treatment:
· allergic diseases
· inflammatory
diseases
· severe asthma
Preparation
- Tablet of 5 mg
Dosage
- Child: initial dose :1 to 2 mg/kg/d maintenance dose: 0.1 to
0.5 mg/kg/d
- Adult: initial dose :20 to 80 mg/d maintenance dose: 5 to 20
mg/d
FIGURE
- In case of prolonged treatment, do not stop the treatment suddenly. Decrease the dose by 5 mg each day.
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer in cases of:
· peptic ulcer,
· fungal and/or viral infections
(herpes), or bacterial infections not controlled by antibiotics.
- May cause: hypokalemia, osteoporosis if prolonged
treatment.
- Risk of oedema and arterial hypertension as a result of sodium
and water retention.
- Risk of adrenal suppression in case of prolonged
treatment with daily doses of 15 to 20 mg.
- If daily administration of more
than 20 mg, a salt-free diet and potassium supplement are recommended.
- If
acute adrenal failure, prescribe hydrocortisone: 100 to 300 mg IV.
-
Pregnancy: avoid in the first trimester
- Lactation :avoid
Remarks
- 5 mg prednisolone has the same anti-inflammatory activity as:
· 5 mg prednisone · 4 mg methyl prednisolone
·
0.75 mg dexamethasone · 20 mg hydrocortisone
- Storage: keep below 30°C.
PROBENECID (Benemid(R).)
Health clinic
Therapeutic action
- Prolongs the action of penicillin and ampicillin
-
(Anti-gout)
Indications
- In combination with procaine penicillin (or possibly with ampicillin or amoxycillin) in the treatment of gonorrhoea. Can be combined with other penicillin preparations. BENZATHINE PENICILLIN CAN NOT BE USED WITH PROBENEClD.
Preparation
- Tablet of 500 mg
Dosage
In conjunction with penicillin treatment:
- Child (above 2 years): 20 to 25 mg/kg/d
- Adult :1 g/d
FIGURE
Duration: depending on the penicillin treatment
Contra-indications, side-effects, precautions
- Do not administer in children under 2 years.
- Do not
combine with acetyl salicylic acid (aspirin).
- Pregnancy :avoid
-
Lactation :avoid
Remarks
- The combination of probenecid and procaine penicillin is
always indicated for the treatment of gonorrhoea, except in pregnant women.
-
Tablets can be taken at the same time as the injection, or preferably, 1/2 hour
before.
- Storage: keep below 30°C.
PROGUANIL (Paludrine(R).)
District hospital
Therapeutic action
- Antimalarial
Indications
- Prevention of malaria in association with chloroquine in countries with rare or moderate resistance to chloroquine.
Preparation
- Tablet of 100 mg
Dosage
Conform to national protocol.
For information:
FIGURE
Duration
- Travellers must start to take proguanil associated with chloroquine 24 hours before departure, continue throughout their journey and for 4 to 6 weeks after return.
Contra-indications, side-effects, precautions
- Transitory digestive problems.
- Pregnancy: no
contra-indication
- Lactation: no contra-indication
Remarks
- Take tablets with some water, every day, at the same time,
after the meal.
- Storage: no special precaution.
PROMETHAZINE (Phenergan(R).)
District hospital
Therapeutic action
- Anti-emetic
- Antihistaminic
- Sedative
Indications
- Vomiting
- Allergic reactions due to:
· contact, seasons.
· drugs, insect bites, food.
- Dry cough of allergic origin
Preparation
- Tablets of 25 mg
Dosage
- Child: 1 mg/kg/d divided in 2 or 3 doses
- Adult: 25 to 50
mg/d divided in 2 or 3 doses
FIGURE
Duration: single dose or 1 to 3 days depending on clinical progress
Contra-indications, side-effects, precautions
- Do not drink alcohol during treatment.
- In case of
drowsiness, administer in the evening.
- Risk of sedation when combined with
alcohol and other drugs that act on the central nervous system: diazepam
(Valium(R), phenobarbitone (Gardenal(R)), chlorpromazine (Largactil(R) and
chlorpheniramine (Teldvin(R).
- Pregnancy: no contra-indication
-
Lactation: no contra-indication
Remarks
- Chlorpheniramine is cheaper, but has no anti-emetic
action.
- Storage: keep below 30°C.
PROPRANONOL (Angilol(R), Inderal(R).)
District hospital
Therapeutic action
Beta-blocker, used against hypertension, angina and arrhythmias
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Arterial hypertension
- Angina pectoris
- Arrhythmia
diagnosed by a doctor (with ECG)
Preparation
- Tablets of 10 mg and 40 mg
Dosage
-Arterial hypertension
80 mg/d divided in 2 doses, to be
increased progressively depending on clinical progress, maximum 320
mg/d
-Prophylaxis for angina pectoris
Initial dose: 30 to 60 mg/d divided
in 3 doses, to be increased every 4 days up to a dose of 160 to 320
mg/d
-Prevention of arrhythmia after myocardial infarction
180 to 240 mg/d
divided in 2 or 3 doses; start as of the 6th or 9th day after the infarction and
continue for 18 months at a dose of 160 mg/d
Duration
- Depending on indication and clinical progress
- Do not stop
abruptly.
Contra-indications, side-effects, precautions
-The drug should only be prescribed for patients who are
following a prolonged treatment. The treatment should never be stopped
suddenly.
- Do not administer in cases of:
· asthma,
· bradycardia below SO/min, bundle-branch
block,
· heart failure (or a history of),
· arteritis of the
lower limbs, Raynaud syndrome.
- Administer with care in cases of diabetes, digitalis treatment
or emphysema, and in cases of renal or liver failure.
- Do not combine with
aminophylline (reciprocal inhibition), digitalis (bradycardia), adrenaline
(hypertension), curare, M.A.O. inhibitors.
- Pregnancy: no
contra-indication
- Lactation :avoid
Remarks
- For the treatment of hypertension, may be combined with a
diuretic.
- Storage: no special temperature requirements.
PYRANTEL (Combantrin(R).)
District hospital
Therapeutic action
- Anthelminthic
Indications
- Ascariasis
- Enterobiasis (pinworm)
- Hookworm
(ankylostomiasis)
Preparation
- Tablet of 125 mg
There are also tablets of 250 mg. Adapt dosage accordingly.
Dosage
- Ascariasis, enterobiasis, hookworm caused by Ancylostoma duodenalis
Child and adult :10 mg/kg in a single dose
- Hookworm caused by Necator americanus
Child and adult :20 mg/kg/d once daily
FIGURE
Duration
- Ascariasis, enterobiasis, hookworm caused by Ancylostoma
duodenalis: single dose
- Hookworm caused by Necator americanus: 3 days
Contra-indications, side-effects, precautions
- Administer with care in case of liver failure.
- May cause:
digestive problems, headache, dizziness.
- Pregnancy: avoid (in most cases,
the treatment can wait until the end of the pregnancy)
- Lactation: no
contra-indication
Remarks
- Generally more expensive than mebendazole and levamisole.
-
Sanitation advice should be given with the treatment.
- Storage: no special
temperature requirements.
PYRAZINAMIDE (Zinamide(R).)
Special department
Therapeutic action
- "Antituberculous" antibacterial
Indications
- Only for tuberculosis, bacteriologically proven if possible
Preparation
- Tablet of 500 mg
Dosage
According to national protocol.
For information
- Child and adult :25 mg/kg/d maximum
- Can also be given in
a dose of 40 mg/kg 2 times a week or 70 mg/kg once a week
Duration: according to national protocol
Contra-indications, side-effects, precautions
- Do not administer in cases of:
· Iiver failure,
· history of allergy to
ethionamide, isoniazid and nicotinamide.
- May cause: anorexia, nausea, vomiting, skin allergies, joint
pains, gout.
- Pregnancy :avoid
- Lactation: avoid
Remarks
- Warning: antituberculous treatment should only be prescribed
in the context of an organised program (well established protocol, regular
patient checks and the possibility of laboratory examination).
- Pyrazinamide
should not be used alone, but in combination with other "antituberculous" drugs
to avoid resistance.
- Storage: keep below 30°C.
PYRIDOXINE = Vitamin B6
District hospital
Therapeutic action
- Vitamin
Indications
- Prevention and treatment of peripheral neuropathies, particularly if isoniazid (INH) has been prescribed
Preparation
- Tablets of 25 mg and 50 mg
Dosage
- Child: 25 to 50 mg/d once daily
- Adult: 50 to 150 mg/d
once daily
FIGURE
Duration: depending on clinical progress or as long as the treatement with isoniazid (INH) continues
Contra-indications, side-effects, precautions
- No contra-indication.
- Pregnancy: no
contra-indication
- Lactation: no contra-indication
Remarks
- Storage: no special temperature requirements
QUININE Salts
District hospital
Therapeutic action
- Antimalarial
Indications
- Treatment of Plasmodium falciparum malaria resistant to
chloroquine
- Follow up of injectable quinine given for cerebral malaria or
chloroquine resistance
Preparation
- Tablets of 200 mg and 300 mg of quinine salts (generally sulphates or chlorhydrates)
There are also tablets of 100 mg, 250 mg and 500 mg. Adapt dosage accordingly.
Dosage
- Child : 25 to 40 mg/kg/d divided in 3 doses
- Adult: 1.5 to
2 g/d divided in 3 doses
Dosages and doses of the tablets are generally expressed in salts. They are all equal (formiate, sulphate, chlorhydrate, bi-chlorhydrate), except for bi-sulphate which is weaker and thus needs its own special dose.
FIGURE
Duration: 7 days
Contra-indications, side-effects, precautions
- Risk of toxicity in case of doses over 4 g: headache,
disturbance of vision, abdominal pain, nausea, buzzing (tinitus) of ears.
-
Possible allergic reactions.
- Pregnancy: no contra-indication (do not exceed
the therapeutic doses)
- Lactation: no contra-indication
Remarks
- In some regions of South-East Asia, the combination of quinine
and tetracycline (25 mg/kg/d) or doxycycline (200 mg/d) for 10 days is necessary
because of resistance.
- Antacids, like aluminium hydroxide, can slow down
the absorption of quinine.
- Storage: keep below 30°C.
RESERPINE (Decaserpyl(R), Rauwiloid(R), Serpasil(R).)
District hospital
Therapeutic action
- Antihypertensive
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Moderate arterial hypertension (in combination with a diuretic)
Preparation
- Tablets of 0.10 mg, 0.25 mg and 0.50 mg
Dosage
- Adult: 0.10 to 0.25 mg/d to be combined with a diuretic and to be adapted according to therapeutic progress
FIGURE
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer in cases of:
· depression or history of depression,
· peptic
ulcer,
· heart and/or severe renal failure,
· epilepsy.
- May cause: nausea, vomiting, gastritis, depression, anxiety,
bronchial spasms.
- It has a slow but long lasting action: risk of
accumulation.
- Avoid combination with digitalis, quinidine and other
anti-arrhythmic drugs, alcohol and suppressors of the central nervous system:
diazepam (Valium(R), phenobarbitone (Gardenal(R)) and chlorpromazine
(Largactil(R)).
- Pregnancy : avoid
- Lactation: avoid
Remarks
- Storage: keep below 30°C.
RETINOL = VITAMIN A (Ro-A-Vit(R)..)
Health clinic
Therapeutic action
- Vitamin
Indications
- Prevention of vitamin A deficiency
- Treatment of
xerophthalmia: reduced night vision, desiccation (drying) and ulceration of the
cornea, Bitot's spots.
- Treatment of children specifically vulnerable for
vitamin A deficiency: measles, malnutrition, respiratory infections.
Preparation
- Capsules of 50,000 IU and 200,000 IU
There are also capsules of 25,000 IU. Adapt dosage accordingly.
Dosage
- Prevention: Adult and Child above 1 year: 200,000 IU in a single dose every 6 months.
Child under 1 year: 100,000 IU in a single dose every 6 months
- Treatment: Adult and Child above 1 year: 1st, 2nd and 8th day, 200,000 IU once daily.
Child under 1 year : 1st, 2nd and 8th day, 100,000 IU once daily
- Do not exceed indicated doses.
For children under 1 year: when capsules of 50,000 IU are not available, pierce a capsule of 200,000 IU and give 3 drops.
FIGURE
Duration
- Prevention: single dose every 6 months
- Treatment: 1st,
2nd and 8th day; thereafter as for "prevention" if necessary
Contra-indications, side-effects, precautions
- Pregnancy: prevention: avoid, give a single dose just after
delivery
treatment: do not exceed a dose of 10,000 Odd (risk of fetal
malformation)
- Lactation: no contra-indication
Remarks
- The injectable form has no advantages.
- Food rich in
vitamin A: dark green vegetables, palm oil, orange or red coloured fruits and
vegetables, eggs, full-cream milk and meat.
- Storage: keep cool.
RIFAMPICIN (Rifadin(R), Rimactane(R).)
Special department
Therapeutic action
- "Antituberculous" and "antileprotic" antibacterial
Indications
- Tuberculosis, bacteriologically proven if possible
-
Leprosy (Hansen's disease)
Preparation
- Tablets or capsules of 150 mg and 300 mg
Dosage
According to national protocol.
For information:
- Tuberculosis: 10 mg/kg/d
- Leprosy : 600 mg once every
month
FIGURE
Duration: according to national protocol
Contra-indications, side-effects, precautions
- Do not administer if liver failure, porphyria or allergy for
rifampicin.
- Risk of hepatotoxicity.
- May cause allergies.
- Urine,
stools and secretions may turn red.
- Pregnancy: avoid
- Lactation: avoid
Remarks
- Warning: antituberculous and antileprotic treatments should
only be prescribed in the context of an organised program (well established
protocol, regular patient checks and the possibility of laboratory
examination).
- Rifampicin should not be used alone, but in combination with
other "antituberculous" or "antileprotic" drugs to avoid resistance.
-
Rifampicin is an expensive antituberculous drug.
- Storage: no special
temperature requirements
SALBUTAMOL = ALBUTEROL (Salbulin(R), Salbutan(R), Ventolin(R).)
District hospital
Therapeutic action
- Bronchodilator
- Uterorelaxant
Indications
- Acute or chronic asthma (with continuous dyspnea).
-
Bronchitis and obstructive pneumopathies with bronchospasm.
- Prevention of
premature delivery: taking over treatment after emergency injectable treatment.
Preparation
- Tablets of 2 mg and 4 mg of salbutamol (in the form of
sulphate)
- Syrup of 2 mg/5 ml
Dosage
- Asthma
· Child: 0.10 mg/kg/d divided in 3 doses
· Adult: 6
to 12 mg/d divided in 3 doses
Prevention of premature delivery: 1 tab of 2 mg 4 times a day
FIGURE
Duration: depending on clinical evolution
Contra-indications, side-effects, precautions
-Do not administer in cases of myocardial infarction or acute
coronary insufficiency.
-Administer carefully if cardiac insufficiency,
arrhythmia, hypertension, diabetes, hyperthyroidism.
-May cause: tachycardia,
trembling, dizziness, headache.
-During the treatment, especially if the
doses are taken too often, the bronchodilatory effect can decrease: stop
treatment.
-Salbutamol is not very efficient for children less than 2
years.
-Pregnancy: no contra-indication
-Lactation: no contra-indication
Remarks
- Storage: keep below 30°C.
SULFADIMIDINE = SULPHADIMIDINE
District hospital
Therapeutic action
- Antibacterial (sulfonamide)
Indications
- Infections of the lower urinary tract without complications: without fever or lumbar pain.
Do not confuse with gonorrhoea (urethral discharge in the morning).
Preparation
- Tablet of 500 mg
Dosage
- Child (above 2 months): 100 to 250 mg/kg/d divided in 3
doses
- Adult: 2 to 6 g/d divided in 3 doses
FIGURE
Duration: minimum 7 days
Contra-indications, side-effects, precautions
- Do not administer:
· for children under 2 months,
· if known allergy
to sulfonamides,
· if hematological disorder.
- Frequently causes digestive problems.
- Allergic reactions
possible. Stop the treatment and refer to a doctor.
- DRINK A LOT during
treatment to prevent kidney stones.
- Do not combine with other
antibacterials.
- Pregnancy: CONTRA-INDICATED (use ampicillin if causative
bacteria is sensitive)
- Lactation: CONTRA-INDICATED
Remarks
- For upper urinary tract infections and those with fever,
cotrimoxazole is more effective.
- Sulfadimidine is nowadays usually replaced
by cotrimoxazole.
- Storage: keep below 30°C.
SULFADOXINE + PYRIMETHAMINE (Fansidar(R).)
Special department
Therapeutic action
- Antimalarial
Indications
- Treatment of Plasmodium falciparum malaria resistant to chloroquine and other amino-4-quinolines (Amodiaquine(R).)
Preparation
- Tablet of 500 mg sulfadoxine + 25 mg pyrimethamine
Dosage
- Child: i/2 tab/10 kg, in a single dose
- Adult: 2 to 3 tab,
in a single dose
FIGURE
Duration: single dose
Contra-indications, side-effects, precautions
- Do not administer if:
· allergy to sulfonamides,
· renal or liver
failure.
- Do not combine with chloroquine.
- Do not administer at the
same time as cotrimoxazole.
- May cause: gastro-intestinal problems, nausea,
vomiting, cutaneous allergic reactions.
- If the attack is pernicious, treat
with quinine.
- Avoid for children under 5 years.
- Pregnancy:
CONTRA-INDICATED
- Lactation :avoid
Remarks
- Sulfadoxine + pyrimethamine as prophylaxis has been abandoned
because of frequent serious side-effects.
- Warning: there is an increasing
number of resistant strains.
- Storage: no special temperature requirements.
SULFAGUANIDINE (Ganidan(R).)
The use of this drug is not advised:
- it has no proven effectiveness;
- it is not included in the
WHO essential drug list;
- its purchase is an useless expense.
Therapeutic action
- Antibacterial (sulfonamide)
Indications
- None. It has no effect on the treatment of bacterial diarrhoea : the pathogens have become resistant
Preparation
- Tablet of 500 mg
Dosage
It used to be given as follows:
- Child (above 2 months): 100 mg/kg/d, divided in 4 doses
-
Adult: 12 g/d divided in 4 doses
Contra-indications, side-effects, precautions
- Do not administer:
· to children under 2 months,
· if known allergy to
sulfonamides.
- Allergic reactions possible. Stop treatment and refer to a
doctor.
- Pregnancy: CONTRA-INDICATED
- Lactation: CONTRA-INDICATED
Remarks
- Storage: no special precautions.
TETRACYCLINE (Abfosan(R), Hexacycline(R), Tetramig(R).)
OXYTETRACYCLINE (Terramycine(R).)
DOXYCYCLINE (Doxy 100(R), Granudoxy(R), Spanor(R), Vibramycin(R).)
District hospital
Therapeutic action
- Antibacterials (of the cycline group)
Indications
- Cholera, brucellosis, borreliosis, rickettsiosis
-
Gonorrhoea (if allergy or resistance to penicillin)
- Syphilis (if allergy or
resistance to penicillin)
- Genital infections with Chlamydia
- Infections
with Balantidium coli
- Atypical pneumopathy
- Chloroquine-resistant
malaria, in association with quinine
Preparation
- Tetracycline: capsule or tablet of 25 mg
- Doxycycline:
capsule or tablet of 100 mg
Dosage
- Tetracycline:
child above 8 years: 25 to 50 mg/kg/d divided in 3
doses
adult: 1 to 3 g/d divided in 3 doses
- Doxycycline:
child above 8 years :4 mg/kg/d once daily
adult: 200 mg/d
once daily
- Cholera:
· tetracycline treatment 2 g/d divided in 4 doses for 3
days prophylaxis 1 to 1.5 g/d divided in 2 or 3 doses for 2 days to be repeated
every 10 to 15 days
· doxycycline treatment and prophylaxis
child: 4 mg/kg in a single dose
adult: 300 mg in a single
dose
Vibrio is increasingly resistant to cyclines.
FIGURE
Duration: 57days (tetracycline or doxycycline); Syphilis :14 days; Chlamydia: 21 days
Contra-indications, side-effects, precautions
- Do not administer:
· to children less than 8 years (colors teeth
yellow)
· if renal diseases
- Do not give together with milk, iron or aluminium
hydroxide.
- May cause: frequent digestive problems (diarrhoea.).
- Do not
combine with other antibiotics.
- Pregnancy: CONTRA-INDICATED
- Lactation:
CONTRA-INDlCATED
Remarks
- Take in-between meals.
- Treatments with doxycycline are
cheaper and more efficient than those with tetracycline.
- Oxytetracycline
has the same indications and doses as tetracycline.
- Storage: keep below
30°C.
Never administer expired tetracyclines or doxycycline
THIABENDAZOLE (Mintezol(R).)
District hospital
Therapeutic action
- Anthelminthic
Indications
- Strongyloidiasis
- Trichinosis
- Cutaneous larva
migrans
- Hookworm (ankylostomiasis) and trichocephalosis: mebendazole
preferred
Preparation
- Tablet of 500 mg
Dosage
- Strongyloidiasis Child and adult: 50 mg/kg in a single
dose
- Trichinosis Child and adult: 50 mg/kg/d divided in 3 doses
-
Cutaneous larva migrans Child and adult: 3 g in 30 g vaseline or antipruritic
ointment, 3 applications per day during one week
- Chew tablets during the
meal.
FIGURE
Duration
- Strongyloidiasis : single dose
- Trichinosis : 5 days
-
Cutaneous larva migrans: 7 days
Contra-indications, side-effects, precautions
- Do not administer if allergy to thiabendazole, renal or liver
failure.
- May cause: drowsiness, frequent dizziness, nausea, vomiting,
diarrhoea.
- Allergic reaction can sometimes be very strong: Quincke oedema,
Stevens Johnson syndrome.
- Pregnancy: avoid
- Lactation: avoid
Remarks
- Because of its limited indications, its price and
side-effects, do not use for systematic elimination of parasites, but administer
cheaper, broad-spectrum anthelminthic drugs.
- Storage: keep below 30°C.
THIAMINE = ANEURIN = VITAMIN B1 (Benerva(R), Bevitine(R).)
District hospital
Therapeutic action
- Vitamin
Indications
- Beri-beri: neurological or cardiac form
- Polyneuritis in
alcoholics or due to nutritional deficiency
Preparation
- Tablet of 50 mg
There are also tablets of 10 mg, 25 mg, 100 mg and 250 mg. Adapt dosage accordingly.
Dosage
- Curative treatment
· Child: 10 to 30 mg/d
· Adult: 50 to 100 mg/d - up
to 300 mg in case of severe deficiency to be taken once daily or divided in
several doses
- Preventive treatment
· Child and adult :5 mg/d
Daily needs
child : 0.3 to 1 mg/d
adult and adolescent : 1.3 to 1.5
mg/d
pregnancy and lactation: 1.5 to 1.8 mg/d
FIGURE
Duration: at least one month for curative treatment
Contra-indications, side-effects, precautions
- No contra-indications, or side-effects with oral
administration of vitamin B1.
- Pregnancy: no contra-indication
-
Lactation: no contra-indication
Remarks
- The use of injectable vitamin B1 is only justified in
exceptional cases (for example in cases of cardiac insufficiency or acute
pulmonary oedema caused by an unbalanced diet).
- Storage: closed,
non-metallic container.
TOLBUTAMIDE (Artosin(R), Dolipol(R), Rastinon(R).)
District hospital
Therapeutic action
- Sulfamide hypoglycemic agent wich stimulates the secretion of pancreatic insulin
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Diabetes of the adult, non acidocetosic, of insulin independent type and not balanced by a well followed diet
Preparation
- Tablet of 500 mg
Dosage
- Adult: 0.25 to 1.5 g/d at once during breakfast or divided in
3 doses before meals
- Adapt dosage progressively and with great care to
elderly people.
FIGURE
Duration: depending on clinical progress and results of laboratory
Contra-indications, side-effects, precautions
- Do not administer to diabetic children under 16 years.
- Do
not administer to an insulin-dependant diabetic, or to a patient with renal or
hepatic failure.
- Do not administer to an alcoholic: antabuse reaction.
-
Hypoglycemic problems to be treated with intake of oral sugar or IV injection if
severe.
- Use with many associations to other drugs not advisable:
sulfadimidine, prednisone, aspirin.
- Pregnancy :avoid
- Lactation :avoid
Remarks
- Chlorpropamide (Diabinese(R)) is an oral long acting
antidiabetic of the same group, used at doses of i/2 to 2 tab/d once daily. Risk
of hypoglycemia is higher.
- Another hypoglycemic sulfamide is glibenclamide
(Daonil(R)), tablet of 5 mg: 1/2 to 3 tab/d.
- Use if failure of proper diet,
and control glycemia regularly.
- Usage of oral antidiabetics does not mean
dietetic measures should be cancelled.
- Storage: keep below
30°C.
Acetyl salicylate
lysine
Adrenaline
Albuterol
Aminophylline
Amoxicillin
Ampicillin
Aspirin
Atropine
sulphate
Benzathine penicillin G
= Benzathine benzyl penicillin
Benzyl
penicillin = Penicillin G
Butylscopolamine =
Butylhyoscine
Chloramphenicol
Chloramphenicol in
oil
Chloroquine
Chlorphenamine =
Chlorpheniramine
Chlorpromazine
Cloxacillin
Dexamethasone
Dexchlorpheniramine
Diazepam
Digoxin
Dihydralazine
Dipyrone*
Epinephrine
Ergometrine
Furosemide
= Frusemide
Gentamicin
Glucose or dextrose
(hypertonic)
Hydralazine
Hydrocortisone
Hydroxocobalamin
Hyoscine
butylbromide
Ketamine
Levorenine
Lignocaine = Lidocaine
Lignocaine
hyperbaric
= Lidocaine
hyperbaric
Metamizol*
Methylergometrine
Metoclopramide
Noramidopyrine*
Oxytocin
Pentazocine
Pentobarbital
Phenobarbitone
= Phenobarbital
Phytomenadione
Procaine penicillin = Procaine benzyl
penicillin
Procaine benzyl penicillin + Benzyl penicillin = PPF
Potassium
chloride
Promethazine
Quinine
(salts)
Theophylline
Salbutamol
Sodium bicarbonate
Sodium chloride
(hypertonic)
Streptomycin
Sulfadoxine + pyrimethamine*
Thiopentone =
Thiopental
Vitamin B12
Vitamin K1
* The use of this drug is not advised.
ACETYL SALICYLATE LYSINE - "ASPIRIN" (Aspegic(R).)
District hospital
Therapeutic action
Same as acetyl salicylic acid (aspirin):
- analgesic
- antipyretic
- anti-inflammatory
The action is fast, intense and prolonged (6 hours).
Indications
- Intense pain
- High fever
Preparation and route of drug administration
- Vial of 0.5 g of aspirin (0.1 g/ml, 5 ml) acetyl salicylate
Iysine for deep IM injection, slow IV or infusion
- Vial of 1 g of aspirin
(0.2 g/ml, 5 ml) acetyl salicylate Iysine for deep IM injection, slow IV or
infusion
Dosage
- Children above 6 years: 10 to 25 mg/kg/d
· from 6 to 10 years
Vial of 0.5 g: 0.5 to 1 ml per injection, or 1/2 to 1 vial/d
divided in 5 injections
· above 11 years
Vial of 0.5 g :1 to 2 ml per
injection, or 1 to 2 vials/d divided in 5 injections
- Adult
0.5 to 1 g per injection, without giving more than 4
g/d divided in 4 injections (8 vials of 0.5 g or 4 vials of 1 g)
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer to children under 6 years.
- Do not
administer if gastro-duodenal ulcer, haemorrhage or risk of haemorrhaging.
-
Do not administer for the treatment of gout.
- Use with care for asthmatic
patients.
- Can cause allergic reactions, haemorrhage.
- Pregnancy: avoid,
especially at the end of pregnancy
- Lactation: avoid
Remarks
- Do not use 1 g vials for children.
- Do not mix other drugs
in the same syringe.
- Do not use solutions that are not clear or which
contain crystals.
- Storage: keep below 30°C.
ADRENALINE = EPINEPHRINE = LEVORENINE
District hospital
Therapeutic action
- Sympathomimetic
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Anaphylactic shock
- Asthma
- Cardio-respiratory
arrest
- Hypotension caused by local or regional anaesthesia (spinal
anaesthesia)
Preparation and route of drug administration
- Ampoule of 0.25 mg (0.25 mg/ml, 1 ml) for SC or slow diluted
IV injection
- Ampoule of 1 mg (1 mg/ml, 1 ml) for SC or given in slowly
diluted IV injection
Dosage
- Child 0 to 1 year : SC: 0.10 mg/injection (IV diluted: same
dose diluted in 20 ml)
- Child 1 to 5 years : SC: 0.25 mg/injection (IV
diluted: same dose diluted in 20 ml)
- Child 5 to 15 years: SC: 0.50
mg/injection (IV diluted: same dose diluted in 20 ml)
- Adult : SC: 1
mg/injection (IV diluted: same dose diluted in 20 ml)
- Do not exceed
indicated doses: risk of arrhythmia.
- Be careful when treating elderly
patients: risk of heart failure.
- For IV injection, dilute with isotonic
solution of sodium chloride or glucose.
FIGURE
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer in cases of:
· arterial hypertension,
· angina.
- If used intravenously (reanimation), preferably use
diluted.
- Pregnancy: CONTRA-INDICATED except in emergencies
- Lactation:
no contra-indication
Remarks
- The adrenaline solution is colourless; discard any ampoules
showing a pink or brown coloration.
- Storage: keep cool
AMINOPHYLLINE (Euphyllin(R).) and THEOPHYLLINE
District hospital
Therapeutic action
- Bronchodilator
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Asthma attacks
- Severe respiratory problems due to
bronchopneumonia
- Apnoea in a premature infant
Preparation and route of drug administration
- Ampoule of 250 mg (25 mg/ml, 10 ml) for very slow IV injection
(10 to 15 minutes) or infusion. NEVER GIVE IV QUICKLY. Better to use 10%
dilutions (especially if rectal use).
- Administration by IM is possible but
painful.
- Children can be treated rectally (dilution 1/10), but the
absorption is irregular.
- Apnoea in a premature infant: can be used orally
(dilution 1/10) as adjuvant in the treatment of apnoea. Dosage: 2.5 to 5 mg/kg
initial dose, following doses 2 mg/kg/24 hours.
Dosage
- Child and adult :5 mg/kg/injection
- Reduce the dose in
cases of heart failure and for elderly patients.
- Make sure the patient has
not taken oral theophylline before-hand.
FIGURE
Duration: depending on clinical progress, change to oral treatment as soon as possible
Contra-indications, side-effects, precautions
- Paediatrics:
· never combine with erythromycin,
· the
therapeutic dose is near the toxic dose.
- Toxic in case of overdose:
· early signs: vomiting, hyperthermia,
· sign of
intoxication: convulsions.
- Administer with care to children under one year.
- Avoid
combination with erythromycin or phenobarbitone.
- Pregnancy: avoid,
particularly at the end of the pregnancy
- Lactation: avoid
Remarks
- Administration of theophylline for the same indications and at
the same dosage (5 mg/kg) in very slow IV injection. Attention, preparation in
ampoule of 240 mg/4 ml: calculate exactly the volume to inject.
- Storage:
keep cool.
AMOXICILLIN (Amoxil(R), Clamoxyl(R).) AMPICILLIN (Amfipen(R), Penbritin(R).)
District hospital
Therapeutic action
- Antibacterial (antibiotic) of the penicillin group
Indications
- Severe infections: septicemia, endocarditis, meningitis,
pulmonary infections, burns
- First choice in the treatment of uro-genital
infections in pregnant women
Preparation and route of drug administration
- Vials of powder of 500 mg or 1 g for IM, IV injection or infusion
Dosage
Amoxicillin and ampicillin have the same indications and doses when injected:
- Child: 50 to 100 mg/kg/d divided in 3 injections
- Adult: 3
to 4 g/d divided in 3 injections
- The 3 injections/day are necessary.
-
In case of severe infections, the dose can be raised to:
Child: 200 mg/kg/d; Adult :12 g/d
FIGURE
Duration: 7 days of antibiotic therapy; change to oral treatment as soon as possible
Contra-indications, side-effects, precautions
- Do not administer if known allergy to penicillin.
- If
allergic reaction, stop treatment and refer to a doctor.
- Pregnancy: no
contra-indication
- Lactation: no contra-indication
Remarks
- Combination with aminoglycoside (e.g. gentamicin) is sometimes
necessary (need medical advice).
- THE POWDER IN THE VIALS IS THE SAME FOR
ALL METHODS OF ADMINISTRATION ALTHOUGH THEY MAY BE LABELEED DIFFERENTLY. Some
solvents that come with the vials contain lidocaine for IM injections. Once
mixed with its solvent, the solution can no longer be used for IV injection. If
you use sterile water as solvent, both IM and IV injections are possible.
-
Storage: keep cool
· Once dissolved, the liquid must be clear and should be
used the same day.
· Diluted in a glucose infusion, ampicillin stays
stable for 6 hours; in sodium chloride it stays stable for 12 hours. It is
recommended that it be injected directly into the infusion tube.
·
Amoxicillin is not as stable as ampicillin (can not be kept more than one hour
in glucose solution) and is more expensive (for the same dosage).
ATROPINE Sulphate
District hospital
Therapeutic action
- Antispasmodic and parasympatholytic
Indications
- Spasms of the digestive and uro-genital tract (colics, ulcers
and severe gastritis)
- Premedication in case of anaesthesia
-
Intoxication with organophosphate insecticide
Preparation and route of drug administration
- Ampoule of 1 mg (1 mg/ml, 1 ml) for SC, IV, IM injection or eventually for oral use
Dosage
- Child: 0.01 to 0.02 mg/injection or per os diluted
- Adult:
0.5 to 1 mg/injection or per os diluted
It is possible to repeat the
injection if necessary.
- Intoxication with organophosphates: 2 to 4 mg/IV
injection every 5 to 10 minutes until signs of effect of the atropine appear
(dilation of pupils).
FIGURE
Duration: depending on clinical progress: single dose or 1 to 3 days
Contra-indications, side-effects, precautions
- Do not administer in cases of:
· urinary retention, cardiac problems, glaucoma,
·
high fever in children: decreased transpiration, risk of hyperpyrexia, anoxia,
convulsions, cardio-respiratory arrest.
- May cause: dry mouth, constipation, dizziness, headache.
-
Do not combine with chlorpromazine or promethazine.
- Do not use for minor
symptoms.
- Pregnancy: avoid, particularly at the end of the pregnancy; NO
PROLONGED TREATMENTS
- Lactation: avoid; NO PROLONGED TREATMENTS
Remarks
- Do not use for convenience.
- Storage: no special
temperature requirements.
BENZATHINE PENICILLIN G = BENZATHINE BENZYL PENICILLIN (Penidural(R).)
District hospital
Therapeutic action
- Antibacterial (antibiotic) with prolonged action: 15 to 20 days
Indications
- Syphilis
- Bejel, Yaws
- Prevention of rheumatoid
arthritis (RA)
Preparation and route of drug administration
- Vial of powder of 2.4 M IU = 1.44 g only for IM injection (NEVER IV or infusion)
There are also vials of 1.2 M IU = 0.72 g and 0.6 M IU = 0.36 g. Adapt dosage accordingly.
Dosage
- Child: 50,000 to 100,000 IU/kg/injection
- Adult: 1 to 3 M
IU/injection
FIGURE
Duration: depending on indications:
- Bejel, Yaws: single dose
- Prevention of rheumatoid
arthritis: every 4 weeks
- Syphilis (primary and secondary): repeat after 15
days
Contra-indications, side-effects, precautions
- Do not administer if known allergy to penicillin.
- If
allergic reaction, stop treatment and refer to a doctor.
- Do not combine
with other antibiotics.
- Pregnancy: no contra-indication
- Lactation: no
contra-indication
Remarks
- After injection, benzathine penicillin releases the penicillin
G very slowly from its complex which provides the long action of 15 to 20 days.
This form of penicillin is not suitable for urgent cases (blood level too low),
nor for gonorrhoea.
- Benzathine penicillin should not be used as prevention,
except in case of RA.
- Storage: keep below 30°C.
Afler preparation, the suspension must be used within 24 hours.
BENZYL PENICILLIN = PENICILLIN G = CRYSTALLINE PENICILLIN (Crystapen(R)...)
District hospital
Therapeutic action
- Antibacterial (antibiotic) with rapid action and elimination (6 hours)
Indications
- Infections sensitive to penicillin: pneumonia, tonsillitis, anthrax, septicemia, meningitis.
Preparation and route of drug administration
- Vials of powder of 1 M IU and 5 M IU for IM, infusion, IV injection (preferably in the infusion tube)
This presentation is rarely used because it requires intensive monitoring in a hospital environment: INJECTION EVERY 6 HOURS THROUGH AN INFUSION TUBE.
Dosage
- Child: 80,000 IU/kg/d divided in 4 injections or infusions
(maximum 400,000 IU/kg/d)
- Adult: 1 to 3 M IU/d divided in 4 injections or
infusions (maximum 10 to 20 M IU/d)
Duration: depending on indications and clinical progress
Contra-indications, side-effects, precautions
- Do not administer in case of known allergy to penicillin.
-
If allergic reaction, stop treatment and refer to a doctor.
- Do not mix in
the same infusion with other antibacterials (gentamicin.).
- Pregnancy: no
contra-indication
- Lactation: no contra-indication
Remarks
- 600 mg benzylpenicillin = 1 million international units (M IU)
= 1 mega unit.
- Warning: the labels are not always very clear. Do not
confuse penicillin G with LONG ACTING PENICILLIN CONTAINING PENICILLIN G:
procaine penicillin G or benzathine penicillin G. Long acting penicillin CANNOT
BE USED FOR IV INJECTION OR INFUSION.
- Storage: keep below 30°C.
After preparation, the solution must be clear and used within 24 hours.
CHLORAMPHENICOL (Chloromycetin(R), Tifomycine(R).)
District hospital
Therapeutic action
- Antibacterial (antibiotic)
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST ME UNDER MEDICAL SUPERVISION
- Typhoid fever
- Meningitis
- Bronchopneumonia
when
oral administration is not possible
Preparation and route of drug administration
- Vial of powder of 1 g of chloramphenicol (as sodium succinate) for IM or IV injection
Dosage
- Child : 50 to 100 mg/kg/d divided in 3 injections
- Adult:
1 to 4 g/d divided in 3 injections
- For any indication except typhoid fever,
do not exceed a total dose of 26 g for adult.
- Typhoid fever: conform to
national protocol; if not available, start the first day with half the dose and
increase gradually.
FIGURE
Duration
- Minimum 5 days, change to oral treatment as soon as
possible.
- Typhoid fever: continue antibiotic therapy for 15 days after the
fever has gone.
Contra-indications, side-effects, precautions
- If treatment causes anaemia, stop treatment and refer to a
doctor.
- Do not combine with other antibiotics without medical advice.
-
For newborn babies: CONTRA-INDICATED.
- Pregnancy: CONTRA-INDICATED
-
Lactation: CONTRA-INDICATED during the first two months
Remarks
- In spite of its severe but rare haematological toxicity, the
use of chloramphenicol is justified because of its effectiveness on the serious
infections mentioned above. This drug has also the advantage of being
cheap.
- ORAL TREATMENT IS MORE EFFECTIVE THAN IM INJECTION (the blood- and
tissue concentrations are better with oral absorption).
- Storage: keep below
30°C.
Once dissolved, the solution must be clear and used within 24
hours.
CHLORAMPHENICOL IN OIL ("long acting") (Tifomycine(R).)
Special department
Therapeutic action
- Antibacterial (antibiotic) with prolonged action (a few weeks)
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Epidemics of purulent mngococcal meningitis
Preparation and route of drug administration
- Ampoule of oily suspension of 500 mg (250 mg/ml, 2 ml) for IM injection only, NEVER IV
Dosage
- Child: 50 to 100 mg/kg/injection
- Adult: 2 to 3
g/injection
- A second injection can be given 3 days later if necessary (same
dose).
FIGURE
Duration: single dose
Contra-indications, side-effects, precautions
- Do not combine with other antibiotics.
- Pregnancy:
CONTRA-INDICATED
- Lactation: CONTRA-INDICATED
Remarks
- "A single dose injection of chloramphenicol in oil has been
proven effective in the treatment of patients of all ages. This antibiotic is
therefore the recommended treatment in case of epidemics, however it is not
suitable for the treatment of patients with Streptococcus pneumoniae or
Haemophilus influenzae" (WHO - epidemiological record, n°16-20, April
1990).
- No chemoprophylaxis is recommended. It is necessary, for suspected
cases, to be examined at the first sign of the disease.
- Storage: keep
belozv 30°C.
CHLOROQUINE (Nivaquine(R), Resochin(R).)
District hospital
Therapeutic action
- Antimalarial
Indications
- Severe malaria: outside chloroquine resistant areas, if oral treatment is not possible.
Attention: if malaria must be treated by injection, use quinine, if available, in preference.
Preparation and route of drug administration
- Ampoules of 80 mg base, 100 mg base, 200 mg base and 300 mg base (40 mg base/ml and 50 mg base/ml) for IM, SC injection, slow infusion
Dosage
- THE THERAPEUTIC DOSES ARE LOWER IF INJECTED THAN IF TAKEN
ORALLY.
- THE MAXIMUM DOSE is 25 mg (base)/kg/d, whatever the way of
injection.
· IM or SC
3.5 mg (base)/kg/6 hours up to a total dose
of 25 mg (base)/kg
· Infusion
5 mg (base)/kg/8 hours up to a total
dose of 25 mg (base)/kg; monitor that the infusion proceeds very slowly
In
case of cerebral malarial, the initial dose can be 10 mg (base)/kg, up to a
total dose of 25 mg (base)/kg.
Duration
- Maximum 1 to 3 days. Do NOT GIVE THE COMPLETE TREATMENT BY CHLOROQUINE INJECTIONS.
AS SOON AS POSSIBLE, CHANGE TO ORAL TREATMENT 24 HOURS AFTER THE LAST INJECTION, give the oral dose as recommended for the second day of the treatment. If necessary, use a gastric tube.
Contra-indications, side-effects, precautions
- Do not use IM for children under 5 years. IN CASE OF VITAL
NEED, USE SC (absorption is slower).
- The therapeutic dose is near the toxic
dose: check that the patient has not taken chloroquine tablets in the preceding
days. If oral treatment, taken correctly, fails, use quinine.
- Risk of
cardiac toxicity and hypotension: sudden death.
- Sign of toxicity:
convulsions.
- Do not combine injectable chloroquine and injectable
quinine.
- Follow strict aseptic procedures because abscesses frequently
develop after injections.
- Pregnancy: no contra-indication
- Lactation:
no contra-indication
Remarks
- Storage: no special temperature requirements
CHLORPHENAMINE = CHLORPHENIRAMINE (Piriton(R), Teldvin(R).)
District hospital
Therapeutic action
- Antihistaminic
Indications
- Severe allergic reactions due to:
· contact, seasons.
· drugs, insect bites, food.
Preparation and route of drug administration
- Ampoule of 10 mg (10 mg/ml, 1 ml) for IM, slow IV or SC injection
Dosage
- Child (above 2 years): 1 mg/kg/injection
- Adult: 25 to 50
mg/injection
FIGURE
Duration: depending on indications and clinical progress; change to oral treatment as soon as possible
Contra-indications, side-effects, precautions
- Risk of drowsiness.
- Do not administer to children under 2
years.
- Risk of sedation when combined with alcohol and other drugs that act
on the central nervous system: diazepam (Valium(R)), phenobarbitone (Gardena(R))
and chlorpromazine (Largactil(R).
- Pregnancy:avoid
- Lactation :avoid
Remarks
- Chlorpheniramine has not anti-emetic properties.
-
Promethazine has stronger sedative effects.
- 5 mg dexchlorpheniramine
(Polaramine(R)) has the same effect as 10 mg chlorpheniramine.
- Storage:
keep below 30°C.
CHLORPROMAZINE (Largactil(R).)
District hospital
Therapeutic action
- Sedative and anti-emetic neuroleptic
- Major tranquillizer
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Severe state of agitation
- Very severe vomiting,
intractable hiccup
Preparation and route of drug administration
- Ampoule of 50 mg (25 mg/ml, 2 ml) for deep IM injection or infusion
Dosage
Varies from one patient to another:
- Child: 0.5 mg/kg/injection
- Adult: 25 to 100 mg/injection
In cases of eclampsia, the dose can be doubled if necessary.
- Do not exceed indicated doses.
FIGURE
Duration
- Depending on indications and clinical progress, several days of treatment are sometimes needed for very agitated patients.
Contra-indications, side-effects, precautions
- If temperature rises after the injection, stop treatment. It
may be a sign of the neuroleptic malignant syndrome.
- Risk of extrapyramidal
disorder in case of prolonged treatment.
- Risk of orthostatic
hypotension.
- Risk of sedation when combined with alcohol and other drugs
that act on the central nervous system: diazepam (Valium(R), phenobarbitone
(Gardenal(R)) and chlorpheniramine (Teldvin(R)).
- Pregnancy: avoid prolonged
use
- Lactation :avoid
Remarks
- Can be used in case of an eclamptic attack. However, the use
of diazepam (Valium(R)) is preferable.
- For intractable hiccup, use a
gastric aspiration tube as well.
- Storage: keep below 30°C.
CLOXACILLIN (Orbenin(R).)
District hospital
Therapeutic action
- Antibacterial (antibiotic) of the penicillin group, acting particularly on penicillinaseproducing staphylococci
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Staphylococcal infections resistant to other antibiotics: chronic osteomyelitis, pulmonary staphylococcal infections of the new-born.
Preparation and route of drug administration
- Vials of powder of 250 mg and 500 mg for IM or IV injection
Dosage
- Child: 100 mg/kg/d divided in 3 or 4 injections
- Adult: 1
to 2 g/d divided in 3 or 4 injections
- If severe infections, the dose can be
doubled: maximum 6 g/d.
FIGURE
Duration
- Minimum 7 days of antibiotic therapy.
- Pulmonary
staphylococcal infections of the new-born: 10 days.
- Change to oral
treatment as soon as possible.
Contra-indications, side-effects, precautions
- Do not administer if known allergy to penicillin.
- If
allergic reaction, stop treatment and refer to a doctor.
- Pregnancy: no
contra-indication
- Lactation:nocontra-indication
Remarks
- A little enters the cerebro-spinal fluid.
- Storage: keep
coal.
After preparation, the solution should be clear and must be used within 24 hours.
DEXAMETHASONE phosphate (Decadron(R), Oradexon(R).)
District hospital
Therapeutic action
- Hormone glucocorticoid
Indications
- Anaphylactic shock
- Status asthmaticus
- Acute
laryngitis with signs of respiratory distress
- Severe allergies: Quincke's
oedema
Preparation and route of drug administration
- Ampoule of 4 mg dexamethasone phosphate (4 mg/ml, 1 ml) for deep IM, IV injection or infusion
Sometimes, the dose is expressed in dexamethasone sodium
phosphate:
4 mg dexamethasone phosphate = 5 mg dexamethasone sodium
phosphate.
Dosage
- Child and adult: 0.5 to 10 mg/d depending on indication and severity
FIGURE
Duration: Depending on clinical progress; for the treatment of shock, a single injection can be sufficient
Contra-indications, side-effects, precautions
- Pregnancy: no contra-indication
- Lactation: no
contra-indication
Remarks
- If prolonged treatment, reduce the doses gradually, otherwise
adrenal failure may develop.
- 5 mg prednisolone has the same
anti-inflammatory activity as:
· 5 mg prednisone
· 4 mg methyl
prednisolone
· 0.75 mg dexamethasone
· 20 mg hydrocortisone
- Dexamethasone acetate (Dectancyl(R) is a suspension only used
for local treatments: intra- or peri-articular injection, peridural.
-
Storage: keep cool if possible.
DIAZEPAM (Tensium(R), Valium(R)
District hospital
Therapeutic action
- Anxiolytic, sedative
- Anticonvulsive
- Muscle relaxant
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Agitation
- Premedication in anaesthesia
- Convulsions,
eclampsia
- Tetanus
Preparation and route of drug administration
- Ampoule of 10 mg (5 mg/ml, 2 ml) for IM, slow IV injection or
rectal administration
- The injectable solution can also be used orally.
Dosage
- Agitation - Premedication child :0.3 mg/kg/injection adult :10
to 20 mg/injection
- Convulsions child :0.5 mg/kg/injection adult :25 mg or +
/injection
- Tetanus child :0.3 to 1 mg/kg/iniection adult :50 to 100
mg/injection
- For elderly patients, halve the dose.
- Newborn and child,
rectal administration: 0.5 mg/kg, repeat if necessary.
FIGURE
Duration
- Depending on clinical progress: 1 to 2 days.
- In case of
tetanus or convulsions: repeat every 6 hours.
- If convulsions do not stop
after the first injection, the same dose can be repeated 10 minutes later.
Contra-indications, side-effects, precautions
- Do not administer if respiratory depression.
- Risk of
respiratory depression if injected IV too quickly.
- IV, IM: painful
injection; rectal or oral administration are preferred.
- If administered IV
or rectally: dilute 1 to 5 = 10 mg in 10 ml.
- Signs of intoxication (5 times
the therapeutic dose): hypothermic coma.
- Risk of sedation when combined
with alcohol and other drugs that act on the central nervous system:
chlorpromazine (Largactil(R), phenobarbitone
(Gardenal(R)) and
chlorpheniramine (Teldvin(R)).
- When used intravenously, make sure that
respiratory equipment is available.
- Pregnancy: avoid, except if vital
risk
- Lactation: avoid
Remarks
- Treat also hyperthermia which often causes convulsions.
-
The diluted solution is normally cloudy.
- Storage: no special temperature
requirements
DIGOXIN (Lanoxin(R)..)
District hospital
Therapeutic action
- Cardiotonic (supports the cardiac contraction, slows down and regulates the cardiac rhythm)
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Heart failure, sinus arrhythmia (fibrillation, flutter,
paroxysmal tachycardia)
DIAGNOSED BY A DOCTOR
Preparation and route of drug administration
- Ampoule of 0.50 mg (0.25 mg/ml, 2 ml) for IM or slow IV injection
Dosage
- Child
· Initial dose : 0.010 mg/kg (= 10 mcg/kg), repeat 3 to 4
times/24 hours if necessary
· Maintenance dose: 0.010 mg/kg/d once daily
- Adult
· Initial dose : 0.25 to 0.5 mg/d, repeat 3 to 4 times/24
hours if necessary
· Maintenance dose: 0.25 mg/kg/d once daily
Duration: depending on clinical progress; change to oral treatment as soon as possible
Contra-indications, side-effects, precautions
- Do not administer if:
· bradycardia,
· ill defined heart rhythm
disorders.
- The pulse must be monitored closely at the beginning of the
treatment.
- The therapeutic dose is near the toxic dose.
- Signs of
overdose: nausea, vision problems, disorientation or confusion, rhythm problems,
problems of atrio-ventricular conduction. If so, decrease dose or stop the
treatment. Nausea or vomiting are early signs of overdose.
- Higher risk of
toxicity in case of hypokalemia (especially in combination with a diuretic
treatment) and in case of calcemia (do not inject calcium at the same
time).
- Administer with care in cases of renal failure.
- Pregnancy: no
contra-indication
- Lactation: no contra-indication
Remarks
- Storage: no special temperature requirements.
ERGOMETRINE and METHYLERGOMETRINE (Methergin(R).)
District hospital
Therapeutic action
- Uterotonic
Indications
- Treatment of post-partum and post-abortion haemorrhage
Preparation and route of drug administration
- Ampoule of 0.2 mg/ml, 1 ml of methylergometrine maleate
-
Ampoule of 0.5 mg/ml, 1 ml of ergometrine maleate for IM, slow IV or intramural
injection (injection in the uterus)
Dosage
- 0.2 mg/injection, to be repeated if necessary every 2 to 4
hours depending on urgency (0.2 mg = 1 ml of methylergometrine = 0.4 mg of
ergometrine)
If bleeding persists after 3 injections, refer to a doctor.
-
Do not exceed a total of 5 doses.
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Before administration, be sure that the expulsion of the
placenta is complete.
- Do not administer during delivery.
- Do not
administer in cases of severe hypertension, pre-eclampsia.
- Pregnancy:
CONTRA-INDICATED
- Lactation :avoid
Remarks
- Before using this drug, be sure there is no multiple
pregnancy. Do not use before the birth of the last child.
- Do not confuse
with ergotamine, a related drug, used for totally different indications.
-
Storage: refridgerated
· Do not freeze.
· The colour of the solution is
normally white to pink; if it becomes yellow/green, the solution has
deteriorated.
· Methylergometrine is as sensitive to heat as
ergometrine.
FUROSEMIDE = FRUSEMIDE (Lasix(R).)
District hospital
Therapeutic action
- Diuretic
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
Emergency treatment of:
- Oedema caused by renal, heart or liver failure
-
Hypertensive crisis
Preparation and route of drug administration
- Ampoule of 20 mg (10 mg/ml, 2 ml) for IM or slow IV injection
Dosage
- Child: 0.5 to 1 mg/kg/injection
- Adult: 20 to 40
mg/injection
- In cases of acute pulmonary oedema, up to 250 mg can be given.
FIGURE
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer in cases of oedema caused by
kwashiorkor.
- Risk of hypokalemia (increased toxicity of digoxin if
administered simultaneously).
- Pregnancy:avoid
- Lactation: no
contra-indication
Remarks
- In case of prolonged treatment, change to oral treatment as
soon as possible, after the injectable emergency treatment.
- Storage: keep
below 30°C.
GENTAMICIN (Cidomycin(R), Garamycin(R), Gentallin(R).)
District hospital
Therapeutic action
- Antibacterial (antibiotic)
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Severe infections caused by bacteria resistant to other
antibacterials (gram negative, pyocyanic): septicemia, osteomyelitis.
-
Severe upper urinary tract infections: pyelonephritis.
Preparation and route of drug administration
- Ampoule of 10 mg (10 mg/ml, 1 ml) for IM or slow IV injection
or infusion
- Ampoule of 40 mg (20 mg/ml, 2 ml) for IM or slow IV injection
or infusion
- Ampoule of 80 mg (40 mg/ml, 2 ml) for IM or slow IV injection
or infusion
- Ampoule of 160 mg (80 mg/ml, 2 ml) for IM or slow IV injection
or infusion
Dosage
- Child and adult: 3 to 6 mg/kg/d divided in 2 or 3 injections
FIGURE
Duration: depending on indications and clinical progress: 7 days minimum Limit the duration of the treatment because of the risk of toxicitv.
Contra-indications, side-effects, precautions
- Do not administer if:
· renal failure,
· hearing and vestibular problems
(dizziness),
· allergy to gentamicin.
- Risk of renal, cochlear and vestibular toxicity.
-
Potentiates the action of muscle relaxants and certain general anaesthetics:
risk of respiratory paralysis.
- Do not use with potent diuretics
(furosemide).
- Gentamicin can be used in combination with a penicillin
(benzyl penicillin or ampicillin), but only on medical advice.
- Gentamicin
must not be mixed with other products in the same syringe or infusion, specially
with penicillin.
- Pregnancy: avoid
- Lactation :avoid
Remarks
- This drug has no effect on gonorrhea and syphilis.
- Does
not enter the cerebrospinal fluid (cannot be used in the treatment of
meningitis).
- Storage: keep below 30°C.
When using plastic syringes, inject immediately after preparation. The solution must be clear.
HYDRALAZINE (Apresoline(R).) and DIHYDRALAZINE (Nepressol(R).)
District hospital
Therapeutic action
- Antihypertensive with vasodilatory action
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Hypertensive crisis and especially eclampsia and pre-eclampsia
Preparation and route of drug administration
- Ampoule of 20 mg (20 mg/ml, 1 ml and 10 mg/ml, 2 ml) of powder for IM or slow IV injection or infusion
Dosage
- Adult: 5 to 20 mg/injection depending on clinical situation;
this dose can be repeated after 20 to 30 minutes.
- Infusion: dilute 4
ampoules in 500 ml sodium chloride 0.9%; increase infusion rate progressively up
to 30 drops/minute; do not dilute in glucose solutions which inactivates
hydralazine.
- Do not exceed indicated doses.
- In case of overdose
(uncontrolled hypotension), use a plasma substitute, preferably a polygeline
fluid (Haemacel(R)).
- If the hypertension is under control, reduce the doses
progressively. A sudden stop can provoke a hypertensive crisis.
FIGURE
Duration: depending on clinical progress; change to oral treatment as soon as possible
Contra-indications, side-effects, precautions
- Do not administer if:
· coronary insufficiency,
· recent myocardial
infarction,
· tachycardia.
- Take care when administering to elderly patients or patients
who have had cerebrovascular accidents in the past.
- Do not combine with
adrenaline.
- Pregnancy: no contra-indication
- Lactation: no
contra-indication
Remarks
- Storage: keep below 30°C.
HYDROCORTISONE phosphate, succinate, hemi-succinate (Efcortesol(R), Solu-cortef(R).)
District hospital
Therapeutic action
- Glucocorticoid hormone
Indications
- Anaphylactic shock
- Status asthmaticus
- Acute
laryngitis with signs of respiratory distress
- Severe allergies: Quincke's
oedema
Preparation and route of drug administration
- Vial of powder of 100 mg for IM or IV injection or infusion
There are also other doses. Adapt dosage accordingly.
Dosage
- Child: 1 to 5 mg/kg/d divided in 2 or 3 injections
- Adult:
100 mg/injection, repeat if necessary
FIGURE
Duration: depending on clinical progress; change to oral treatment as soon as possible
Contra-indications, side-effects, precautions
- Avoid prolonged administration if:
· peptic ulcer,
· diabetes
· cirrhosis.
- Increases the toxicity of digoxin.
- Pregnancy: avoid,
particularly during the first 3 months
- Lactation: no contra-indication
Remarks
- 5 mg prednisolone has the same anti-inflammatory activity as:
· 5 mg prednisone
· 4 mg methyl
prednisolone
· 0.75 mg dexamethasone
· 20 mg hydrocortisone
- Hydrocortisone acetate suspension is only used as a local
treatment: intra- or periarticular injection, epidural.
- Storage: keep below
30°C.
HYDROXOCOBALAMIN = VITAMIN B12 (Cobalin(R), Docemine(R), Novobedouze(R), Redisol(R).)
District hospital
Therapeutic action
- Vitamin
Indications
- Biermer anaemia (due to decreased absorption of vitamin
B12).
- Intoxication with cyanide ions, caused by a diet based on
insufficiently prepared cassava.
Preparation and route of drug administration
- Ampoule of 1 mg/ml, 1 ml (1 mg = 1,000 microgrammes) for IM injection
Dosage
- Child and adult
· Initial treatment: 1 mg/d or 3 times/week up to a total
dose of 10 mg
· Followed by :1 mg/month
Duration
- Biermer anaemia: continue for life.
Contra-indications, side-effects, precautions
- Do not administer in cases of malignant tumor.
- May cause
allergic reactions (urticaria, erythema.), pain at injection site, acne.
-
Colors urine red.
- Pregnancy: no contra-indication
- Lactation: no
contra-indication
Remarks
- Cyanocobalamin has the same indications, the same preparation
and the same dosage.
- Except for Biermer anaemia, lack of vitamin B12
(stored in the liver) is rare. Daily needs: 0,002 to 0,004 mg.
- Vitamin B12
at high doses is recommended as an antalgic by certain manufacturers (2 mg, 10
mg, 20 mg/ampoule): this antalgic activity has not been proven.
- Storage:
keep below 15°C.
HYOSCINE BUTYLBROMIDE = BUTYLSCOPOLAMINE = BUTYLHYOSCINE (Buscopan(R).)
District hospital
Therapeutic action
- Antispasmodic, parasympatholytic
Indications
- Spasms of the digestive and uro-genital tract (colics, ulcers and severe gastritis)
Preparation and route of drug administration
- Ampoule of 20 mg (20 mg/ml, 1 ml) for IM or IV injection
Dosage
- Child: 0.3 to 1 mg/kg/injection
- Adult: 10 mg/injection
It is possible to repeat the injection if necessary.
FIGURE
Duration: depending on clinical progress: single dose or 1 to 3 days
Contra-indications, side-effects, precautions
- Do not administer if:
· urinary retention, cardiac problems, glaucoma,
·
high fever in children: loss of transpiration, risk of hyperpyrexia, anoxia,
convulsions, cardio-respiratory arrest.
- May cause: dry mouth, constipation, dizziness, headache.
-
Do not combine with chlorpromazine or promethazine.
- Do not use for minor
symptoms.
- Pregnancy: avoid, particularly in the third trimester of
pregnancy, NO PROLONGED TREATMENTS
- Lactation: avoid, NO PROLONGED
TREATMENTS
Remarks
- Storage: no special temperature requirements.
KETAMINE (Ketalar(R), Ketanest((R).)
District hospital
Therapeutic action
- General anaesthetic
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- General anaesthesia for short interventions
Preparation and route of drug administration
- Ampoule of 10 mg/ml (5 ml and 20 ml) for IM or IV injection or infusion of 50 mg/ml (5 ml and 10 ml) for IM or IV injection or infusion of 100 mg/ml (5 ml) for IM or IV injection or infusion
Dosage
- Child and adult
· IV : 2 mg/kg injected slowly over 1 to 2 minutes. The
anaesthesia lasts for 5 to 10 minutes
· IM: 10 mg/kg in deep IM over 3
to 4 minutes. The anaesthesia begins after 10 minutes and lasts for 12 to 25
minutes.
Duration: depending on the duration of the intervention
To prolong the anaesthesia, repeat with half dose injection.
Contra-indications, side-effects, precautions
- Do not administer if:
· arterial hypertension, intracranial or intraocular
pressure
· renal or heart failure or pre-eclampsia.
- Risk of hypertension, hallucinations on waking (less frequent
with children or when injected IM).
- Use with care for obstetric cases:
passes the placenta barrier.
- Give atropine premedication to prevent
hypersalivation and vagal reactions.
- Use diazepam as premedication.
-
Always have resuscitation and respiratory equipment available and ready for
use.
- Pregnancy: no contra-indication, except in case of pre-eclampsia; with
caesarian sections, there is a risk of the newborn having respiratory
problems.
- Lactation: no contra-indication
Remarks
- Do not mix in the same syringe with barbiturates (thiopentone,
phenobarbitone).
- Ketamine has no muscle relaxant properties.
- In
certain countries, ketamine is on the list of narcotics. In that case, follow
the national rules for imports, handling and storage.
- Storage: no special
temperature requirements
LIGNOCAINE = LIDOCAINE (Xylocaine(R), Xylocard(R).)
District hospital
Therapeutic action
- Local anaesthetic
Indications
- Local anaesthesia:
· suturing, whitlow (= panaris): solution of 1%.
·
dental care: solution of 2%, (with or without adrenaline)
Preparation and route of drug administration
- Solution of 1% (10 mg/ml), vials of 20 and 50 ml, for SC
injection (and infusion)
- Solution of 2%, (20 mg/ml), vials of 20 and 50 ml,
for SC injection (and infusion)
Dosage
- The volume to be injected depends on the surface area to be
anesthetized.
- Do not exceed:
Child: 5 mg/kg/injection
Adult: 200 mg = 20 ml solution of 1%
or 10 ml solution of 2%
FIGURE
Duration: single injection, to be repeated if necessary
Contra-indications, side-effects, precautions
- Do not administer if known allergy to lignocaine, problems of
blood coagulation or impairment of cardiac conduction.
- Lignocaine with
adrenaline:
· In dental care, adrenaline added to lignocaine prolongs
the anaesthesia.
· Do not administer solutions containing adrenaline for
the anaesthesia of the extremities (fingers, penis): risk of ischemia and
necrosis.
- When anaesthetizing the extremities, inject distally (at the
root), in circle, without tourniquet and without adrenaline.
- Do not use
lignocaine for the incision of abscesses: risk of spreading the infection.
-
Pregnancy: no contra-indication
- Lactation: no contra-indication
Remarks
- The anaesthesia sets in after 2 to 5 minutes and lasts 1 to
1.5 hours.
- Preferably use lignocaine 2% for dental applications.
- Do
not confuse with lignocaine 5% hyperbaric which is reserved for spinal
anaesthesia.
- The more concentrated the lignocaine, the more localised the
anaesthetic effect.
- To simplify the protocol, choose lignocaine 2% with
adrenaline for dental use and lidocaine 1% without adrenaline for skin
anaesthesia.
- Storage: keep below 30°C.
LIGNOCAINE Hyperbaric = LIDOCAINE Hyperbaric (Xylocaine(R) of 5% for spinal anaesthesia)
Special department
Therapeutic action
- Local or regional anaesthetic
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Spinal anaesthesia = injection in the cerebro-spinal fluid: anaesthesia for the surgery of the lower limbs and the lower abdomen (below the umbilicus)
Preparation and route of drug administration
- Ampoule of 100 mg (50 mg/ml, 2 ml, equals 100 mg lignocaine in a hyperbaric glucose solution), for injection in the cerebro-spinal fluid
Dosage
According to the weight of the patient:
- Adult (shorter than 1.55 m): 50 to 75 mg
- Average adult :
100 mg
- Heavy adult : 150 mg
FIGURE
Duration: the anaesthesia sets in after 2 to 3 minutes and lasts 90 minutes
Contra-indications, side-effects, precautions
- Spinal anaesthesia should not be applied if there is no proper
intubation and respiratory equipment.
- Do not administer in cases of :
· shock,
· disease of the central or peripheral
nervous system,
· septicemia, meningitis,
· coagulation
problems; severe haemorrhages, skin infection near the place of
injection,
· known allergy to local anaesthetics.
- May cause:
· hypotension which should be prevented by the
administration of a 500 ml ringer lactate infusion before spinal
anaesthesia,
· nausea, vomiting, often linked to hypotension,
·
sometimes urine retention,
· frequent headache after surgery.
- Use spinal anaesthesia only for adults.
- Before
anaesthesia, the patient should be premedicated with atropine.
- Before
spinal anaesthesia, the patient should be very well hydrated with ringer lactate
or isotonic sodium chloride (500 ml). There should be good venous access, and
the arterial pressure should be strictly monitored.
- Pregnancy: no
contra-indication
- Lactation: no contra-indication
Remarks
- Lignocaine hyperbaric is strictly reserved for spinal
anaesthesia.
- Storage: keep below 30°C.
METAMIZOL = DIPYRONE = NORAMIDOPYRINE (Nolotil(R), Novalgin(R), Novaminsulfon(R).)
RESERVE THIS DRUG FOR SERIOUS SITUATIONS WHERE NO OTHER TREATMENT IS POSSIBLE:
- it is potentially dangerous;
- it is not included in the
WHO essential drug list;
- its marketing is forbidden in several
countries;
- its use is never justified as a first-line treatment.
District hospital
Therapeutic action
- Analgesic
- Antipyretic
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Severe pain
- High fever
Preparation and route of drug administration
- Ampoule of 1 g (500 mg/ml, 2 ml) for IM, SC or slow IV injection or infusion
Dosage
- Child: 10 mg/kg/injection
- Adult: 500 mg/injection
FIGURE
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer if gastric ulcer.
- SEVERE AND LETHAL
CASES OF AGRANULOCYTOSIS HAVE BEEN FOUND. THE RISK IS UNPREDICTABLE AND
INDEPENDENT OF THE DOSE ADMINISTERED.
- Pregnancy: avoid
- Lactation:
avoid
Remarks - Storage: no special precautions.
METOCLOPRAMIDE (Anausin(R), Maxolon(R), Primperan(R), Reglan(R).)
District hospital
Therapeutic action
- Anti-emetic
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Vomiting
Preparation and route of drug administration
- Ampoule of 10 mg (5 mg/ml, 2 ml) for IM or slow IV injection
Dosage
- Adult: 5 to 10 mg/injection 1 to 3 times per day, IM or slow IV injection
FIGURE
Duration: depending on clinical evolution, as short as possible
Contra-indications, side-effects, precautions
- Contra-indicated in case of gastro-intestinal haemorrhage,
obstruction or perforation.
- In case of elevated doses or prolonged
treatments, risk of extrapyramidal disorder (agitation and spasms), specially in
young patients.
- Increase of crisis for epileptics and those suffering from
Parkinson's disease.
- Reversible methaemoglobinemia in newborns.
-
Association with propanthelin, hyoscine, atropine and chlorpromazine is not
advised.
- Risk of drowsiness.
- Pregnancy: no contra-indication
-
Lactation : avoid
Remarks
- It is most important to treat the cause of vomiting; look for
bowel obstruction or malaria.
- Storage: keep below 30°C.
OXYTOCIN (Pitocin(R), Syntocinon(R).)
District hospital
Therapeutic action
- Uterotonic
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Induction of delivery on medical indication
Preparation and route of drug administration
- Ampoule of 5 IU (5 IU/ml, 1 ml) for injection in infusion
-
Ampoule of 10 IU (10 IU/ml, 1 ml) for injection in infusion
Dosage
- 1 to 5 IU diluted in 500 ml isotonic solution in a very slow infusion :2 to 4 drops a minute. Increase the dose progressively until the contractions are normal: maximum 40 drops a minute.
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer if:
· hypertonia of the uterus,
· fragile uterus:
former caesarian section,
· placenta praevia,
· pre-eclampsia.
- The cervix of the uterus should be dilated (3 to 4 cm) and
effacing.
- The foetal membranes should be ruptured.
- The foetus must be
monitored throughout, since there is a risk of fetal distress.
Remarks
- If not contra-indicated, preferably use (methyl)-ergometrine
for uterine atonies and postpartum haemorrhage.
- Storage: refrigerated
Do not freeze.
PENTAZOCINE (Fortal(R).)
District hospital
Therapeutic action
- Central analgesic (opioid analgesic)
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Severe pains not responding to other analgesics
Preparation and route of drug administration
- Ampoule of 30 mg (30 mg/ml, 1 ml) for IM, slow IV or SC injection, infusion or rectal administration
Dosage
- Child (above 3 years): 0.5 mg/kg/injection for slow IV
injection 1 mg/kg/injection for IM or SC injection
- Adult: 30 to 60
mg/injection, repeat every 3 to 4 hours if necessary
FIGURE
Duration: depending on indications and clinical progress
Contra-indications, side-effects, precautions
- Do not administer if:
· liver impairment,
· respiratory
depression,
· head injury.
- May cause: sedation, dizziness, hypotension, respiratory
depression.
- Prolonged treatment can cause addiction.
- Signs of
overdose: respiratory depression, hypotension, hypothermia.
- Pregnancy
:avoid
- Lactation: avoid
Remarks
- In some countries, pentazocine is on the list of narcotics. In
that case, follow the national rules for imports, handling and storage.
-
Storage: keep cool.
PHENOBARBITONE = PHENOBARBITAL (Gardenal(R), Luminal(R).)
District hospital
Therapeutic action
- Anticonvulsive, sedative and hypnotic
Indications
- Epilepsy: tonic-clonic ("grand mal") and partial (focal) seizures
Preparation and route of drug administration
- Ampoule of 200 mg (100 mg/ml, 2 ml) for deep IM or slow IV injection
Dosage
- Child and adult: 3 to 5 mg/kg/d (maximum 200 mg/d)
- Do not
exceed indicated doses.
Duration: depending on clinical progress; change to oral treatment as soon as possible
Contra-indications, side-effects, precautions
- Do not administer in case of respiratory depression.
-
Depresses the central nervous system: drowsiness, respiratory depression.
-
Risk of sedation when combined with alcohol and other drugs that act on the
central nervous system: diazepam (Valium(R)), chlorpheniramine (Teldvin(R)) and
chlorpromazine (Largactil(R)).
- Pregnancy: avoid (refer to a doctor)
-
Lactation: no contra-indication
Remarks
- For convulsions, in cases of extreme agitation and in
emergencies, it is better to use diazepam (Valium(R)).
- Phenobarbitone
should be injected in glass syringes; if not available, inject immediately after
filling the syringe.
- Do not mix phenobarbitone with other drugs in the same
syringe.
- Storage: no special temperature requirements.
PHYTOMENADIONE = VITAMIN K1 (Konakion(R).)
District hospital
Therapeutic action
- Vitamin
Indications
- Haemorrhagic disease of the newborn: treatment and
prevention.
- Haemorrhage in patients subject to an anti-coagulant treatment
(anti-vitamin K).
- Lack of vitamin K.
Vitamin K has no immediate
haemostatic action: it is not indicated in cases of haemorrhagia of traumatic
origin. Its therapeutic indications are very limited since vitamin K1 deficiency
is rarely seen.
Preparation and route of drug administration
- Ampoule of 1 mg/ml, 1 ml for oral, IM or IV injection
Dosage
- Haemorrhagic disease of the newborn: oral
· prevention: 1 mg in a single dose at birth
·
treatment : 1 mg/d x 7 days
- Prophylaxis and treatment of lack of vitamin K: 10 to 20 mg/IM
injection
- Haemorrhagia due to anti-vitamin K: 10 to 20 mg/slow IV injection
Duration
Contra-indications, side-effects, precautions
- Injectable administration is contra-indicated in newborn and
infants.
- Risk of haematoma at IM injection point.
- Risk of allergic
reactions by IV injection.
- Pregnancy: no contra-indication
- Lactation:
no contra-indication
Remarks
- Vitamin K should not be mixed with another medicine.
- Use
glass syringe.
- Storage:
PROCAINE PENICILLIN = PROCAINE BENZYL PENICILLIN = PROCAINE PENICILLIN G
District hospital
Therapeutic action
- Antibacterial (antibiotic) with prolonged action (24 hours)
Indications
- Pneumonia
- Gonorrhoea
- Anthrax
- Prophylaxis of
septicemia following abortion
Preparation and route of drug administration
- Vial of powder of 3 M IU procaine penicillin for IM injection, NEVER IV injection or infusion After diluting the powder with distilled water, the suspension has to be shaken before it can be used.
Dosage
- Child : 50,000 to 100,000 IU/kg/d
- Adult: 1 to 4 M IU/d
FIGURE
Duration
- Gonorrhea: single dose divided between each buttock. COMBINE
WITH A DOSE OF 1 G PROBENECID TABLETS at the time of injection.
- Other
indications: 5 days minimum.
Contra-indications, side-effects, precautions
- Do not administer if known allergy to penicillin.
- If
allergic reaction, stop treatment and refer to a doctor.
- For children under
1 year, administer with care: risk of convulsions and allergies caused by the
procaine.
- Pregnancy: no contra-indication
- Lactation: no
contra-indication
Remarks
- Procaine penicillin is penicillin G bound to procaine, which
gives it an action lasting for 24 hours.
- 1 g procaine penicillin equals 1 M
IU penicillin.
- Procaine penicillin is replaced in some countries by a
mixture of procaine penicillin and penicillin G (3 + 1 M IU), often called
procaine penicillin forte (PPF) which has the advantage of the immediate action
of penicillin G, followed by the delayed action of procaine penicillin.
-
Penicillin benethamine (Bi-clinocilline(R)) has a prolonged action (2 to 3
days): administer every other day.
- In case of gonorrhea, ALWAYS TREAT THE
PARTNER AS WELL.
- Storage: keep below 30°C.
After preparation, the
suspension must be used within 24 hours.
PROCAINE BENZYL PENICILLIN + BENZYL PENICILLIN = PROCAINE PENICILLIN FORTE = PPF (Bicillin(R).)
District hospital
Therapeutic action
- Antibacterial (antibiotic) with double action prolonged (24 hours) by the procaine penicillin and immediate by the benzyl penicillin
Indications
- Pneumonia
- Gonorrhoea
- Anthrax
- Prophylaxis of
septicemia following abortion
Preparation and route of drug administration
- Vial of powder of 3 M IU procaine penicillin + 1 M IU benzyl penicillin (penicillin G) for IM injection, NEVER IV injection or infusion. After diluting the powder with distilled water, the suspension has to be shaken before it can be used.
There are also vials of 600,000 IU procaine penicillin + 300,000 IU benzyl penicillin.
Dosage
- Child: 50,000 to 100,000 IU/kg/d
- Adult: 1 to 4 MIU/d
FIGURE
Duration
- Gonorrhea: single dose divided between each buttock. COMBINE
WITH A DOSE OF 1 G PROBENECID TABLETS at the time of injection.
- Other
indications :5 days minimum.
Contra-indications, side-effects, precautions
- Do not administer if known allergy to penicillin.
- If
allergic reaction, stop treatment and refer to a doctor.
- For children under
1 year, administer with care: risk of convulsions and allergies caused by the
procaine.
- Pregnancy: no contra-indication
- Lactation: no
contra-indication
Remarks
- Compared to procaine penicillin, PPF has the advantage of the
immediate action of penicillin G, and 24 hours action of procaine
penicillin.
- In case of gonorrhea, ALWAYS TREAT THE PARTNER AS WELL.
-
Storage: keep below 30°C.
After preparation, the suspension must be used within 24 hours.
PROMETHAZINE (Phenergan(R).)
District hospital
Therapeutic action
- Anti-emetic
- Antihistaminic
- Sedative
Indications
- Vomiting
- Allergic reactions due to:
· contact, seasons.
· drugs, insect bites, food.
Preparation and route of drug administration
- Ampoule of 50 mg (25 mg/ml, 2 ml) for IM or IV injection or infusion
Dosage
- Child: 1 mg/kg/d
- Adult: 25 to 100 mg/d
FIGURE
Duration: depending on clinical progress; change to oral treatment as soon as possible
Contra-indications, side-effects, precautions
- Risk of drowsiness.
- Risk of sedation when combined with
alcohol and other drugs that act on the central nervous system: diazepam
(Valium(R)), phenobarbitone (Gardenal(R)), chlorpromazine (Largactil(R)) and
chlorpheniramine (Teldvin(R)).
- In case of anaphylactic shock: use
adrenaline and/or corticoid-steroids.
- Pregnancy: avoid in the first 3
months of the pregnancy and in the perinatal period
- Lactation: no
contra-indication
Remarks
- The use of promethazine as an anti-emetic can mask the
symptoms of the causal disease. Do not use for convenience.
- Storage: keep
below 30°C.
QUININE Salts
District hospital
Therapeutic action
- Antimalarial
Indications
- Plasmodium falciparum malaria, pernicious attack, when the patient cannot take oral treatment: cerebral malaria (coma), convulsions, vomiting and diarrhoea
Preparation and route of drug administration
- Ampoules of 200 mg (100 mg/ml, 2 ml), 300 mg (150 mg/ml, 2 ml) and 600 mg (300 mg/ml, 2 ml) for infusion
There are also other doses. Adapt dosage accordingly. IM injection is possible, but only when absolutely necessary because there are numerous complications: paralysis of sciatic nerve, muscular necrosis, infections.
Dosage
- Child and adult: 30 mg/kg/d in slow infusion divided in 3 infusions of 10 mg/kg in 500 ml glucose 5% administered slowly (4 hours or 40 drops/minute)
FIGURE
Doses and dosages are expressed in salts. They are all equal: formiate or bi-chlorhydrate (quinine dihydrochloride).
Duration
- One day or more until oral treatment is possible: change to quinine or chloroquine tablets according to national protocol.
Contra-indications, side-effects, precautions
- Possible allergic reactions.
- Never inject in direct IV,
always dilute: risk of cardiac depression. Infuse slowly. Do not combine with
chloroquine.
- Signs of overdose: obvious hearing and visual
disturbances.
- If shock or renal failure: halve the dose.
- If
convulsions, combine with diazepam (Valium(R)).
- Pregnancy: no
contra-indication (do not exceed the therapeutic doses)
- Lactation: no
contra-indication
Remarks
- In some regions of South-East Asia, the combination of quinine
+ tetracycline (25 mg/kg/d) or doxycycline (10 mg/kg/d orally) for 10 days is
necessary because of resistance.
- Storage: keep below 30°C.
SALBUTAMOL = ALBUTEROL (Salbulin(R), Salbutan(R), Ventolin(R).)
District hospital
Therapeutic action
- Bronchodilator
- Uterorelaxant
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Treatment of severe asthmatic crisis and of status
asthmaticus
- Emergency treatment of threatening premature delivery, except
in case of toxemia or haemorrhage
Preparation and route of drug administration
- Ampoule of 0.5 mg/ml, 1 ml for SC, IM injection or infusion
Dosage
- Asthma
Adult: 0.5 mg SC or IM to be repeated every 4 to 6 hours if necessary
- Threatening premature delivery
· Emergency treatment: 5 mg (10 ampoules) in infusion,
diluted in 500 ml of dextrose; approximately 30 to 40 drops/minute, to be
progressively increased until contractions stop, then decrease dosage.
Injectable salbutamol should only be used under strict medical surveillance,
with regular checking of the pulse, blood-pressure and the ftal heart
rate.
· Maintenance dose: 2 mg/d divided in 4 IM injections; change to
oral medication as soon as possible.
Duration: depending on clinical progress
Contra-indications, side-effects, precautions
- Do not administer to children.
- Do not administer in cases
of myocardial infarction and acute coronary insufficiency.
- Administer with
care to patients with cardiac insufficiency, arrhythmia, high bloodpressure,
haemorrhage, diabetes, hyperthyroidism.
- May cause: tachycardia, trembling,
dizziness, headache.
- Do not use with beta-blocking agents
(propranolol).
- Pregnancy: no contra-indication
- Lactation: no
contra-indication
Remarks
- Storage: keep below 30°C.
STREPTOMYCIN
Special department
Therapeutic action
- "Antituberculous" antibacterial (antibiotic)
Indications
- Only for tuberculosis, bacteriologically proven if possible
Preparation and route of drug administration
- Vials of powder of 1 g and 5 g (base) to be diluted respectively in 5 or 10 ml sterile water, for IM injection, NEVER IV injection of infusion.
Dosage
According to national protocol.
For information:
- Child: 20 mg (base)/kg/d in 1 injection
- Adult: 750 mg to
1 g/d depending on the weight of the patient, in 1 injection
- Do not exceed
a total dose of 60 g because of the oto-toxicity of streptomycin.
Duration: according to national protocol (generally 2 months)
Contra-indications, side-effects, precautions
- Do not administer if severe renal failure.
- Stop treatment
if dizziness, buzzing of ears, hearing loss.
- Pregnancy:
CONTRA-INDICATED
- Lactation: CONTRA-INDICATED
Remarks
- Streptomycin is also used for the treatment of plague and
brucellosis. Other antibacterials are active against these diseases. Reserve
this drug for the treatment of tuberculosis.
- Warning: antituberculous
treatment should only be prescribed in the context of an organised program (well
established protocol, regular patient checks and the possibility of laboratory
examination).
- Streptomycin should not be used alone, but in combination
with other "antituberculous" drugs to avoid resistance.
- Storage: keep cool.
After preparation, the solution must be clear and can be kept for only one hour.
SULFADOXINE + PYRIMETHAMINE (Fansidar(R).)
Therapeutic action
- Antimalarial
Indications
- Treatment of Plasmodium falciparum malaria resistant to chloroquine and other amino-4 quinolines (amodiaquine(R).)
Preparation and route of drug administration
- Ampoule of 400 mg sulfadoxine + 20 mg pyrimethamine (200 mg sulfadoxine + 10 mg pyrimethamine/ml, 2 ml) for IM injection or infusion
Dosage
- Child: 25 mg/kg sulfadoxine in a single dose for IM injection
or infusion (1/2 amp./10 kg)
- Adult: 800 ma sulfadoxine in a single dose for
IM injection or infusion
- Never give in direct IV, always dilute.
FIGURE
Duration: single dose
Contra-indications, side-effects, precautions
- Do not administer if:
· allergy to sulfonamides,
· renal or liver
failure.
- May cause: gastro-intestinal problems, nausea, vomiting,
sometimes severe allergic reactions.
- Do not combine with chloroquine.
-
Avoid for children under 5 years.
- Pregnancy: CONTRA-INDICATED
-
Lactation: avoid
Remarks - Preferably use injectable quinine.
- Warning: there is an increasing number of resistant
strains.
- Storage: no special precautions
THIOPENTONE sodium = THIOPENTAL sodium = PENTOBARBITAL sodium (Pentothal(R).)
Special department
Therapeutic action
- Anaesthetic
- Anticonvulsive
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Induction of general anaesthesia
- Anaesthesia of short
duration (not more than 15 minutes)
- This drug has no analgesic action and
is not a muscle relaxant
Preparation and route of drug administration
- Vials of powder of 0.5 g or 1 g for IV injection, to be dissolved in a glucose 5% solution or in 0.9% NaCl solution (0.5 g in 20 ml)
Dosage
- Dose:
· average :1 to 10 mg/kg
· total maximum :1 g
- Induction of anaesthesia: test dose 50 mg, afterwards 100 to
200 mg in 20 seconds
- Lower dose for elderly patients.
Duration: depending on duration of the intervention
Contra-indications, side-effects, precautions
- Use only if intubation and ventilation equipment are
available.
- Do not administer in cases of shock.
- Do not administer to
ambulatory patients or to children under 4 years.
- May cause:
· apnoea, laryngospasm, bronchospasm,
· initial
bloodpressure drop.
- Possible depression of circulation and respiration if
overdose.
- Risk of pain and necrosis if extravenous or intra-arterial
injection.
- Use with care in cases of asthma, heart failure, liver, renal or
severe adrenal insufficiency, porphyria, myasthenia.
- The anaesthesia has to
be preceded by a premedication with atropine and, if necessary, with analgesics
and muscle relaxants.
- Pregnancy: use with care near term (causes foetus to
sleep)
- Lactation :avoid
Remarks
- The concentration should not exceed 2.5% due to risk of
thrombo-phlebitis.
- Do not mix with another injectable drug, nor with ringer
lactate.
- Storage: keep cool.
After preparation, the solution can be kept for up to 24 hours if kept cool.
Use of infusion solutions
Dextran
Dextrose -
Glucose
Half Strength Darrow's solution
Polygeline
Potassium
chloride
Ringer lactate (Hartmann)
Sodium bicarbonate
Sodium chloride
Use of infusion solutions
Choice of infusion solutions according to the indications
There is no justification for using more than 3 kinds of infusion solution:
- one kind for IV rehydration (ringer lactate is the most
suitable);
- one kind for dilution of IV injectable drugs (isotonic dextrose
solution is the most suitable);
- one kind for fluid replacement (best choice
is polygeline).
FIGURE
Precautions for the use of infusion solutions
- Read the labels on the infusion bottle (or bag) well to avoid
mistakes.
- Indicate on the label any drugs added to the infusion.
- If
drugs are added in a vial, think of the risks of:
· physical or chemical incompatibility,
·
contamination: strict asepsis.
- Inspect each bottle against the light to check its clarity: discard any bottles that show particles in suspension.
DEXTRAN (Macrodex(R), Rheomacrodex(R))
solution for INFUSION
District hospital
Preparation
- Bottle of 500 ml
Composition
- Dextran 40,000 or 70,000 (composition and concentration varies with manufacturer) in a sorbitol, glucose, NaCI or ringer lactate solution
Indications
- Restoring macromolecules and maintaining the blood pressure and volume. Fluid replacement in case of hypovolemic shocks: trauma, surgery and sepsis.
Contra-indications, side-effects, precautions, remarks
- Risk of inducing renal failure: do not exceed 1000 ml for an
adult and/or 500 ml/d if the treatment has to be prolonged.
- Risk of
haemostatic disorder.
- Risk of allergy.
- In case of dehydration, correct
electrolyte imbalance.
- Draw blood for type and cross-match before
infusing.
- Do not mix other drugs in the infusion solution.
- Storage:
keep below 30°C, but over 4°C.
The solution must be clear.
DEXTROSE 5% = GLUCOSE 5%
isotonic solution in INFUSION
District hospital
Preparation
- Bottle/bag of 500 ml of 5%
- Bottle/bag of 1 litre of 5%
Composition
- Isotonic solution: dextrose 5 g per 100 ml
Indications
- Infusion medium
- Intra-cellular dehydration (rare):
fevers, sunstroke
Contra-indications, side-effects, precautions, remarks
- This solution contains no electrolytes or lactate. Therefore
it is not recommended for the treatment of dehydration. Preferably use ringer
lactate. If this is not available, take a solution of dextrose 5% and add KCI (2
g/l) + NaCI (4 g/l).
- The solutions of dextrose 5% 1/2, 1/3 or 1/4 salted
have the same indications and inconveniences as the isotonic NaCI solution.
-
Do not confuse with the 10%, 15%, 30% and 50% hypertonic solutions.
-
Storage: keep below 30°C
DEXTROSE 30 or 50% = GLUCOSE 30 or 50%
hypertonic solution in
AMPOULE
District hospital
Preparation
- Ampoule of 10 ml of 30% or 50%
There are also ampoules of 20 ml and bottles of 50 ml, 500 ml
Composition
- Hypertonic solution: dextrose 30% = 3 g/10 ml dextrose 50% = 5 g/10 ml
Indications
- Energy supplementation (1 g dextrose provides 4 calories)
-
Hypoglycaemia
Contra-indications, side-effects, precautions, remarks
- Do not administer hypertonic solution IM or SC. The injections
must be given in slowly direct IV injection or in IV infusion.
- Storage:
keep below 30°C
Half Strenght DARROW'S SOLUTION
solution for INFUSION
District hospital
Preparation
- Bottle/bag of 500 ml
- Bottle/bag of 1 litre
Composition
- Varies with manufacturer. Example (ionic composition per
litre):
Sodium (Na+) : 61 mmol = 61 mEq
Potassium (K+) : 18 mmol = 18
mEq
Chloride(Cl-) : 51 mmol = 51 mEq
Bicarbonate : 27 mmol = 27 mEq
Indications
- Severe dehydration
Contra-indications, side-effects, precautions, remarks
- Isotonic solution without providing calories.
- This
solution has the disadvantage of not providing enough NaCl, but the advantage of
providing suitable quantities KCI. For prolonged use, double the amount or add
10% or 20%, NaCl by ampoule in order to obtain sufficient concentrations (1
ampoule per litre = 1 to 2 g NaCl).
- Preferably use ringer lactate when
available.
- There are also hypertonic solutions.
- Storage: keep below
30°C
POLYGELINE (Hcel(R).)
solution for INFUSION
District hospital
Preparation
- Bottle of 500 ml
Composition
- Varies with manufacturer. Example (ionic composition per litre):
|
Haemacel(R) |
Polygeline |
35 g/l |
Sodium (Na+) |
145.00 mmol = 145.00 mEq |
Potassium (K+) |
5.10 mmol = 5.10 mEq |
Calcium (Ca++) |
6.25 mmol = 12.50 mEq |
Chloride (Cl-) |
145.00 mmol = 145.00 mEq |
Magnesium (Mg++) |
---- |
Indications
- Fluid replacement in cases of hypovolemic shock: trauma, surgery and sepsis.
Contra-indications, side-effects, precautions, remarks
-This solution combines replacement of electrolytes and
macromolecules. It has almost no effect on haemostasis.
-Administer 1 or 2
bottles on average. Adapt dosage according to the needs of the patient.
-In
case of haemorrhagic shock, infuse one after the other. If polygelines are not
availabe, use ringer lactate, giving three times the lost volume.
-For other
forms of shock, infuse quickly until a good pulse reappears.
-Risk of
allergy.
-Draw blood for type and cross-match before infusing.
-Do not
dilute other drugs into this type of infusion.
Storage: stable between
18°C and +50°C.
Usable after freezing.
POTASSIUM Chloride 10%
hypertonic solution in AMPOULE
District hospital
Preparation
- Ampoule of 10 ml of 10% = 1 g KCI per ampoule
- Ampoule of
20 ml of 10% = 2 g KCl per ampoule
There are also ampoules of 10 ml and 20 ml of 7.5%, 15% and 20%. Adapt dosage accordingly.
Composition
Potassium chloride: 10 g per 100 ml
- Hypertonic solution
- Ionic composition:
potassium (K+): |
13.4 mmol per ampoule of 10 ml (13.4 mEq) |
|
26.8 mmol per ampoule of 20 ml (26.8 mEq) |
chloride (Cl-): |
13.4 mmol per ampoule of 10 ml (13.4 mEq) |
|
26.8 mmol per ampoule of 20 ml (26.8 mEq) |
Indications
- Treatment and prevention of hypokalemia
Contra-indications, side-effects, precautions, remarks
- Do not administer hypertonic solution IM or SC. Administer
slowly as direct IV injection or infusion (in dextrose 5%).
- Risk of
ventricular rhythm problems if injected too quickly : do not exceed 2 to 3 g
KCl/hour.
- If ringer lactate is not available, take a 5% solution of
dextrose and add KCl (2 g/l) + NaCl (4 g/l)
- Storage: no special precautions
RINGER LACTATE = COMPOUND SODIUM LACTATE SOLUTION = Hartmann's
solution
isotonic solution for INFUSION
District hospital
Preparation
- Bottle/bag 500ml
- Bottle/bag 1 litre
Composition
- Varies with manufacturer
- Most usual ionic composition per
litre:
Sodium (Na+) : 130.50 mmol = 130.50 mEq
Potassium (K+) : 4.02 mmol
= 4.02 mEq
Calcium (Ca++) : 0.67 mmol = 1.35 mEq
Chloride (Cl-) : 109.60
mmol = 109.60 mEq
Lactate : 28.00 mmol = 28.00 mEq
Indications
-Severe dehydration
Contra-indications, side-effects, precautions, remarks
-Isotonic solution without providing calories.
-Ringer
lactate provides appropriate quantities of electrolytes. It contains lactate
which transforms into bicarbonate in the body and corrects metabolic acidosis if
it exists (if haemodynamic and liver function are normal). WARNING, SOME
COMMERCIALLY AVAILABLE SOLUTIONS DO NOT CONTAIN LACTATE.
-It does not contain
much KCl (5 mEq/litre), but sufficient for short term use. For prolonged use
(after 2 to 3 days), a supplement of potassium is necessary. Add 1 or 2 g KCl
per litre = 1 to 2 ampoules of 10 ml KCl 10%/litre.
-For moderate and mild
dehydration, administer ORS (Oral Rehydration Salts).
-This solution can be
used for haemorrhagic shock. In that case, 3 times the lost volume has to be
infused.
Storage: keep below 30°C
SODIUM Bicarbonate 1.4%
isotonic solution for INFUSION
District hospital
Preparation
- Bottle/bag 500 ml
Composition
Sodium bicarbonate :1.4 g per 100 ml
- Isotonic solution
- Ionic composition per litre:
Sodium (Na+): 167 mmol = 167 mEq
Bicarbonate 167 mmol = 167 mEq
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Severe metabolic acidosis
Contra-indications, side-effects, precautions, remarks
- Do not use in case of metabolic alkalosis or respiratory
acidosis.
- Contains a high concentration of bicarbonate and sodium ions.
This is seldom justified in the case of metabolic acidosis caused by
dehydration. Poor monitoring of use may induce hypernatremia and
hypokalemia.
- Do not mix in the same infusion: penicillin, chloramphenicol,
aspirin, atropine, calcium, insulin, vitamins.
- Storage: keep below
30°C
SODIUM Bicarbonate 8.4%
hipertonic solution in AMPOULE
District hospital
Preparation
- Ampoule of 10 ml or 20 ml
Composition
Sodium bicarbonate: 8.4 g per 100 ml
- Hypertonic solution
- Ionic composition:
Sodium (Na+):
10 mmol = 10 mEq per ampoule of 10 ml
Bicarbonate : 10 mmol = 10 mEq per
ampoule of 10 ml
Indications PRESCRIPTIONS AND FOLLOW-UP OF TREATMENT MUST BE UNDER MEDICAL SUPERVISION
- Severe metabolic acidosis
Contra-indications, side-effects, precautions, remarks
- Do not administer hypertonic solutions IM or SC. Administer
under strict medical supervision, slowly direct IV injection or infusion (in
dextrose 5%).
- Do not use in case of alkalosis or respiratory acidosis.
-
Contains a high concentration of bicarbonate and sodium ions. This is seldom
justified in the case of metabolic acidosis caused by dehydration. Poor
monitoring of use may induce hypernatremia and hypokalemia.
- Do not mix in
the same infusion: penicillin, chloramphenicol, aspirin, atropine, calcium,
insulin, vitamins.
- Storage: keep below 30°C
SODIUM Chloride 0.9% = NaCl physiological salt = normal
saline
isotonic solution for INFUSION
District hospital
Preparation
- Bottle/bag of 500 ml or 1 litre of 0.9%
There are also ampoules of different volumes.
Composition
Sodium chloride :0.9 g per 100 ml
- Isotonic solution
- Ionic composition: Sodium (Na+) : 154
mmol per litre (154 mEq)
Chloride (Cl-) : 154 mmol per litre (154
mEq)
Indications
- Infusion medium (administration of drugs, instant
venous access)
Contra-indications, side-effects, precautions, remarks
- Do not use in case of water-salt retention, heart failure,
oedema and ascites due to cirrhosis.
- This solution contains neither lactate
nor potassium. Its use is therefore not recommended for the treatment of severe
dehydration. Preferably use ringer lactate.
- If ringer lactate is not
available, take a 5%, solution of dextrose and add KCI (2 g/l) + NaCl (4
g/l).
- Storage: keep below 30°C
SODIUM Chloride = NaCl
hypertonic solution in AMPOULE
District hospital
Preparation
- Ampoules of 10 ml or 20 ml of 10% and 20%
Composition
Sodium bicarbonate: 10 g per 100 ml and 20 g per
100 ml
- Hypertonic solution
- Ionic composition:
Sodium (Na+) :
1.7 mmol per litre (1.7 mEq), solution 10%
3.4 mmol per litre (3.4 mEq),
solution 20%
Chloride (Cl-): 1.7 mmol per litre (1.7 mEq), solution
10%
3.4 mmol per litre (3.4 mEq), solution 20%
Indications
- Hyponatremia
Contra-indications, side-effects, precautions, remarks
- Do not administer hypertonic solutions IM or SC. Administer
slowly direct IV injection or IV infusion.
- Do not use in case of water-salt
retention, heart failure, oedema and ascites due to cirrhosis.
- Storage:
keep below
30°C
Antiamaril vaccine
Antimeningococcal vaccine A +
C
Antitetanic serum
BCG vaccine
DPT vaccine
Measles vaccine
Oral
antipoliomyelitis vaccine
Tetanus vaccine
Vaccines and sera are sensitive products to heat and light. Even if new productions give vaccines more stable to heat (called "thermostable"), they still have to be stocked in the refrigerator between 0 and 8°C, and cold chain strictly have to be respected during transport.
Information mentioned hereafter concerning stability only helps to decide if vaccines stocked during a short time at a temperature superior to 8°C could be used or have to be destroyed.
ANTIAMARIL VACCINE (Stamaril, Amarela)
Health clinic
Indications
- Prevention of yellow fever
- Must be integrated in the
national Expanded Program of Immunization (EPI)
Presentation and route of drug administration
- Live attenuated viral vaccine, freeze-dried powder to be
diluted with a special solvent. There are vials of powder for 10 doses, 20 doses
and 50 doses, with the vials of solvent.
- Administration in deep
subcutaneous or IM injection in the deltoid muscle of the arm.
Dosage and vaccination scheme
- Child and adult :0.5 ml
- May be administered as of the age
of 6 months (4 months during epidemics)
- Efficiency: after 10 days for 10
years
Contra-indications, side-effects, precautions
- Contra-indicated in case of immunodeficiency and genuine
allergy to eggs.
- Local reaction possible in 20% of the cases.
- Fever
and myalgia 4 to 10 days after the injection in 5 to 10% of the cases.
-
Complications:
· neurological reactions (encephalitis),
· allergic
reactions: erythema, urticaria, oedema (1 case in 1 million doses).
- Pregnancy: this vaccine can be administered to pregnant women
only if there is a major risk of infection (epidemic)
-Lactation: no
contra-indication
Remarks
- It is always better to use the solvent delivered with the
vaccine. In case of loss, we recommend sodium chloride 0.9% or water for
injection as the solvent, using the same quantity as the solvent delivered.
-
Combinations
· Simultaneous combination (at the same time, in a separate
syringe)
Compatible with other vaccines given by EPI; contra-indicated with
cholera and typhoid A and B.
· Combinations with other vaccines (in the
same syringe)
Possible with measles vaccine.
- Storage
· Freeze-dried powder
Store between O and 8°C.
Freezing (-20°C) recommended for long periods. At 37°C, freeze-dried
vaccine is stable for 7 to 14 days.
· After dilution
Between O and
8°C, the vaccine is stable for 3 hours; at 37°C, it becomes
unefficient in less than 1 hour. This vaccine is one of the most sensitive to
heat. At the moment of dilution, the solvent must be at the same temperature as
the vaccine (0 to 8°C).
ANTIMENINGOCOCCAL VACCINE A + C
Health clinic
Indications
- Prevention of meningococcal meningitis type A and C
Presentation and route of drug administration
- Polysaccharide vaccine from meningococcal serogroup A and C,
freeze-dried powder to be diluted with a solvent.
There are vials of powder
for 10 doses and 50 doses.
- Administration in deep subcutaneous or IM
injection in the deltoid muscle of the arm.
Dosage and vaccination scheme
- Child and adult :0.5 ml
- Age of administration
· meningococcus type A: from 3 months of age
·
meningococcus type C: the vaccine is effective only if given after 18 months of
age
- Efficiency: 1 week after injection for 3 years (if injection after 2 years of age)
Contra-indications, side-effects, precautions
- There are no contra-indications.
- There are no
side-effects, vaccine is well tolerated.
- In some cases, redness at
injection site for 24 hours.
- In 0.4% of the cases, fever (up to
38.5°C).
- Pregnancy: no contra-indication
- Lactation: no
contra-indication
Remarks
- It is always better to use the solvent delivered with the
vaccine. In case of loss, we recommend sodium chloride 0.9% or water for
injection as the solvent, using the same quantity as the solvent delivered.
-
Combinations
· Simultaneous combination (at the same time, in a separate
syringe)
Compatible with other vaccines given by EPI.
· Combinations
with other vaccines (in the same syringe)
Possible with measles and
antiamaril vaccine.
- Storage
· Freeze-dried powder
Store between 0 and
8°C.
Freezing (-20°C) recommended for long periods.
The
freeze-dried vaccine is very stable (18 months: at 37°C; 4 weeks: at
45°C).
· After dilution
Store between 0 and 8°C is
possible.
Vaccine remains stable for 4 days at 37°C, but, for asepsis,
it is preferable to destroy the vial when the vaccination session is over.
At
the moment of dilution, the solvent must be at the same temperature as the
vaccine (0 to 8°C).
ANTITETANIC SERUM equine tetanus antitoxin
District hospital
Therapeutic action
- Neutralises the tetanus toxin
Indications
- Prevention of tetanus for non-vaccinated wounded patients
-
Treatment of tetanus
Preparation and route of drug administration
- Ampoule (or ready-to-use syringe) of 1,500 IU/ml, 1 ml for SC or IM injection Serum equine origin (horse)
Dosage
- Prevention of tetanus: 1,500 IU
- Treatment of tetanus
· Newborn: 1,500 IU
· Child : 5,000 IU
·
Adult : 10,000 IU
It is necessary to administer the injection following the Besredka method: inject 0.1 ml, wait 15 minutes leaving the needle and syringe in place, inject 0.25 ml and wait 30 minutes; if there is no reaction, finish the injection.
- Efficiency: during 1 to 2 weeks.
Duration: single dose
Contra-indications, side-effects, precautions
- Do not administer if known allergy to anti-tetanic serum.
-
May cause severe, sometimes deadly, allergic reactions.
- Anti-tetanic serum
only has a transitory action and must be combined with anti-tetanic
vaccination.
- Pregnancy: CONTRA-INDICATED
- Lactation: no
contra-indication
Remarks
- In cases of tetanus, immediately apply antibiotic and
symptomatic treatment.
- Anti-toxin from human origin (tetanus
immunoglobulin) exists. It does not cause allergic reactions and is not
contra-indicated during pregnancy, but it is much more expensive.
- This
product is not included in the WHO essential drug list.
- Storage: keep
refrigerated, between 2 and 8°C. Do not freeze.
BCG VACCINE (Glutamate BCG vaccine)
Health clinic
Indications
- Prevention of tuberculosis
- Must be integrated in the
national Expanded Program of Immunization (EPI)
Presentation and route of drug administration
-Live attenuated bacterial vaccine, freeze-dried powder to be
diluted with a solvent. There are vials of powder for 10 doses, 20 doses and 50
doses, with the vials of special solvent.
-Injections are given strictly
intracutaneously ("pig skin") in the middle third of the upper arm, external
side.
Dosage and vaccination scheme
- 0.05 ml for child under 1 year.
- 0.10 ml for child abeve 1
year.
-BCG is given at birth in a single dose. If after 3 months, there is no
scar, BCG vaccine must be repeated (maximum 3 times).
- Efficiency: (80%)
during 10 years.
Contra-indications, side-effects, precautions
- Absolutely contra-indicated in patients with Acquired or
Congenital Immune Deficiency Syndrome (AIDS).
- Contra-indicated in cases of
progressive dermatoses.
- Normal local reaction: after 2 to 4 weeks,
appearance of a small red nodule, becoming a vesicle. - This reaction will
remain for 2 to 5 months and leave a superficial scar, 2 to 10 mm in
diameter.
- Possibility of abscess on the scar (Becegitis).
- Presence of
an axillary or cervical adenitis in 1 to 4% of the cases, 2 to 3 months after
the injection. The adenitis may sometimes cause suppuration and
fistulization.
- Fatal disseminated infections with the BCG are very seldom.
Remarks
- It is always better to use the solvent delivered with the
vaccine. In case of loss, we recommend sodium chloride 0.9% or water for
injetion as the solvent, using the same quantity as the solvent delivered.
-
Combinations
· Simultaneous combination (at the same time, in a separate
syringe)
Compatible with other vaccines given by EPI.
· Combinations with other vaccines (in the same
syringe)
Impossible.
-Storage
· Freeze-dried powder
Store between 0 and
8°C.
Freezing is possible.
Defrosting/re-freezing is possible. At
37°C, stability of the freeze-dried vaccine is very variable, with loss of
effectiveness after 3 to 14 days.
· After dilution
Keep for maximum 5 to 6 hours between 0
and 8°C.
Protect from light.
DPT VACCINE (DTP, DTCoq)
Health clinic
Indications
-Prevention of diphteria, tetanus and pertussis
-Must be
integrated in the national Expanded Program of Immunization (EPI)
Presentation and route of drug administration
-Adsorbed vaccine (diphtheric and tetanic toxoid and killed
bacterial vaccine against pertussis), ampoule with ready to use
solution.
There are ampoules of 10 doses, 20 doses and 50
doses.
-Administration in deep subcutaneous or IM injection in the outer part
of the mid-thigh or in the deltoid muscle of the arm.
Dosage and vaccination scheme
- 0.5 ml per injection
3 injections given 4 weeks apart,
followed by a booster 1 year after the 3rd dose.
- Age of
administration
The first dose may be given from 6 weeks of age.
-
Efficiency: during several years after 3 doses.
Contra-indications, side-effects, precautions
- Contra-indicated if history of neurological disorder.
- In
case of significant reactions after the first dose of DTP (high fever,
convulsions, neurological signs), only give diphtheria-tetanus vaccine.
-
Febrile reactions (39° - 40°C) during approximately 48 hours.
-
Local reactions: induration and painful reaction at injection site.
-
Complications are often due to the anti-pertussis component: toxic shock,
encephalopathies.
Remarks
-Combinations
· Simultaneous combination (at the same time, in a separate
syringe)
Compatible with other vaccines given by EPI.
· Combinations
with other vaccines (in the same syringe)
Possible with measles vaccine (DPT
serves as solvent).
-Storage
Between 2 and 3°C.
NEVER FREEZE: if frozen,
the adjuvant can cause aseptic abscesses and a poor diffusion of the
vaccine.
At 37°C, the vaccine will remain stable for 6
weeks.
Attention: univalent pertussis vaccine: will remain stable for only 3
to 7 days at 37°C.
MEASLES VACCINE (Rouvax, Morbilvax, Rimevas)
Health clinic
Indications
- Prevention of measles
Must be integrated in the national Expanded Program of Immunization (EPI)
Presentation and route of drug administration
- Live attenuated viral vaccine (Schwarz strain), freeze-dried
powder to be diluted with a special solvent.
There are vials of powder for 10
doses, 20 doses and 50 doses, with the vials of solvent.
- Administration in
deep subcutaneous or IM injection in the outer part of the mid-thigh or in the
deltoid muscle of the arm.
Dosage and vaccination scheme
- 0.5 ml in a single dose
- Age of administration
· From the age of 9 months to 5 years.
· If the
population is concentrated, 2 doses may be given:
1 first dose from 6 months
of age (between 6 and 8 months),
1 second dose from of 9 months of age.
- Efficiency: undefinitly, some days after injection (when injection after 9 months of age)
Contra-indications, side-effects, precautions
- Contra-indicated in case of genuine allergy to eggs.
- Wait
6 weeks after injection of gammaglobulins to give measles vaccine.
- Local
reactions: none.
- Generalized reactions:
· fever after 5 to 10 days (in 15% of the cases),
·
cutaneous rash for 48 hours,
· rhinopharyngitis.
- Complications:
· hyperthermic convulsions,
· encephalitis (1 case
in 1 million vaccinations).
Remarks
- It is always better to use the solvent delivered with the
vaccine. In case of loss, we recommend water for injection (distilled water) as
the solvent, using the same quantity as the solvent delivered.
- A new high
dose strain vaccine (AIK C, Edmonstron Zagreb), administered as of the age of 6
months in a single dose of 0.5 ml in deep subcutaneous ir IM injection, should
be available in the near future.
- Combinations
· Simultaneous combination (at the same time, in a separate
syringe)
Compatible with other vaccines given by EPI.
· Combinations
with other vaccines (in the same syringe)
Possible with the DPT vaccine,
which can be used as solvent, and with antimeningococcal and antiamaril vaccine.
- Storage
· Freeze-dried powder
Store between O and
8°C.
Freezing (-20°C) recommended for long
periods.
Defrosting/re-freezing is possible, but not advisable.
At
37°C, the freeze-dried vaccine is stable for 7 days.
· After dilution
Store between 0 and 8°C, maximum 8
hours; at 37°C, maximum 1 hour.
At the moment of dilution, the solvent
must be at the same temperature as the vaccine (0 to 8°C).
Protect from
light.
ORAL ANTIPOLIOMYELITIS VACCINE (Polioral trivalent, Polio Oral Sabin, Oral Poliomyelitis
Health clinic
Indications
- Prevention of poliomyelitis (for the 3 types of polio 1, 2 and
3)
- Must be integrated in the national Expanded Program of Immunization
(EPI)
Presentation and route of drug administration
- Live attenuated viral vaccine, monovalent (Sabin), vial with
liquid vaccine, limpid and pink colored, ready for administration (do not use
the vaccine when cloudy). There are vials of 10 doses, 20 doses, 25 doses and 50
doses, with a plastic dropper.
- Administration: orally, on the tongue.
Dosage and vaccination scheme
- 2 to 3 drops (depending on manufacturer)
Three doses of
vaccine must be given, minimum 4 weeks apart.
- Age of administration
The
first dose is administered at the age of 6 weeks at the same time as DPT.
The
WHO recommends an additional dose at birth (Polio zero).
- Efficiency: 5
years after 3 doses.
Contra-indications, side-effects, precautions
- Contra-indicated in case of immunodeficiency.
- Diarrhoea
is not a contra-indication, but it is preferable to give a supplementary dose
once the child is cured.
- No reactions to this vaccine.
- Complications:
1 case of encephalitis out of 3 million administered doses.
- Pregnancy:
CONTRA-INDICATED during the first trimester of pregnancy, except if there is a
major risk for poliomyelitis.
Lactation: no contra-indication
Remarks
- Other antipoliomyelitis vaccines: injectable inactivated
vaccine.
Not used very often in developing countries because of the high
cost.
- Combinations
· Simultaneous combination (at the same time, in a separate
syringe)
Compatible with all other vaccines given by EPI.
·
Combinations with other vaccines (in the same syringe)
Impossible since this
is an oral vaccine and not an injection.
- Storage
Between 0 and 8°C.
Freezing (-20°C)
recommended for long periods.
Defrosting/re-freezing is
possible.
Stability: the most fragile vaccine (1 day: at 37°C; 1 to 3
hours: at 50°C).
TETANUS VACCINE (Tetanus toxoid, Tetanol)
Health clinic
Indications
- Prevention of tetanus
- Must be integrated in the national
Expanded Program of Immunization (EPI)
Presentation and route of drug administration
- Adsorbed tetanic toxoid, monovalent, vial with ready to use
solution.
There are vials of 10 doses, 20 doses and 50 doses.
-
Administration in deep subcutaneous or IM injection in the outer part of the
mid-thigh or in the deltoid muscle of the arm.
Dosage and vaccination scheme
- 0.5 ml per injection.
Vaccinate all women of child-bearing
age. 5 doses are needed to give a definitive immunization status.
- Newborn
child: give 3 doses, one month apart, followed by boosters later. 5 doses are
needed to give a definitive immunization status.
Contra-indications, side-effects, precautions
- Slight but rare side-effects, this vaccine is extremely well
tolerated.
- Painful, red reaction at injection site possible.
-
Complications: none.
Remarks
- Combinations
· Simultaneous combination (at the same time, in a separate
syringe)
Compatible with other vaccines given by EPI.
· Combinations
with other vaccines (in the same syringe)
Possible with anti-pertussis,
diphtheria and polio vaccine.
- Storage
Between 2 and 8°C.
NEVER FREEZE: if frozen,
the adjuvant can cause aseptic abscesses and poor
diffusion of the
vaccine.
At 37°C, the vaccine remains stable for at least 2
months.
Antitetanic toxoid is the vaccine the most resistant to
heat
Benzoic acid + Salicylic acid
Benzyl benzoate
Calamine
lotion
Cetrimide
Chloramine T =
Chloramine
Chlorhexidine
Chlorhexidine +
Cetrimide
Chlorine
Chlortetracycline, eye ointment
Cresol
Dakin's
solution
(Ethyl) alcohol
Ethanol 70%
Gentian violet
Iodine
(alcoholic solutions)
Lysol
Merbromine
Mercuresceine
sodium
Methylrosanilinium chloride
Oxytetracycline, eye
ointment
Polyvidone iodine = PVI
Potassium permanganate
Tetracycline,
dermal ointment
Tetracycline, eye ointment
Tosylchloramide
sodium
Whitfield's ointment
Zinc Oxide (vaseline)
BENZOIC ACID + SALICYLIC ACID ointment = Whitfield's ointment
District hospital
Therapeutic action
- Antifungal and keratolytic
Indications
- Fungal infection of the skin
- Fungal infection of the
scalp (tinea)
Preparation
- Ointment with 3% salicylic acid and 6% benzoic acid
Dosage
- 2 applications per day
Duration
- 3 weeks minimum depending on progress
Precautions
- Do not apply to open wounds or mucous membranes (mouth, nose,
vagina, rectum).
- Local irritation and inflammation can occur (if a severe
reaction, stop treatment).
Remarks
- Storage: exposure to high temperature may cause the active parts to separate from the mixture. Stir well before use.
BENZYL BENZOATE = BENZOATE DE BENZYLE (BBL (R).)
Health post
Therapeutic action
- Parasiticidal preparation for external use (skin)
Indications
- Scabies
- Pediculosis (lice)
Preparation
- Emulsion containing 25% benzyl benzoate
- Concentrated
emulsion containing 90% benzyl benzoate
FIGURE
Directions for use
- Shake well before use.
- For the treatement of
scabies
Warning: in case of secondary infection, first clean and apply
gentian violet for several days before applying benzyl benzoate.
· Wash the patient.
· Apply the product all over
the body, except for the face and the mucous membranes.
· Leave the
product on the body for 24 hours (12 hours for children under 2
years).
· Wash.
· Repeat the following morning if possible,
washing the patient between the two applications.
- For the destruction of lice
· Apply the product, leave for 24 hours (12 hours for children under 2 years), wash the patient afterwards.
Precautions
- NEVER SWALLOW: VERY DANGEROUS.
- In case of ingestion, DO
NOT INDUCE VOMITING, refer to a doctor.
- Do not apply to mucous membranes
(mouth, nose, vagina, rectum).
- Lactation: avoid applying to the nipples.
Remarks
- Examine the other family members and treat everyone affected
with scabies simultaneously. Have the clothing and bed linen washed with boiling
water.
- Itching can continue for several days which does not imply that the
treatment is ineffective.
- The concentration recommended by WHO is 25%.
Storage: no special precautions
CALAMINE lotion and Vaseline with ZINC OXIDE
District hospital
Therapeutic action
- Astringent, soothing, antipruritic
- Skin protection
Indications
- Burns
- Eczema
- Psoriasis
- Varicose ulcers
Preparation
- Calamine lotion (15% zinc carbonate)
- Vaseline with 10%
zinc oxide, jar or tube
Dosage
- 1 to 3 applications per day
Duration
- Depending on clinical progress.
Precaution
- Clean and disinfect the skin well before applying the ointment or lotion.
Remarks
- These two products are used in the same way. In general,
calamine lotion is better known in english speaking countries and zinc oxide in
french speaking countries.
- Zinc oxide can be used to replace sterile paste
for burns: sterilize in a pressure-cooker or heat while stirring until boiling
point, allow to cool, coat the sterile compresses and apply.
- Storage: no
special temperature requirements. Exposure to high temperatures may cause the
active parts to separate from the mixture. Stir well before use.
CETRIMIDE (Cetavlon (R).)
The use of this drug is not advised:
- it has almost no advantage over ordinary scop;
- the
aqueous solution is very often contaminated;
- it is not included in the WHO
essential drug list.
Therapeutic action
- Antiseptic detergent and disinfectant
Indications
- Cleaning of wounds
- Cleaning of dirty materials
Preparation
- Powder for dissolving
- Concentrated solution of 20% to be
diluted
- Concentrated solution of 40% to be diluted
Dilution
- It is used in a 1% solution of cetrimide
10 g of powder in
1 litre of water
or 50 ml of the solution of 20% in 950 ml
or 25 ml of the
solution of 40% in 975 ml
- Prepare the solutions with drinking water from
the water mains or use boiled water, filtered if necessary.
- Wash the bottle
carefully with hot water and let it dry before refilling.
Precautions
- The aqueous solution diluted for use are easily contaminated
by pathogenic germs (if possible, prepare the solution just before use).
-
Incompatible (causes inactivation) with soap and iodine (polyvidone
iodine).
- Not suitable for the sterilization of instruments (nor for sterile
storage).
Remarks
- Use of the product is not advised (limited efficiency and high
risk of contamination of the aqueous solutions).
- The combination of
chlorhexidine + cetrimide is much more efficient.
- Storage. no special
precautions
Never keep diluted solutions for more than 1 week.
CHLORAMINE = CHLORAMINE T = TOSYLCHLORAMIDE SODIUM
Health clinic
Therapeutic action
- Antiseptic and disinfectant (generates chlorine)
Indications
- Antiseptic
· Cleaning of dirty wounds
· Disinfection of wounds
or infected mucous membranes (abscess, ulcers.)
- Disinfectant
· Disinfection of medical instruments
·
Disinfection of floors, surfaces, various objects.
Preparation
- Powder or tablets of 250 mg, 500 mg or 1 g, with a slight odour of chlorine. The tablets must be easily and completely soluble, otherwise the powder is preferable.
Dilution
- Antiseptic
· For general use :5 g per litre
· For repeated use
on mucous membranes: 2 g per litre
- Disinfectant
· Disinfection of instruments: 20 g per litre
·
Disinfection of floors, surfaces, various objects: 5 g per litre
- Prepare the solutions with drinking water from the water mains or use boiled water, filtered if necessary.
Use
- For wounds and mucous membranes: bath, irrigation or
compresses (solutions of chloramine are better than DAKIN). For prolonged use,
protect the healthy skin around the wound with vaseline.
- Rapid disinfection
of instruments and laboratory equipment: soak for 15 minutes in a solution of 20
g/litre (the instruments must be cleaned first).
Precautions
- Protect people from accidental swallowing of the tablets: DO NOT STORE NEAR ORAL TABLETS.
Remarks
- There are tablets of 12 or 20 mg for the disinfection of
drinking water for individuals and families (1 tablet per litre clear
water).
- 1 g of chloramine generates 250 mg of active chlorine.
- Storage:
· Storage of r eady to use solutions: maximum 1
week.
· The solutions use for soaking instruments must be renewed every
day.
· The solutions must be stored in the shade and protected from
direct sunlight: use an opaque bottle or brown glass (do not use a metal
container).
CHLORHEXIDINE (Hibitane (R).)
Health post
Therapeutic action
- Antiseptic
Indications
Cleaning and disinfection of:
- skin and mucous membranes
- wounds
- burns
-
ulcers
- abscesss
Preparation
- Concentrated solution of 5% chlorhexidine digluconate to be
DILUTED before use. Check whether the supplied concentrated solution can be
diluted with non-distilled, ordinary water (in this case, the solution must
contain a cosolvent).
- There are solutions of 20% chlorhexidine, but they
contain generally no cosolvents and must therefore be DILUTED WITH DISTILLED
WATER to avoid a possible precipitation of chlorhexidine.
Dilution
- Used in an aqueous solution of 0.05% chlorhexidine = 10 ml of
the 5% solution in 1 litre of water.
- Use drinking water from the water
mains or boiled water, filtered if necessary.
- Wash the bottle carefully
with hot water and let it dry before refilling.
Precautions
- Do not bring into contact with cerebral tissue, the meninges
or an injured ear-drum.
- Do not use with soap (rendered inactive).
- Do
not use for cleaning the ears.
- Not suitable for the sterilization of
instruments (nor for sterile storage).
Remarks
- The combination of chlorhexidine + cetrimide is more useful:
better detergent properties (cleaning) and it can always to be diluted with
non-distilled water (cetrimide operates as a cosolvent).
- Storage:
· concentrated solution: no special precautions.
·
solution diluted ready for use: maximum 1 week
CHLORHEXIDINE + CETRIMIDE (HAC (R)), Savlon(R).)
Health post
Therapeutic action
- Combination of an antiseptic and a detergent
Indications
Cleaning and disinfection of:
- skin and mucous membranes
- wounds
- burns
-
ulcers
- abscesss
- various objects
Preparation
- Concentrated solution of 1.5% chlorhexidine and 15% cetrimide to be DILUTED before use.
Dilution
- Make a 2% solution from the concentrate: 20 ml of the
concentrated solution in 1 litre of water. This solution contains 0.03%
chlorhexidine and 0.3% cetrimide.
- Use drinking water from the water mains
or boiled water, filtered if necessary.
- Wash the bottle carefully with hot
water and let it dry before refilling.
Precautions
- Do not bring into contact with cerebral tissue, the meninges
or an injured ear-drum.
- Do not use with soap (rendered inactive) or with an
iodine disinfectant (e.g. polyvidone iodine).
- Do not use for cleaning the
ears.
- Not suitable for the sterilization of instruments (nor for sterile
storage).
Remarks
- Storage:
· concentrated solution: no special precaution.
·
solution diluted ready for use: maximum 1 week
Products that generate CHLORINE (Calcium hypochlorite = HTH, Chlorinated lime, Bleach, Sodium dichloroisocyanurate or NaDCC)
Therapeutic action
- Strong disinfectants (generate active chlorine)
Indications
- Disinfection of objects, instruments, linen.
- Disinfection
of floors, surfaces (tables, sinks.)
Preparation
- Calcium hypochlorite grains (HTH).+/-70% active chlorine
-
Chlorinated lime powder, bleaching powder+/- 25% active chlorine
- Solutions
of sodium hypochlorite (bleach, Milton(R):
· Bleach 12° chlorometrical degrees. +/- 4% active
chlorine
· Bleach 15° chlorometrical degrees.+/- 5% active
chlorine
· Concentrated bleach 48° chlorometrical degrees. +/- 15%
active chlorine
(to be diluted in 3/4 litre water to become bleach with 4%
active chlorine)
- Sodium dichloroisocyanurate or NaDCC:
· Powder.60-65% active chlorine
· Tablets (Javel
solid(R)) 1.5 g active chlorine per tablet
The power of the disinfectants that generate chlorine is expressed in active chlorine (generally percentage in active chlorine).
The amount of active chlorine is sometimes expressed in
chlorometrical degrees.
1° chlorometrical = approximately 0.3% active
chlorine
The amount of chlorine in diluted solutions is expressed in% or in ppm (parts per rnillion) of active chlorine (1 ppm = 1 mg/litre = 0.0001%).
Dilution
- The amount of active chlorine must always be checked on the
packaging of the product to correct the dosage if necessary.
- In certain
conditions, solutions with a stronger content of active chlorine can be made by
adjusting the dosage.
- Always dilute in non-metal containers just before
use.
- A deposit in HTH or chlorinate lime solutions is normal (use the upper
part). - Prepare solution with clean water.
FIGURE
Precautions
- Handle the concentrated products with care (avoid jolts and
exposure to high temperatures or flames).
- Avoid inhaling vapours and dust
when opening or handling the containers.
- Do not mix with detergents.
-
Do not bring the dry product, particularly calcium hypochlorite, in contact with
organic materials (for example: corpses): risk of explosion.
- Disinfection
of linen
Only suitable for cotton and linen (but risk of discolouration). Soak for maximum 15 minutes. Do not exceed 0.1% (1,000 ppm) of active chlorine. Rinse abundantly (at least 3 times) with clear water after soaking.
- Disinfection of instruments
To avoid corrosion, use only
for stainless steel instruments. Do not use solution containing more than 0.1%
(1,000 ppm) of active chlorine frequently, do not leave in contact for more than
30 minutes, instruments and solution should be cold, rinse abundantly and dry
after disinfection.
- NaDCC is less corrosive than solutions of calcium
hypochlorite and bleach.
Remarks
- Chloramine T (sodium tosylchloramide) also produces chlorine
(25% active chlorine), but acts more slowly than the products described above.
It is especially suitable as an antiseptic for infected wounds and mucous
membranes because it is less irritating.
- Calcium hypochlorite, bleach and
concentrated bleach can be used to prepare antiseptic solutions (DAKIN solution)
if 1 teaspoon of sodium bicarbonate is added to the final solution (to
neutralise the alkalinity).
· For wounds: solution of 0.1% (1,000 ppm) active
chlorine.
· For mucous membranes: solution of 0.05% (500 ppm) active
chlorine.
- Trichloro-isocyanuric acid containing 90% of active chlorine
is very similar to NaDCC, but its use is limited by poor solubility. It is
mainly used for chlorination of pool water as pellets placed in a float.
-
Storage:
· Store in air-tight containers: protectedfrom light and
heat (and humidityfor solids).
· Chlorinated lime, bleach and
concentrated bleach are difficult to keep (maximum a few months for the last
two).
· Calcium hypochlorite is relatively easy to keep.
· NaDCC
is much more stable.
Soapy solution of CRESOL = Lysol
District hospital
Therapeutic action
- Disinfectant and detergent
Indications
- Cleaning and disinfection of materials (floors, objects, instruments, surfaces, linen.)
Preparation
- Concentrated solution (containing 50% cresol and 50% liquid soap) to be DILUTED before use
Dilution
- Dilute in water just before use: 2 to 5% depending on amount of dirt (1 part of concentrated solution in 20 to 50 parts of water = 200 to 500 ml for 10 litres of water)
Use
- Objects and instruments
Soak in the diluted solution during
30 minutes, brush with care, rinse and sterilize if necessary.
-
Rooms
Evacuate the patients, clean with the diluted solution, rinse and
ventilate to eliminate the smell and irritating odour.
- Linen
Soak in
the diluted solution during 6 hours, rinse abundantly.
Precautions
- Do not confuse with pure cresol, without soap (see
remarks).
- Do not use for the disinfection of food, or for materials than
can come in contact with drinking water or food.
- Very irritating for skin
and mucous membranes:
· Never use for wounds, skin.
· Avoid contact with
the hands.
Remarks
- Lyorthol (R), sodium cresylol, Cresyl (R), Creolin (R),
chloroxylenol 5%, Dettol (R), are similar products used for the same purposes
and diluted in the same way, but Dettol (R) can also be used for skin, wounds
and mucous membranes.
- Cresol (without soap) can be used but is not advised
since it is more difficult to dissolve in water and is more irritating than the
soapy solution. Furthermore, it has no detergent properties and stains
linen.
- Storage: keep containers tightly closed.
(ETHYL) ALCOHOL = ETHANOL 70%
The use of this drug is not advised for general use: it is expensive, irritating and less effective than polyvidone iodine or chlorhexidine
Therapeutic action
- Antiseptic
Indications
- Used only for disinfection and cleaning of healthy skin before injections.
Preparation
- Alcohol of 95%, 92%
1 litre of 95% alcohol contains 950 ml
of pure alcohole. Use diluted.
Dilution
- To obtain 1 litre of 70% alcohol from 95% alcohol, you need approximately 740 g (737 ml) of 95% alcohol and 260 g (263 ml) of distilled or filtered water. 95% alcohol must always be diluted 70% alcohol has the best antiseptic strength.
Contra-indications, side-effects cautions
- Do not apply to the eyes, mucous membranes, wounds or burns.
Remarks
- Can be easily replace polyvidone iodine. The use of alcohol
can be justified only when it is available locally at a competitive price.
-
Dilution can be expressed in% or in alcoholic degres: alcohol 95% = alcohol
95°.
- Storage: keep below 30 C
Close bottles tightly to avoid
evaporation.
Alcoholic solutions of IODINE (iodised alcohol, iodine tincture)
The use of this drug is not advised: see remarks
Therapeutic action
- Strong, rapid acting antiseptic
- Antifungal
Indications
- Disinfection of healthy skin (surgery, injection or
puncture)
- Treatment of fungal skin infection.
Preparation
- Iodised alcohol (1 or 2% in ethanol 70 or 80°)
-
Iodine tincture (5% in ethanol 80 or 90° + 3% potassium iodine) is very
concentrated preparation that should no longer be manufactured or prepared.
Precautions
- Very irritating solutions.
- Can provoke allergic
reactions.
- Should not be used on wounds as it is painful and slows the
healing process.
- Incompatible with mercury derivatives.
Remarks
- Alcoholic solutions of iodine have very limited use. They are
very irritating, expensive and difficult to preserve; the alcohol evaporates
(solutions become even more irritating as they age).
- They should be
replaced by polyvidone iodine that is much less irritating and easier to
preserve (see polividone iodine).
- Storage: maximum of a few weeks
MERBROMINE = MERCURESCEINE SODIUM (Mercurochrome(R).)
The use of this drug is not advised:
- it is toxic and allergenic;
- as an antiseptic, it is weak
and expensive;
- it is not included in the WHO essential drug list.
Therapeutic action
- Antiseptic
Indications
- Disinfection of small superficial wounds
Preparation
- Powder to be dissolved
- Aqueous solutions of 1 or 2% ready
for use
- Alcoholic solutions of 2% ready for use
Precautions
- Toxic for kidneys, nervous system and digestive system
(resorption of mercury through skin).
- Allergic reactions, frequently
accompanied by a sensitivity to all mercury derivatives (other mercury
antiseptics, amalgam for dental applications, preservation agents in
cosmetics..).
- Colours the skin which can mask an inflammatory
reaction.
- Never use together with an iodine product (iodised alcohol,
polyvidone iodine): risk of necrosis.
Remarks
- The aqueous solutions; have a very weak antiseptic
capacity.
- The alcoholic solutions are more efficient but mercuresceine has
such a high level of toxicity that its use, in all forms, should be
banned.
-Storage:
· Powder and alcoholic solutions: no special
precautions.
· Aqueous solutions: never preserve diluted solutions for
more than 1 week.
METHYLROSANILINIUM CHLORIDE = GENTIAN VIOLET = GV = Crystal violet
Health post
Therapeutic action
- Antifungal
- Antiseptic
- Drying
Indications
- Treatment of fungal infections of:
· the skin
· the scalp (tinea)
· the oral
and vaginal mucous membranes
- Treatment of wet dermal disorders (eczema, impetigo.)
-
Treatment of burns and superficial wounds
Preparation
- Powder to be dissolved
- Solution of 0.5%
Dilution
- It is used in a 0.5% solution = 5 g per litre (saturated
solution). Dissolve one teaspoon in 1 litre of water. Stir several times and
leave to settle. Filter through cotton or pour carefully into another bottle to
eliminate possible sediment.
- Use drinking water from the water mains or
boiled water, filtered if necessary.
- Wash the bottle carefully with hot
water and let it dry before refilling.
Use
- Apply once a day.
- The solution can be applied in the
mouth without danger.
Precautions
- May cause permanent pigmentation (do not use on the face of light skinned people).
Remarks
- Storage:
· of powder: unlimited.
· solution diluted ready
for use: maximum 1 week.
POLYVIDONE IODINE = PVI (Betadine (R), Videne (R).)
District hospital
Therapeutic action
- Antiseptic and disinfectant
Indications
- Disinfection of the skin, wounds and burns
- Treatment of
fungal and other skin infections, and skin manifestations caused by certain
viruses (herpes, shingles.)
- Disinfection of medical instruments
-
Disinfection of the hands before surgery
Preparation
- Concentrated solution of 10% PVI to be used pure or diluted
Dilution
- Pure (= solution 10% PVI) for the disinfection of the
skin.
- Diluted to 2.5% PVI for the disinfection of wounds, burns and
instruments (1 part of concentrated solution of 10% + 3 parts water).
-
Diluted to 0.5% PVI for the mucous membranes (1 part of concentrated solution of
10% + 19 parts water).
- Prepare the dilutions with drinking water from the
water mains or boiled water, filtered if necessary.
Use
- Disinfection of the skin
· Before injection or setting up IV catheter: one
application of the diluted solution of 2.5% PVI (if the skin is dirty, first
wash with soap and water).
· Before surgery: two applications of
concentrated solution (10% PVI) after washing with soap and water, rinsing and
drying.
- Disinfection of the umbilical cord
Concentrated solution
(10% PVI).
- Treatment of fungal skin infections and viral manifestations
(herpes, shingles)
Concentrated solution (10% PVI) twice a day.
-
Disinfection of wounds and burns
One application of diluted solution of 2.5%
PVI every time the dressing is changed.
- Treatment of infections and fungi
on mucous membranes
Diluted solution of 0.5% PVI twice a day.
- Rapid
disinfection of stainless steel instruments
Soak the clean instruments for 15
minutes in the diluted solution of 2.5% PVI.
- Disinfection of the
hands
After careful and prolonged washing with soap, and rinsing with boiled
water, rub the
hands while still damp with a small amount of 10% PVI solution
until dry.
Precautions
- Do not use repeatedly on very large surfaces or with
infants.
- Never use with a mercury derivative (e.g. Mercurochrome (R),
certain disinfecting soaps) because of necrosis risk.
- Stop treatment if
allergic reaction.
Remarks
- Relatively expensive product, but very efficient and polyvalent.
Storage:
· Concentrated solution 10% PVI: no special
precautions.
· Diluted solution of 2.5% PVI: maximum 1 week.
·
Diluted solution of 0.5% PVI: prepare just before use.
· Solution used
for the disinfection of instruments: renew every day.
POTASSIUM PERMANGANATE
The use of this drug is not advised:
- the risk of misuse is too great;
- it is not included in
the WHO essential drug list.
Therapeutic action
- Antiseptic
- Astringent
Indications
- Superficial wounds.
- Eczema.
- Fungal infection, in
particular of the toes (athlete's foot)
Preparation
- Dark crystal violet to be dissolved
- Tablets to be
dissolved; exist in various doses: 0.25 g, 0.50 g and 1 g
Dilution
- Dilute to 0.01% (100 mg in 1 litre water)
- The
concentration must be precise:
· if it is too high: caustic
· if it is too low :
inefficient
Scales must be used to obtain the proper concentration from the crystals.
Precautions
- Handle the dry product the concentrated solutions with care
(burning of the skin and risk of explosion when brought in contact with an
easily oxidizable material).
- Take precautions to avoid swallowing the
tablets. Do not store near oral tablets, INGESTION IS VERY HARMFUL: risk of
digestive perforation.
- Repeated applications will dry out the skin.
Remarks
-This product has no special advantages, except for its cheap
price.
- Its use is discouraged because of constant mistakes in dilution and
the risk of ingestion of the tablets.
- Storage:
· dry product: protect against air (air-tight
containers).
solution diluted for use maximum 1 week.
TETRACYCLINE dermal ointment
The use of this drug is not advised:
- local applictions of antibiotics also utilised orally
increase
- the risk of selecting resistent strains of bacteria.
Therapeutic action
- Antibacterial
Indications
- No indications. The use of antibacterial ointments is discouraged (risk of selecting resistant strains). Regular washing with antiseptic is often enough to heal a skin infection. If this fails, the treatment with oral antibiotics is preferable.
Preparation
- Ointment of 3% tetracycline (tube of 15 g or jar of 1 kg)
Precautions :
- Do not apply the dermal ointment to the eyes. Use only eye ointment for the eyes.
Remarks
- Storage: keep below 30°C.
Do not use after the expiry
date.
TETRACYCLINE eye ointment CHLORTETRACYCLINE eye ointment and OXYTETRACYCLINE eye ointment
Health post
Therapeutic action
- Antibacterial
Indications
- Eye infections (conjunctivitis)
- Trachoma
- Prevention
of eye infections in the newborn (chlamydia and gonococcus)
Preparation
- Sterile ointment of 1% or 3% (tube of 5 g)
Dosage
Applied under the eyelids.
- Conjunctivitis :2 applications per day for 1 week.
-
Trachoma: 2 applications per day for 4 to 6 weeks.
- Prevention of eye
infections in the newborn: 1 single application at birth.
Duration
- Depending on indications
Precautions
- Allergic reactions possible. Stop treatment and refer to a doctor.
Remarks
- The ointments of 1% and 3% are used in the same way.
- Do
not apply the dermal ointment to the eyes. Use only eye ointment for the
eyes.
- The tetracycline eye ointment is better than SILVER NITRATE for the
prevention of conjunctivitis in the newborn.
- Oxytetracycline and
chlortetracycline are used in the same way as tetracycline.
- Storage: keep
below 30°C.
Do not use after the expiry date.
After opening, close
the tube well to avoid
contaminahon.
Preliminary stage
Layout of the pharmacy
Management of the
pharmacy
Organisation and rigorous management of the pharmacy are vital in all health structures, particularly when the resources are limited. These activities are often entrusted to doctors and nurses with little preparation and no experience in this area. The principles set out concisely in this guide concern the organisation and the management of a pharmacy in a health centre or health post; they are directed towards the following objectives:
- to maintain a permanent stock of drugs and appropriate medical
supplies;
- to reduce the costs: purchase - management - wastage;
- to
save time and optimise the work of the staff;
- to make it easier to check
the management and continuously evaluate consumption.
During an emergency programme or in a precarious situation, the first objective is to ensure that the health structures are supplied. Pharmacy management (supply storage, distribution) should be both simple and precise enough to:
- set up the system quickly;
- integrate non-specialised,
even non-qualified staff;
- replace the person in charge of the pharmacy if
necessary, without adversely affecting medical activity;
- facilitate the
later evolution towards a more complex management system.
In any case, it is essential to bear in mind the national pharmaceutical strategy and regulations, within which any pharmaceutical activities must be fitted.
To organise a regional or national programme, refer to the specialist works (see bibliography), especially "Managing drug supplies" (18) and "Approvisionnement en medicaments" (21).
Preliminary stage
Choice of drugs - Therapeutic regimens
Drawing up a list of basic drugs and standard therapeutic regimens offer two major advantages:
- better therapeutic treatment due to more rational and safer
use of a restricted number of essential drugs;
- economic and administrative
improvements at the level of purchase, storage, distribution and control.
If a recently adapted national essential drug list exists, it should be respected. Otherwise the list proposed by the WHO (Technical reports series 796,1990) is adapted to suit the needs and priorities of each programme, based on the recommended selection procedures.
The use of such a list, which has generally proved its worth in practice, has several advantages:
- it makes it easier to coordinate international aid and obtain
the approval of the organisations which subsidise the projects (United Nations,
European Economic Community...);
- it simplifies and reduces the costs of
supply: most drugs on the WHO list are available in generic form, at a price far
more affordable than the corresponding patent drugs.
It is advisable to conform to certain treatment habits. For example, the doses of certain common drugs: in francophone Africa, tablets of 100 mg (base) of chloroquine are used, and 500 mg tablets of aspirin; in anglophone Africa, it is 150 mg (base) tablets of chloroquine and 300 mg aspirin tablets that are commonly used.
It will usually be necessary to avoid including the same drug under several dosages, which risks causing confusion in prescription and complicates management: paediatric doses can be obtained by dividing adult doses, made easier if the tablets are divisable.
The choice can also be affected by availability on the local market, if quality products are available at competitive prices.
Medical items (material for sterilisation, injection, suture.) should also be limited to the essentials and a standard list prepared.
Designation of drugs
Each active ingredient has an International Nonproprietary Name (INN) given by the WHO: drugs are designated by their INN in all standard lists. This name should be use in therapeutic protocols and management, so that everyone speaks the same language and there is no confusion. Common drugs are sold under a wide variety of brand names, depending on the manufacturer and distributor; same laboratory product may even have different names in different countries. For example, ampicillin can be Totapen (R), Penbritin (R), Pentrexil (R), Binotal (R).
Generic drugs are copies of drugs whose patents have expired. They can therefore be made by any pharmaceutical laboratory and are most often sold under their INN or occasionally under a new brand name.
Classification of drugs
Drugs can be classified in several ways.
- Pharmaco-therapeutic classification
In the WHO list, drugs are grouped according to their therapeutic action. In some cases, a drug can appear in several groups, sometimes in a different form (atropine, diazepam.). With this classification (and its peadagological advantage), it is easier to insert supplies from different origins as well as find a substitute for a missing product.
- Alphabetic classification according to administration
The drugs are divided into four groups and listed in alphabetical order within each group:
· oral drugs,
· injectables,
·
infusions,
· drugs for external use.
This classification is used throughout this document since it satisfies the criteria of simplicity and standardization needed for the whole management system. Nonspecialised personnel can work with it.
Whichever classification is adopted, it should be used at every level of the management system (ordering, storage, distribution, dispensing) in order to facilitate all these procedures.
Levels of use
More limited lists should be drawn up depending on the capacities of the health facilities and the competence of the prescribers.
- "Health Post"
For the viIlage health workers.
- "Health
Clinic"
For clinics with nurses or health auxiliaries.
- "District
Hospital"
For health centres with doctors and physician's assistants.
-
"Special Department"
To deal with the major endemic diseases and specialised hospital services: surgery, anaesthesia, obstetrics.
These restricted lists and the designation of the different levels must be adapted to the terminology and context of each country.
Quantitative evaluation of the needs
To define or reorganise a supply system, it is necessary to determine the quantities of drugs and materials needed. Once the list and therapeutic regimens have been established, it is possible to calculate the respective quantities of each drug from the expected number of patients and the diseases seen.
Several methods have been suggested: see "Estimating drug requirements" (41). The figures obtained can differ from those corresponding to the true needs or demand: this is the case when the improvement of a health centre increases its use, or when the prescribers do not follow the proposed lists and therapeutics regimens. It may be possible to refer to the consumption of drugs in other situations that are comparable in terms of population and pathology.
When the system is well organised, the management aids will easily supply the necessary figures.
In all precarious situations, the "Emergency Health Kit" provides a rapid response to the medical needs, both qualitative and quantitative. Each kit is intended to supply the drugs and material needed to cater to the health needs of a population of 10,000 people for 3 months. Afterwards, the specific local needs must be quickly evaluated to establish a suitable supply.
The systematic evaluation of the needs also makes it possible to check how well the prescription schemes are respected.
Layout of the pharmacy
The premises
It is necessary to design working premises sufficient to enable:
- the safekeeping of stocks,
- the preservation of the drugs
and material,
- rational and straightforward management.
Whether it is a question of building from scratch or converting an existing building, a regional warehouse or a clinic pharmacy, the objectives are the same, only the means of reaching these objectives differ. The proposals in this chapter apply to a district pharmacy, responsible for supplying the district health centre as well as the clinics and village health posts that refer to it.
In this case, two separate areas, which may or may not be adjacent, are needed: one for the daily dispensing to the patients of the centre, the other a warehouse where the drugs and medical material intended for all of the health facilities of the district can be stored, managed and distributed.
Characteristics of the warehouse
The dimensions of the warehouse will be determined by the storage needs which depend on:
- the number of drugs and kinds of material held,
- the
number and activities of the facilities supplied,
- the timespan between
distributions of supplies and deliveries received: the further apart these are,
the bulkier the stocks are and the bigger the space needed.
It is better to have something too big than too small: a cramped warehouse is difficult to work in and keep tidy, and any necessary increases in stock or activity are awkward.
The security of the goods stored necessitate that the doors, locks, windows and even ceilings are solidly built.
Whether the drugs are well preserved or not depends on the ambient temperature and humidity, factors that are often hard to control in a tropical environment.
- It should be well-aired, with fans if possible, or even air
conditioning which reduces the heat and humidity, but is very costly.
-
Isolating construction materials can be used.
- The floors will be sloped so
that water can run away, which makes maintenance far easier.
In colder
countries, it should not be forgotten that frost can cause ampoules and bottles
to break.
Layout of the interior of the warehouse
The layout should be logical and correspond to the circuit: reception, storage, distribution.
Shelving
Solid and stable shelving is vital. In tropical countries where termites attack wood, metal structures are preferred; if they can be taken apart, it is easy to adjust the distances between the shelves to suit the goods to be stored.
The arrangement of the shelves, tables. varies according to the arrangement of the premises.
Space between the shelves and the walls will improve ventilation. No products or package, even large-sized, should be stored on the floor, but on pallets which permit air circulation and protect against flooding.
Examples of layout of a peripheral pharmacy (Health Center). For more larger stock or for a central pharmacy, use several rooms and apply the same principles by adapting the layout to the needs: administration, cold room or refrigerators.
Inside the room, or if this is not possible in an adjoining room, it is necessary to prepare the following storage areas:
- Incoming storage area
For the storage of packages, unpacking and checking of goods before they are placed on the shelves.
- Outgoing storage area
For the storage of peripheral orders before they are distributed. Every destination should have its assigned area where it is possible to store the packages until their distribution.
Those two storage areas will be situated close to the entrance to facilitate handling.
It is also recommended to plan a storage area for empty boxes which will be used to prepare the orders from peripheral pharmacies.
A working area has to be included to check the orders or to prepare the orders.
A desk, close to a light source if possible, will be used by the person in charge of the pharmacy for administration.
Arrangement of medicines and materials
The stock will be arranged according to the classification adopted:
- oral drugs,
- injectable drugs; infusion solutions will be
stored separately due to their bulk
- drugs for external use and
disinfectants,
- smaller medical materials classified in sub-categories:
dressing, injection, suture
In every category (oral, injectable, infusions, external usage), the product will be classified alphabetically.
Every product needs its own well defined place, shown by a large label giving the name of the product in INN, its form and dose; for example:
Ampicillin caps 250 mg
Every box and bottle will be correctly labelled, a new label being put on if necessary (old one illegible, in a foreign language). A label should clearly show:
- the name of the product in INN,
- the dose,
- the
form,
- the expiry date.
Narcotic drugs should be kept in a locked cupboard: fentanyl, pethidine, morphine (as well as ketamine. pentazocine and codeine in certain countries).
Clearly indicate on the boxes (chalk, large marker) the expiry date. Arrange the products with the latest expiry date at the back of the shelves and those that should be used first in the front. This arrangement is essential to avoid products passing their expiry date and becoming unusable.
- Storing bulky materials
Put a few boxes in their normal place and, on the label, state where the rest of the stock is kept. Do not separate the rest of the stock in several places.
- Storing medical materials
Given the diversity of the articles to be stored, it is preferable not to use a strict alphabetical ordering, but to group the articles by category: injection material, dressing, sutures.
Using the same order for the arrangement in the pharmacy, for the inventory lists and for orders makes the work far easier.
Further, to enable a person who is not familiar with the INN system to find their way around in times of emergency or in case of sudden replacement, or in order to train the auxiliary staff, a list of the commercial names and the corresponding INN can be put up,
BACTRIM (R) |
see Cotrimoxazole |
FLAGYL (R) |
see Metronidazole |
VALIUM (R) |
see Diazepam |
TOTAPEN (R) |
see Ampicillin |
- Allow enough space for each drug.
- The arrangement should
make it possible to work "by sight".
It should be possible to pick out the number of boxes of each product. In a few minutes, it should be possible to work out how many weeks or months stock of a given product remains.
- An empty space behind a label immediately shows that that product is out of stock.
This way of arranging the supplies is essential to a simple and effective management. A few hours should be enough to do a complete stock inventory.
Management of the pharmacy
Organisation of activities
The management of a district pharmacy should be entrusted to a single person with adequate training. He will be responsible for both the health centre pharmacy and the warehouse; he will be helped by one or more assistants, depending on the workload anticipated.
The job of each worker must be defined exactly: one of them should be able to replace the person in charge if necessary.
The timetable and calendar of work (orders, distributions, stock-control activities) will be planned to spread the workload as evenly as possible.
Stock-control
STOCK CARDS
The stock-card is the main instrument for stock-control. For each item (drug and material), a stock-card is made out and regularly updated, always by the same person. These cards allow:
- the identification of all movements of stock, in or out;
-
the theoretical stock level to be available at any time;
- the consumption of
the different users to be monitored;
- the orders to be correctly
foreseen;
- an assessment of what and how much has been lost (difference
between the theoretical stock and the actual stock after inventory).
On this stock-card, the following will be noted:
- The name of the product in INN, the form and the dose.
-
All the movements (entries, exits, origin, destination) and the date.
-
Orders made and the date.
- Inventories and the date. If the cards are well
kept, and there are no thefts, the stock column corresponds to a permanent
inventory.
- The following can also be included:
· safety stock,
· maximum stock,
· other
storage areas for this product,
· unit price.
- The amounts are always recorded in units (5,000 tablets, 80
ampoules.) and never by box (10 boxes of ampicillin tablets could correspond to
200 tablets [10 boxes of 20 tablets] or 10,000 tablets [10 boxes of 1,000
tablets]).
- Write only one movement on each line, even if several operations
take place the same day.
When an order is made, the date, supplier, and amount ordered are recorded. The stock column is not changed. When the order arrives, the amount received is included in the "incoming" column, and the "stock" column is then modified.
Example of a stock card
CALCULATION OF QUANTITIES TO RETAIN IN STOCK AND TO ORDER(STOCK LEVELS)
- Monthly consumption
This is calculated from the exits recorded on the stock cards: add the quantities in the outgoing column from several months (3, 6 or 12) and divide the total by the number of months.
- Working stock
Working stock corresponds to the amount of each drug consumed
between supply of the pharmacy. For example, if the supplies arrive every three
months,
working stock = monthly consumption x 3.
- Safety stock (or reserve stock)
This stock is planned to compensate for any delays in delivery, increases in consumption or possible losses. It depends on the delivery time of the orders.
This is the quantity below which the stock should never fall, at the risk of running out of stock.
The quantity to be kept as a safety stock is generally calculated as half of the consumption during the time between two deliveries. It depends on the risks that the programme is able to take: running out of stock and having drugs pass their expiry date, in its particular context (resources, seasonal supply problems.).
- Quantity to order
The amount to order is based, for each item, on the information on the stock cards:
· stock according to the inventory when the order is
made,
· safety stock,
· working stock.
Order = (working stock + safety stock) - remaining stock on the day the order was made.
ORDER AND DELIVERY FORMS
Pre-printed order forms make it easier to prepare orders and inventories, and to avoid transcription errors.
Order forms are drawn up according to the classification of the stock; the drugs are recorded using their INN names and the form (tablet, gel, bottle, ampoule.), dosage, amount ordered. The following can also be included:
- The unit price, so that the person in charge of the health
facility can calculate the cost of his order.
- The packaging generally
supplied (box of 1,000 tabs, 100 ampoules).
- The level of distribution: each
product is allocated to a level of health facility (the same order form is used
for all facilities).
- The stocks: it is best to make an inventory before
every order.
- The monthly consumption.
Three copies of the order should be made, dated and countersigned by the person in charge of the health facility. Two copies will be sent to the supplier: one of which will be used as a delivery note and can also be used for invoicing, the second one rests at suppliers. The third copy will be kept for the facility itself.
Example: health centre order form, supplied every 3 months, with a reserve stock of 4 months
Name of the facility: Beboro
Person responsible: Dr A.
Bernard
Date: 29.04.92
Signature: XXX
ORAL ADMINISTRATION
RECEPTION OF THE ORDER
The order should be accompanied by a delivery note or an invoice showing the number of packages and their contents.
On reception, the number of packages should be checked immediately. Then, their contents can be checked:
- Ensure that the items delivered correspond to the items
ordered, and that the quantities conform to those on the delivery note.
- The
packaging of each drug is checked, its labelling, its expiry date and the
appearance of the product if possible.
The dispatcher will be informed immediately of any discrepancy.
The drugs and materials will be arranged, as soon as possible, in the place assigned to them. The quantities received are recorded on the stock-cards.
The delivery notes and invoices are filed with the order forms in an "orders" file to be kept for three years or more depending on the regulations in force.
INVENTORY
At least once a year, but if possible before every order, an inventory of the quantities actually in stock and their expiry dates should be made.
The stock cards give a theoretical figure for the stock, but the quantities actually available should be checked, product by product. Differences can arise through theft or errors in the record-keeping. These differences should be thoroughly investigated.
An inventory can be made easily in a correctly arranged pharmacy. It is a vital job.
During the inventory, the pharmacy or warehouse should arrange that there is no movement of stock.
DISTRIBUTION
The warehouse supplies the pharmacies in the district following a timetable agreed between the warehouse manager and the persons in charge of the district health facilities. Each pharmacy will send the warehouse two copies of an order form (as described earlier):
- the quantities actually supplied by the warehouse in
completing the order will be filled in on both copies;
- one copy will be
sent along with the delivery;
- the other will be placed in a file that has
been created for each pharmacy in the district, after checking that each item
sent has been correctly recorded on its stock card; the date of this recording
will be on the order form as proof.
The orders and deliveries to the pharmacy of the district health centre will proceed in the same manner.
Each pharmacy in the district will have its own file intended for its own internal management. The entries in this file will keep an account of all that has come in from the order forms and all that has gone out from the consultation and (for the structures that have this facility) hospitalisation registers.
- Re-packaging drugs in view of their distribution
The drugs are delivered in large boxes (or containers) holding, for example, 1,000 tablets or 100 ampoules. It is necessary to divide the boxes of certain little-used or expensive drugs (e.g. ampoules of adrenaline - praziquantel) to distribute them to the pharmacies of small clinics.
To dispense the drugs to patients, it is better to pre-packe.
To do this:
· make a list of the most commonly prescribed
drugs,
· note the usual treatment regimens for each of these drugs, for
adults and for children in each age range;
· obtain small plastic bags
(rather than paper);
· prepare labels for each drug, showing clearly:
- the name of the centre,
- the name of the drug (INN) and
its dose,
- the dosage written out in full (and in symbols for the
illiterate);
· put the number of tablets corresponding to a single
treatment and add the corresponding label into the bag;
· seal the bags:
there are bags that can be resealed by pressure; if not it is possible to staple
them closed or, preferably, to use a small heat-sealing machine which welds both
sides.
Prepacking has many advantages:
· easier and quicker distribution;
· the drugs keep
better;
· easier and more rigorous control over drugs going
out;
· a more acceptable presentation to the patient; at the same time,
the drug is easier to identify and the way to use it clearly indicated.
Drugs should be pre-packed according to precise procedures and checked to ensure hygiene norms are respected (cleanliness of hands, tables, containers before they are opened, bags.), to avoid the risk of making mistakes in the drugs dispensed or in counting, as well as to avoid drugs being lost while this work is being done. It is necessary for all health structures which have more than 20 consultations per day.
Remarks
To get 100, 200 or 500 tablets from a container of 1000, it is possible to weigh them, rather than counting, if a sufficiently accurate balance is available.
To repackage large quantities of tablets (health centres of large districts) tablet-counters exist, either for manual counting or for automatic counting through a simple electrical device.
- Dispensing drugs to the pahent
For the patient to correctly follow his treatment, adequate explanation should be given to ensure that they understand:
· how to take the medicine;
· how often a for how
long;
· why the entire course of an antibiotic treatment must be taken,
whilst treatment with an analgesic should be stopped when the pain
stops;
· possible side-effects: for example, drowsiness caused by
anti-histamines, the need to avoid alcohol with metronidazole.
The person dispensing the drugs should be able to give the patient the information that he needs.
The packaging of the drug should be presentable; its label sufficiently legible and complete to remind the patient how to use the drug.
In busy centres, it is better to have two people responsible for dispensing to double check the delivery of prescriptions; the first assembles the drugs prescribed, the second checks that they are correct and gives them to the patient giving him all necessary explanations, a little apart from the other users.
Interpreters are needed if several languages or dialects exist in the same region.
Gifts of recuperated medicines and medical samples
It is recommended that you do not seek or accept supplies coming from collections of medicines retrieved from consumers in industrialised countries, or the samples that the manufacturers give freely to doctors.
Very often, they are proprietary drugs that are unknown to the prescribers and unsuitable for the local pathologies. The many brand drugs that are supplied in this way interfere with the implementation of standardised therapeutic regimens and makes any form of management impossible.
In certain individual cases, this support can be valuable, provided the drugs have been rigorously sorted and reply to the precise needs of competent prescribers. However, for most health centres and for the clinics, it is far better to use an autonomous supply system, based on a limited number of drugs at an acceptable cost, that can be used and managed correctly.
The choice of suppliers
To buy or to import? A choice has to be made whenever there is the possibility of obtaining supplies locally (manufacturers and/or wholesalers) and that, at the same time, individual importation procedures are permitted. Other than in emergencies, the decision depends on two factors, quality and cost.
QUALITY
There are poor quality drugs on the market that have not passed the necessary controls: some of them do not contain enough of the active ingredients, or even no active ingredients at all, while others are poorly made and deteriorate quickly.
To identify the dubious suppliers, those in charge of supply centres can seek advice from the local health authorities and hospital pharmacists who know the local pharmaceutical market that they must use.
COST
You should compare the local price of supplies against the cost price of importing the same items, including freight charges (by sea of by air), transit costs and, sometimes, the payment of various duties.
Local supplies can have an advantage, even if the prices are slightly higher than the cost price of importation: they make it possible to reduce the level of stocks, since more frequent resupplies are possible, and therefore to reduce the risks of losses (expiry, misappropriations.) and the volume of storage needed.
For infusion solutions, which are very bulky and cost a lot in freight charges, it is recommended to buy locally if they are available and of good quality.
For rarely used drugs, which represent a negligible percentage of the total cost of supplies, it is not worth the effort of importing them if they are available on the spot and of good quality.
General remarks
Quality
Identification
Stability -
Storage
Expiry period
Deterioration
To guarantee effective treatment, it is vital to maintain the quality of the drugs, which means that their identity, dosage and condition have to be assured.
General remarks
Storage conditions and climatic conditions such as temperature, humidity and light are often very different in tropical countries than in those countries in which the drug was tested. This raises the question whether the drug is still reliable and effective upon arrival.
First, we ought to bear in mind that drugs do not lose their efficacy suddenly at the expiry date. The deterioration process is very slow and varies widely.
There are not only many different products but any given product may also come in various forms and the process of deterioration may vary accordingly.
The determination of the conventional expiry date is based upon the average rate of deterioration that is supposed to occur under normal conditions of light, temperature and humidity. When the expiry date has been calculated on the basis of such conditions, drugs will keep their original therapeutic effect up to the very date of expiry (at least 90% of the active ingredients should be still present and there should not be any substantial increase in toxicity).
Quality
In order to obtain good quality drugs, we should try to acquire them in the best possible manner, which means dealing with reliable suppliers and being able to assure quality maintenance through optimum transport and storage conditions.
The quality of generic drugs is equal to that of specialized pharmaceutical products, provided that they are manufactured and controlled properly. When no laboratory is available to test the quality of these generics, we have to rely on the manufacturers and wholesalers for proof of that quality. The choice of a supplier should never depend exclusively upon price.
Identification
All drugs should be easily identifiable, both by the medical staff and the patient. In whatever form the drug is packed (bottle, bag or box), it must bear not only the name of the product inside, but also its dose and expiry date. This is particularly important for generic drugs which are sometimes hard to recognize. Different products often look alike or, on the other hand, the same product may exist in different colours and/or forms (e.g. tablets or capsules).
StabilityStorage
Environmental conditions, such as temperature, air and light, are all factors that influence the storage of drugs.
TEMPERATURE
Standard storage conditions are normally defined as the following temperatures:
deep freeze |
-15 to 0°C |
refrigerator |
0 to + 6°C |
cooled |
+6 to +15°C |
room temperature |
+ 15 to + 30°C |
However, temperatures during transit and transport may reach 56;C to 60°C in vehicles, wagons or on loading platforms. This means that very often the original expiry dates cannot be guaranteed.
Freezing can be particularly damaging to solutions, causing precipitation of the active ingredients or breaking the ampoules.
AIR
Drugs may also be damaged by the influence of humidity and oxygen. Therefore all drug containers must remain closed. Special medical packing, often opaque and waterproof, offers protection against the influences of air and light. Avoid repackaging, until first distribution.
LIGHT
Excessive light may also harm drugs. Solutions are particularly sensitive to light. Injectable preparations have to be kept in the dark in their original packing. Certain types of coloured glass give the misleading impression that they protect drugs from light.
Remark
Laboratory equipment, such as chemical substances or rubber and sometimes plastic materials, require protective measures that are comparable to those for drugs.
Expiry date
In most countries, manufacturers art bound by law to have the stability of their products tested under standard conditions. They have to be able to ensure a minimum period of preservation. This is usually between 3 and 5 years, although certain sophisticated products have only a 1 to 2 year period before they expire.
Packaging should bear the expiry date and any specifications as to storage conditions.
When there is no such expiry date, the manufacturing date can be used as a basis for calculating the expiry period. Common antibiotics, hormone preparations, vitamins and liquid drugs in general will last 3 years from the date of manufacture. Other preparations usually have a 5-year period before expiry. This is only a very general rule and there are many exceptions. For instance, it does not apply to products that have to be stored under special conditions (refrigerated.).
Disposable material in sterilized packs may be used as long as the packaging remains intact.
Deterioration
Being well acquainted with the normal characteristics of every drug (colour, smell, solubility, appearance) is essential. It will enable you to detect any changes as soon as they occur. Certain processes may however occur without any detectable change in the appearance of the products.
Active agents that lose their power may have consequences varying in severity both for the individual patient or for a larger group of users.
Antibiotics that have expired, and become less active, may encourage resistant strains.
Any loss in effectiveness should not be compensated for by administering higher doses, since this may lead to serious risks of overdosage of toxic drugs.
Some drugs may even undergo changes that bring about the formation of substances which are far more dangerous and lead to an increase in toxicity. A classic example is tetracycline: when this pale-yellow powder has become brownish and viscous, it must not be used; tetracycline would then be dangerous to use, even if the expiry date has not yet been reached.
Other drugs which lose their effectiveness may produce an increase of allergic reactions. This is the case with penicillin and cephalosporin.
Do not use suppository, ovules, creams or ointments that have melted because of the heat. The active substance will no longer be homogeneously mixed.
Oral rehydration salts can be used as long as they maintain their typical white powdery aspect. Humidity will turn them into a compact mass, more or less brownish and insoluble. Whatever their expiry date, they are then no longer fit for consumption.
DRUGS THAT HAVE EXPIRED
When the only drug available has passed its expiry date, the doctor may in certain cases decide to use it anyway.
It is better to use such drug than to leave a seriously ill patient without treatment. Although a particular drug will not suddenly become unfit for consumption from one day to the next, the following factors should be considered before using any drug after its expiry date. Storage conditions should have been consistently acceptable, i.e. packaging undamaged, stored at an average temperature and protected against humidity and light. It should also be remembered that its physical appearance may not reveal some problems such as insolubility.
The drug sheets give information on the stability of a individual drugs. Unfortunately, research does not yet offer enough readily available information.
Expiry dates on drugs that require a precise dosage need to be strictly respected because of the risk of under-dosage. This is especially the case for cardiotonic drugs or anti-epileptics, and for drugs that may become toxic such as tetracyclines.
THROWING AWAY EXPIRED OR USELESS DRUGS AND MATERIALS
Do not throw away or bury any expired products without taking special precautions. It is advisable to incinerate them. If any tablets, capsules or liquid drugs are enclosed in incombustible packing, that packing should first be removed before incinerating the drugs. Keep a special spot for this operation and bury residual material at a great depth, far away from any well or water reservoir.
SOME SUGGESTIONS FOR
Reducing costs - Facilitating control - Reducing risks
Limiting the use of injectable drugs
Limiting the use of syrups and other drinkable solutions
Looking at other regimens of treatment
Considering the prescription of non-essential drugs and placebos
Using the traditional pharmacopoeia as a supplement to essential drugs
A more effective, safe and economical use of drugs can result from carefully choosing treatment protocols and the corresponding list of drugs.
Limiting the use of injectable drugs
Many patients ask to be treated by means of injection because they imagine it to be more effective. There are also prescribers who attach greater value and effectiveness to injections and transfusions.
Treatment by injection is always more costly than oral treatment. The price of the drug is higher for an equal dose of effective, active substance. More over, treatment by injection requires the strict sterilization of injection material or even the use of expensive disposable material. It may also expose the patient to complications due to poorly tolerated products (e.g. abscess, gangrene as a result of quinine injections, transfused antibiotics). Complications may arise when the injection technique is performed badly (overdose symptoms following an IV injection administered too quickly, paralysis of the sciatic nerve). If sterilization does not meet optimum standards, there may also be a risk of bacterial or viral contamination (tetanus, hepatitis, AIDS.).
If the drug required also exists in the form of tablets or capsules, injections should not be administered except in emergency cases when the patient's digestive system would not tolerate any other treatment or when he or she is incapable of taking the drug orally.
In such a case, treatment by means of oral drugs should replace treatment by injection as soon as possible (antimalarials, antibiotics, diuretics.).
Limiting the use of syrups and other drinkable solutions
It is often easier to take drugs in liquid form, especially for children who like the nice-smelling sweetened solutions. There are however numerous reasons to avoid the use of such syrups:
- Risk of incorrect usage
Away from controlled hospital conditions, people with little medical understanding may often take a dangerous dose of the drug. Spoons are never of a standard size (there are spoons used for soup, coffee, tea.). Solutions have to be prepared in advance, using an exact measure of clean boiled water and should be shaken before use. There is therefore a high chance of an under- or overdose.
Solutions can only be stored for a few days and carry the risk
of contamination or fermentation.
In many countries, syrups are thought of as
cough mixtures. This may account for much confusion between such cough mixtures
and antibiotic syrups or solutions.
- Economic considerations
Compared with the price of tablets or capsules, the price of syrups and drinkable solutions is substantially higher. Even if used in the form of a powder for subsequent preparation, costs may be between 2 and 7 times higher than for an equivalent active dose. This is because of the drug bottle itself and the higher transportation costs caused by weight and volume.
Looking at other regimens of treatment
The initial choice of a particular treatment will often determine compliance and its medium-term cost. It is preferable to choose those treatments that are as short as possible and require fewest doses (once or twice a day). Obviously, treatment with a single dose daily is the ideal. In this respect, the following cases are good examples:
- An "instant" treatment using a single dose is often preferable, even if such a treatment is sometimes less effective from a pharmacological point of view. For instance, the treatment of amoebiasis with a single dose of 8 tablets of 250 mg metronidazole may be preferred to a dassic 7-day treatment.
- The combination of pyrimethamine-sulfadoxine for treating malaria should not be given as a first choice treatment in those zones where chloroquine is effective. But a single dose which may be taken immediately may be preferable for those patients who may not be very disciplined.
- A short-course anti-tuberculosis chemotherapy including rifampicin may seem a costly treatment. Those costs might be even higher if poorly monitored treatment is interrupted, followed by relapse or reinfection.
Considering the prescription of non-essential drugs and placebos
Psychosomatic illnesses occur frequently in developing countries, just as they do in industrialised ones. It is not always possible to prescribe a specific therapy in order to overcome these complaints. Is it really possible and desirable to send those patients home without giving them a symptomatic drug or a placebo? And what kind of placebo should be used?
When local medication rules are quite strict and do not allow the use of any placebo or non-essential symptomatic medication, we often see an abuse of other products (chloroquine, acetyl salicylic acid, diazepam and even antibiotics).
On the other hand, you may sometimes run the risk of using a placebo when genuinely effective and necessary medication should be prescribed. This happens, but not very frequently. Therefore, the introduction of a placebo on the drug list may be justified. Multivitamins may, for example, act as a harmless and relatively cheap placebo. Their composition is generally that necessary to prevent vitamin deficiencies and they have no contra-indications.
Many specialized pharmaceutical products (tonics, liver treatments presented as drinkable ampoules) have no real therapeutic justification and, as they cost more, they should not be used as placebos.
Using the traditional pharmacopoeia as a supplement to essential drugs
Effective traditional medication, usually intended for the treatment of symptoms, still exists nearly everywhere in the world. Prepared from local plants and used for generations, these remedies often have all the advantages and half the cost of industrially-prepared drugs for the same indications.
This may be the case for laxatives, cough mixtures, anti-diarrhoea, cholagogue and dermatological preparations. They may be administered in the form of infusions, decoctions or various other mixtures and they can be prepared at health care facilities.
Medical personnel should of course be aware of the existence of
these treatments and suggest their use to patients as a complement to the
therapeutic treatment that has already been chosen.
Nevertheless, the patient
must understand the limits of traditional remedies when it comes to serious
illnesses such as tuberculosis,meningitis. In these cases, there is no effective
treatment other than "modern"
drugs.
ANTIBACTERLAL = ANTIBIOTICS + SULPHAMIDES.
Possible causes for failure of antibiotic treatment
Choice of
antibiotic therapy
Combination of antibiotics
Principal antibiotic groups
Knowing which antibiotic to prescribe is difficult in precarious situations.
The diagnosis of an infection is essentially based on clinical criteria. It is practically impossible to rely on bacteriology (culture, isolation and identification of the bacteria). At best, a Gram stain can give an idea of the nature of the bacteria involved.
The choice of treatment protocol depends on the context in which the patient is seen:
- Dispensary: many patients examined rapidly and therefore difficult to follow up for treatment. Standard protocols should be drawn up for diagnosis and treatment of the most frequently encountered diseases. The number of available antibiotics will be restricted.
- Health centre and hospital: prescriptions can be more versatile. In case treatment fails or the patient tolerates the initial treatment badly, altematives are available. More antibiotics are available.
Possible causes for failure of antibiotic treatment
- Poor diagnosis: clinical signs of infection may be caused by
diseases that are not of bacterial origin: viral, parasitic.
- The dosage or
the length of treatment has been inadequate.
- The treatment has not been
followed properly.
- Vomiting occurs after the drug has been taken
orally.
- The interaction between different types of drugs taken by the
patient decreases their absorption (e.g. tetracyclines with ferrous salts or
antacids).
- The antibiotic does not diffuse well into the infected tissue
(abscess, cerebro-spinal fluid).
- The antibiotic becomes inactive after
several products have been mixed in the same infusion bag.
- The antibiotic
has passed its expiry date or has lost its efficacy due to poor storage
conditions (most antibiotics simply lose their effectiveness; tetracyclines,
however, become toxic for the kidneys and they must be avoided).
- Bacterial
resistance to the chosen antibiotic.
Choice of antibiotic therapy
The following table gives, for each type of infection, the bacteria most often responsible for such an infection and the antibiotics most suited both to these bacteria and diffusion into the infected tissue.
Explanatory notes:
- Medication preceded by an asterisk (*) is contra-indicated
during pregnancy.
- Figures between brackets give an idea of the average
price per treatment in French Francs (standard treatment being 5 days, except
for typhoid fever: 3 weeks, and for trachoma: 1 month).
It is interesting to
compare prices of different treatments. The cost would affect the choice of a
particular treatment, along with other criteria such as effectiveness, tolerance
and expected results.
- Antibiotics under the heading "alternative" should be
prescribed if the initial choice of antibiotic fails, is not tolerated or is
contra-indicated.
FIGURE
FIGURE
PPF = Procaine Penicillin Forte (3 MIU procaine penicillin + 1
MIU penicillin G)
Metro. = Metronidazole
Genta. = Gentamicine
Combination of antibiotics
A combined treatment using several antibiotics can only be justified in cases of severe infections.
Certain combinations are to be avoided because the effect of one antibiotic may neutralize the effect of the second when administered at the same time.
At any rate, the decision to use antibiotics in combination must be made by a doctor for each case and such a decision must never be made as a matter of course.
Penicillin and its derivatives should not be used in combination with tetracycline, chloramphenicol, erythromycin or rifampicin.
Principal antibiotic groups
PENICILLIN AND ITS DERIVATIVES
· Ampicillin and amoxycillin
· Benzathine
penicillin
· Benzyl penicillin (Penicillin G)
·
Cloxacillin
· Phenoxymethyl penicillin (Penicillin V)
· Procaine
penicillin with or without benzyl penicillin
Fast-acting types
- Penicillin V or phenoxymethyl penicillin taken orally is the
first treatment for tonsillitis. However, its effect on pulmonary infections is
variable.
- Penicillin G or benzylpenicillin should be reserved for acute
infections only. Because of its rapid elimination, injections every six hours
are vital. This is difficult to manage outside a hospital environment.
Long-acting types
- Procaine penicillin has the advantage that it can be injected in one single dose once a day. It reacts quickly (45 to 60 minutes) and can only be injected IM.
For the treatment of gonorrhoea, it must be combined with probenecid.
- Procaine penicillin forte (PPF) is a combination of procaine
penicillin and benzylpenicillin. It acts 15 to 30 minutes after injection, more
rapidly than the procaine penicillin on its OWll, because of the penicillin G.
For the treatment of gonorrhoea, it must be combined with probenecid.
- The
concentration of the benzathine penicillin builds up progressively in the 24
hours following injection. It remains active for 15 to 20 days. Because of the
delayed action and the low concentrations in the blood, it is only used for
infections susceptible to penicillin which evolve slowly. Its use is
contra-indicated in cases of acute infections.
Derivatives of penicillin
- Ampicillin is a broad-spectrum antibiotic. It is only to be
used for the treatment of respiratory infections in children under 5 years of
age: it is active against Hphilus influenzfrequently the cause of these
infections. Its use is also recommended for pregnant women, for whom other
antibiotics are frequently contra-indicated. Apart from these examples, the use
of cheaper antibiotics is preferred. The injectable forms should only be used in
cases of severe infections.
- Amoxycillin has the same spectrum as ampicillin
and has the advantage of a better intestinal absorption rate which allows lower
doses to be given.
If orally administered, use amoxycillin rather than
ampicillin if the cost is more or less the same.
- Cloxacillin is a small
spectrum antibiotic, limited to the treatment of staphylococcus infections, as
most of these have become resistant to penicillin.
MACROLIDES
- Erythromycin
Erythromycin should only be used in cases of penicillin allergy
because it is expensive.
It is the only macrolide available in generic form.
The others have the same indications.
PHENICOLS
- Chloramphenicol
Chloramphenicol is a broad spectrum antibiotic, effective against many types of infections. It should be the antibiotic of first choice in cases of typhoid fever.
Because of its efficacy and low cost, it is still widely used, but because of the risks of haematological toxicity, its use should be strictly limited to specific indications: typhoid fever, meningitis and broncho-pneumonia.
The injectable form of chloramphenicol in oil should be reserved for meningitis epidemics.
SULPHONAMIDES
· Sulfadimidine
· Sulfadoxine
·
Cotrimoxazole (sulfamethoxazole + trimethoprim)
Simple sulphonamides
- The use of sulphonamides in the form of sulphadimidine is
limited to lower urinary infections without complications (without lumbar pain
or fever).
- Sulfadoxine is a long-acting antibiotic (about one week).
Despite the existence of resistant strains and significant side-effects, it is
still incorrectly used for meningitis or cholera epidemics.
- The use of
non-absorbing sulphonamides (sulfaguanidine, phtalysulfathiazole) is not
recommended because they rarely work in cases of intestinal infections of
bacterial origin.
Combined sulphonamides
- The use of a sulphonamide in
combination with trimethoprim (e.g. cotrimoxazole) benefits from the synergic
effect of the two products. Indications are more numerous than for simple
sulphonamides: urinary infections with fever, pneumonia's..
CYCLINES
· Tetracycline and oxytetracycline
· Doxycycline
- Because of the multiplication of organisms resistant to
cyclines, they should be kept for specific infections: brucellosis, cholera,
borreliosis, typhus, gonorrhoea resistant to penicillin and certain chronic
pneumopathies. They must not be used as a matter of course and must always be
prescribed under medical supervision.
- Doxycycline has the advantage of
being able to be administered in a single dose for the treatment and prevention
of cholera or typhus. It is still less widespread and better tolerated than
tetracycline, even in case of renal disease.
AMINOSIDES
- Gentamicin
The specific indications for gentamicin are such that they should always be prescribed under medical supervision because of its toxicity, cost and frequent appearance of resistance.
ANTIBACTERIAL (ANTISEPTIC) OF THE URINARY TRACT
- Nitrofurantoin
It acts over a sufficiently wide spectrum to cover the majority of lower urinary tract infections in young women. In that case, it can be prescribed as first choice except late in pregnancy. Its cost is low.
Definition
Selection
Table for the use of antiseptics and
disinfectants
Preparation and storage of antiseptic solutions
Preparation
and use of disinfectant solutions for floors and surfaces
Preparation and use
of disinfectant solutions for medical material
Definition
Antiseptics are products used for the disinfection (asepsis) of living tissues (skin, wounds, mucosa.).
Disinfectants are products used for the disinfection of objects and surfaces (floors, tables.).
Certain products can be used both as antiseptic and as disinfectant (e.g. polyvidone iodine, chloramine T), but, unfortunately, the perfect product, which is cheap, effective for all bacteria, stable, easy to transport and suitable for use both on living tissue and objects, does not exist - at least not yet.
Selection
We can nevertheless suggest a restricted list of products that meet all the demands of medical facilities:
- normal soap,
- tosylchloramide sodium (= chloramine
T),
- chlorhexidine (or preferably chlorhexidine + cetrimide),
-
polyvidone iodine,
- gentian violet,
and for floors and surfaces:
- a
soapy solution of cresol (= Lysol) or preferably a product that generates
chlorine like calcium hypochlorite (HTH), bleach, sodium dichloro-isocyanurate
(= NaDCC) or even chloramine T.
In the chapter "Drugs for external use and disinfectants", the descriptions for each product give details on the use of these products. Other widely-used products are also described.
Finally, some notes on particular products:
- Alcohols (ethanol and isopropanol)
Good disinfectants at 60-70° (60-70%) for objects or intact skin (more effective at 60-70° than at 90-95°), but:
They are not good for wounds because they are painful and slow the healing process.
They are expensive both to buy and to transport (they require special packing for air transport). Moreover, the purchase, transport and importation of ethanol often require complicated administrative procedures.
They can be advantageously replaced by polyvidone iodine.
- Chloroxylenol (Dettol (R))
An efficient but expensive product which can be used as an antiseptic (0.25% chloroxylenol solution) and disinfectant (see "soapy solution of cresol").
Can be of interest if locally available.
- Eosin
Antiseptic with limited effectiveness, but useful as a drying agent. Its aqueous solutions are easily contaminated by pathogenic bacteria.
Can be replaced by gentian violet.
- Hydrogen peroxide (hydroperoxide)
Very useful for certain indications (e.g. dirty wounds), but very hard to preserve in diluted and ready-to-use form. Concentrated hydrogen peroxide is dangerous to transport and handle.
- Hexachlorophene
Antiseptic with limited effectiveness and toxic for the central nervous system. Usage not advised.
- Mercury derivatives: e.g. Phenylmercury (Merfen (R)),
Mercuresceine (Merbromine, Mercurochrome (R), Mercurobutol (Mercryl (R)),
Thiomersal (Merthiolate (R), Timerosal (R))
Antiseptics with limited
effectiveness in aqueous solutions (mercurosceine has very little effect).
Toxic for the kidneys and the central nervous system, often cause allergies and pollute the environment.
Forbid their use.
- Ether
Often wrongly used as an antiseptic. It has no disinfecting properties, but degreases the skin and removes sticky residues of elastoplast and similar dressings.
Table for the use of antiseptics
and disinfectants
Preparation and storage
Although it may seem paradoxical, the aqueous solutions of antiseptics can become contaminated when handled and turn into bacterial cultures, especially Pseudomonas aeruginosa (pyocyanic).
To avoid this, the following precautions must be taken:
- Make all aqueous dilutions with either:
· drinking water,
· water filtered by a
well-maintained candle type filter,
· boiled water (previously filtered
through cotton if it is turbid).
- RENEW ALL AQUEOUS SOLUTIONS AT THE LAST ONCE A WEEK.
- Only
prepare small amounts at a time to avoid wastage and the temptation to keep and
use expired solutions.
- Never mix the fresh solution with the expired one
(wash and dry the bottle before each refill).
- Do not use a cork.
On the bottles, mark the name and concentration of products.
Preparation and use of disinfectant solutions for floors and surfaces
- The dilutions of Lysol (or similar) and the dilutions of
chlorinated disinfectants must be prepared just before use. Make the dilutions
with clear water.
- The chlorinated disinfectants are only fully effective on
clean surfaces. The area must be cleaned before they are applied. Nevertheless,
they have the advantage of clearly proven antiviral activity and are relatively
cheap.
Preparation and use of disinfectant solutions for medical material
Soaking clean material for 15 minutes in the disinfectant solutions indicated in the table below gives a very effective disinfection for bacteria in vegetative forms and for viruses (including the AIDS and hepatitis B virus). However, the bacterial spores are generally not destroyed (e.g. tetanus spores).
Sterilization (elimination of all bacteria, including the spores) can only be obtained with an autoclave or a good electric hot air sterilizer. Sterilization is obligatory for all materials that come in contact with sterile parts of the body (equipment for punctures, injections and surgery.)
Soaking in strong disinfectant solutions can sometimes be an alternative to sterilization when the latter is impossible. However, in that case, boiling is still the best approach. The effectiveness of chemical disinfection can be impaired by an error in the dilution or the degradation of the disinfectant resulting from poor storage conditions.
Chemical disinfection is never recommended for sterilizing syringes and needles.
Powerful disinfectants suitablefor
use on medical material
CLEANING OF DIRTY EQUIPEMENT
Reusable equipment must be carefully cleaned before sterilization or disinfection.
The cleaning is carried out with water and soap (or another detergent).
To facilitate cleaning, the material should be soaked in water immediately after use, so soiled parts will not dry. Half an hour before cleaning the equipment, a disinfectant can be added to this water for an initial decontamination (e.g. chloramine 20 g/litre, Lysol 50 g/litre). Soaking for too long or with too high a concentration of disinfectant can cause corrosion of metal instruments.
After cleaning, the equipment must be carefully rinsed with clean water and then dried.
Lists of drugs and medical supplies for a population of 10,000 persons for approximately 3 months
Introduction
In recent years the various organizations and agencies of the United Nations system have been called upon to respond to an increasing number of large-scale emergencies and disasters, many of which pose a serious threat to health. Much of the assistance provided in such situations by donor agencies, governments, voluntary organizations and others is in the form of drugs and medical supplies. But the practical impact of this aid is often diminished because requests do not reflect the real needs or because these have not been adequately assessed. This can result in donations of unsorted, unsuitable and unintelligibly labelled drugs, or the provision of products which have passed their expiry date. Such problems are often compounded by delays in delivery and customs clearance.
The World Health Organization, which is the directing and coordinating authority for international health work within the United Nations system, took up the question of how emergency response could be facilitated. After several years of study, field testing and modifications, standard lists of essential drugs and medical supplies for use in an emergency were developed. The aim was to encourage the standardization of drugs and medical supplies used in an emergency to permit a swift and effective response with supplies that meet priority health needs. A further goal was to promote disaster preparedness since such standardization means that kits of essential items can be kept in readiness to meet urgent requirements.
The WHO Emergency Health Kit, which resulted from this work, was originally developed in collaboration with the Office of the United Nations High Commissioner for Refugees (UNHCR) and the London School of Hygiene and Tropical Medicine. It has now been revised in collaboration between the Action Programme on Essential Drugs (WHO, Geneva), the Emergency Preparedness and Response Unit (WHO, Geneva), the unit of Pharmaceuticals (WHO, Geneva), the Office of the United Nations High Commissioner for Refugees, UNICEF, Mcins Sans Frontis, the League of Red Cross and Red Crescent Societies (Geneva), the Christian Medical Commission of the World Council of Churches and the International Committee of the Red Cross. A review of the experience of previous users of the kit, prepared by the London School of Hygiene and Tropical Medicine, as well as field experience of UNICEF and Mcins Sans Frontis, were also considered during the revision. Major suppliers of the kit were consulted on the specifications of its contents.
The kit has now been adopted by many organizations and national authorities as a reliable, standardized, inexpensive, appropriate and quickly available source of the essential drugs and health equipment urgently needed in a disaster situation. Its contents are calculated to meet the needs of a population of 10,000 persons for three months. It has been renamed the: "New Emergency Health Kit" because of the number and diversity of United Nations agencies and other bodies which have adopted this list of drugs and medical supplies for their emergency operations and which participated in its revision.
This booklet provides background information on the development of the kit, a description of its contents, comments on the selection of items, treatment guidelines for prescribers and some useful checklists for suppliers and prescribers. Chapter 1 (Essential drugs and supplies in emergency situations) is intended as a general introduction for health administrators and field officers. Chapter 2 (Comments on the selection of drugs, medical supplies and equipment included in the kit) contains more technical details and is intended for prescribers.
Publication of this document was made possible by financial contributions received from the United Nations High Commissioner for Refugees, the Government of the Netherlands, the WHO Emergency Preparedness and Response Unit and the WHO Action Programme on Essential Drugs.
Chapter 1: Essential drugs and supplies in Emergency situations
What is an Emergency?
The term "emergency" is applied to various situations resulting from natural, political and economic disasters. The New Emergency Health Kit is not intended for the acute phase of epidemics, war, earthquake, floods, etc. but is designed to meet the needs of a population with disrupted medical facilities in the second phase of a natural or other disaster, or a displaced population without medical facilities. It has also been used in countries with acute shortages of drugs due to economic reasons.
It must be emphasized that, although supplying drugs and medical supplies in the standard kits is convenient in the second phase of an emergency, specific local requirements need to be assessed as soon as possible and further supplies must be ordered accordingly.
Quantification of drug requirements
Morbidity patterns (the relative frequency of different illnesses) may vary considerably between emergencies. For example, in emergencies where malnutrition is common morbidity rates may be very high. For this reason an estimation of drug requirements from a distance can only be approximate, although certain predictions can be made based on past experience. For the present kit estimates have been based on the average morbidity patterns and the use of standard treatment guidelines. The quantities of drugs supplied will therefore only be adequate if prescribers follow these guidelines (given in Annexes 1-3).
Contents of the kit
The New Emergency Health Kit consists of two different sets of drugs and medical supplies, named a BASIC UNIT and a SUPPLEMENTARY UNIT(The previous version consisted of three lists: A = basic drugs; B = supplementary drugs; C = medical supplies and equipment for basic and supplementary lists). To facilitate distribution to smaller health facilities on site, the quantities of drugs and medical supplies in the basic unit have been divided into ten identical units for 1,000 persons each.
FIGURE
The BASIC UNIT contains drugs, medical supplies and some essential equipment for primary health care workers with limited training. It contains twelve drugs, none of which are injectable. Simple treatment guidelines, based on symptoms, have been developed to help the training of personnel in the proper use of the drugs. Copies of these treatment guidelines, an example of which is printed in Annexes 1-3, should be be included in each unit. Additional copies can be obtained from the Action Programme on Essential Drugs, WHO, Geneva, and from UNICEF Copenhagen (see Annex 7 for addresses).
The SUPPLEMENTARY UNIT contains drugs and medical supplies for a population of 10,000 and is to be used only by professional health workers or physicians. It does not contain any drugs or supplies from the basic units and can therefore only be used when these are available as well.
The selection and quantification of drugs for the basic and supplementary units have been based on recommendations for standard treatment regimens from technical units within WHO. A manual describing the standard treatment regimens for target diseases, developed in collaboration between Mcins sans Frontis and WHO, is available from Mcins sans Frontis at cost price and is to be included in each supplementary unit.
To facilitate identification in an emergency, one green sticker (international color code for medical items) should be placed on each parcel. The word "BASIC" should be printed on stickers for basic units.
Referral system
Health services can be decentralized by the use of basic health
care clinics (the most peripheral level of health care) providing simple
treatment using the basic units. Such a decentralization will:
1) increase
the access of the population to curative care; and 2) avoid overcrowding of
referral facilities by solving all common health problems at the most peripheral
level. Basic treatment protocols have been drawn up to allow these health
workers to take the right decision on treatment or referral, according to the
symptoms (see Annexes 1-3).
The first referral level should be staffed by professional health workers, usually medical assistants or doctors, who will use drugs, supplies and equipment from both the basic and the supplementary units. It should be stressed here that the basic and supplementary units have not been intended to enable these health workers to treat rare diseases or major surgical cases. For such patients a second level of referral is needed, usually a district or general hospital. Such facilities are normally part of the national health system and referral procedures are arranged with the local health authorities.
Procurement of the kit
The New Emergency Health Kit can be provided from a number of major pharmaceutical suppliers, some of which will have a permanent stock of kits ready for shipment within 48 hours. It may however be desirable to secure procurement at the regional level to reduce the cost of shipping. The procuring agency should ensure that manufacturers comply with the guidelines for quality, packaging and labelling of drugs (see Annex 6).
It is important to note that many drugs in the kit can be considered as examples of a therapeutic group, and that other drugs can often serve as alternatives. This should be taken into consideration when drugs are selected at the national level, since the choice of drugs may then be influenced by whether equivalent products are immediately available from local sources, and their comparative cost and quality. National authorities may wish to stockpile the same or equivalent drugs and supplies as part of their emergency preparedness programme. The kit can also serve as a useful baseline supply list of essential drugs for primary health care.
Donor guidelines
Whatever the source of drugs, it is very important that:
- No drugs should be sent from a donor country without a
specific request, or without prior clearance by the receiving country;
- No
drugs should be sent that are not on the List of Essential Drugs of the
receiving country, or, if such a national list is not available, on the WHO
Model List of Essential Drugs;
- No drugs should arrive with a future life
(before expiry date) of less than one year;
- Labelling of the drugs should
be in the appropriate language(s) and should at least contain the generic name,
strength, name of manufacturer and expiry date (see Annex 6);
- Labelling on
the outside package should contain the same information, plus the total quantity
of drugs in the package.
Immunization in emergency
Experience in past emergencies involving displacements of populations has shown measles to be one of the major causes of death among younger children. The disease spreads rapidly in overcrowded conditions, and serious respiratory tract infections are frequent, particularly in malnourished children. An adequate supply of essential drugs may reduce the mortality rate, but measles can be prevented by immunization. A measles immunization programme should therefore be given high priority in the early phase of an emergency. The WHO Expanded Programme on Immunization (EPI), UNICEF, the Office of the High Commissioner for Refugees (UNHCR) and OXFAM have collaborated in the development of the Emergency Immunization Kit, which may be used to set up an emergency immunization programme against measles. This kit contains cold chain and injection equipment for 5,000 immunizations and may be ordered from OXFAM. Vaccines are not included.
Post emergency needs
After the acute phase of an emergency is over and basic health needs have been covered by the basic and supplementary units, specific needs for further supplies should be assessed as soon as possible. In most cases this will necessitate a quick description and, if possible, quantification of the morbidity profile. It should characterise the most common diseases and should identify the exposed and high risk groups in the population (e.g. children below 5 years of age and pregnant women). These high risk groups should be the first target of the continuing health care programme. Any other factors that may influence requirements should also be taken into account, e.g. the demographic pattern of the community, the physical condition of the individuals, seasonal variations of morbidity and mortality, the impact of improved public health measures, the local availability of drugs and other supplies, drug resistance, usual medical practice in the country, capabilities of the health workers and the effectiveness of the referral system.
Much time and money may be saved by adapting re-order forms to the specific needs of the situation and by standardizing re-order procedures for all locations and health teams, regardless of whether supplies are available locally or must be ordered from abroad.
Chapter 2: Comments on the selection of drugs, medical supplies and equipment included in the kit
The composition of the New Emergency Health Kit is based on epidemiological data, population profiles, disease patterns and certain assumptions borne out by emergency experience. These assumptions are:
· The most peripheral level of the health care system will
be staffed by health workers with only limited medical training, who will treat
symptoms rather than diagnosed diseases and who will refer to the next level
those patients who need more specialized treatment.
· Half of the
population is 0-14 years of age.
· The average number of patients
presenting themselves with the more common symptoms or diseases can be
predicted.
· Standardized schedules will be used to treat these symptoms
or diseases.
· The rate of referral from the basic to the next level is
10%.
· The first referral level of health care is staffed by experienced
medical assistants or medical doctors, with no or very limited facilities for
inpatient care.
· If both the basic and first referral health care
facilities are within reasonable reach of the target population, every
individual will, on average, visit such facilities four times per year for
advice or treatment. As a consequence the supplies in the kit, which are
sufficient for approximately 10,000 outpatient consultations, will serve a
population of 10,000 people for a period of approximately three months.
Selection of the drugs
Injectable drugs
There are no injectable drugs in the basic unit. Basic health workers with little training have usually not been taught to prescribe injections, neither are they trained to administer them. Moreover, the most common diseases in their uncomplicated form do not generally require an injectable drug. Any patient who needs an injection must be referred to the first referral level.
Antibiotics
Infectious bacterial diseases are common at all levels of health care, including the most peripheral, and basic health workers should therefore have the possiblity to prescribe an antibiotic. However, many basic health workers have not been trained to prescribe antibiotics in a rational way. Cotrimoxazole is the only antibiotic included in the basic unit, and this will enable the health worker to concentrate on taking the right decision between prescribing an antibiotic or not, rather than on the choice between several antibiotics. Cotrimoxazole has been selected because it is active against the most common bacteria found in the field, especially S. pneumonind H. influenzor acute respiratory infections. It is also stable under tropical conditions, needs to be taken only twice daily and its side-effects (exfoliative dermatitis or bone marrow depression) are uncommon. In addition to this it is less expensive than other antibiotics. The risk of increasing bacterial resistance must be reduced by rational prescribing practice.
Drugs not included in the kit
The kit includes neither the common vaccines nor any drugs against communicable diseases such as tuberculosis or leprosy. The vaccines needed and any plans for an expanded programme on immunization should be discussed with the national authorities as soon as possible; the same applies for programmes to combat communicable diseases. In general no special programme should be initiated unless there is sufficient guarantee for its continuation over a longer period.
In addition, drugs in the kit do not cover some specific health problems occurring in certain geographical areas, e.g. specific resistant malaria strains.
Selection of renewable supplies
Syringes and needles
Considering the risk of direct contamination with hepatitis and AIDS during handling, needles are dangerous items. The health risk for the staff should be limited by the following means:
· Limiting the number of injections;
· Using
disposable needles only;
· Strictly following the destruction procedures
for disposable material.
It is less dangerous to handle syringes than needles. For this reason a system with resterilisable nylon syringes and disposable needles has been chosen for the supplementary unit. However, in the very first stage, when sterilization procedures are not yet established, some provision will be necessary for giving injections by means of fully disposable materials. A small number of disposable syringes are therefore provided in the supplementary unit and their destruction should be supervised by the person in charge.
Gloves
Disposable protective gloves are provided in the basic unit to protect health workers against possible infection during dressings or handling of infected materials. In any case a dressing should be applied or changed with the instruments provided in the kit. Surgical gloves, which should be resterilizable, are supplied in the supplementary unit. They are to be used for deliveries, sutures and minor surgery, all under medical supervision.
Selection of equipment
Resuscitation / Surgical instruments
The kit has been designed for general medicine under primitive conditions, and for that reason no equipment for resuscitation or major surgery has been included. In situations of war, earthquakes or epidemics, specialised teams with medical equipment and supplies will be required.
Sterilization
A complete sterilization set is provided in the kit. The basic units contain two small drums each for sterile dressing materials. Two drums are included to enable the alternate sterilization of one at the first referral level while the other is being used in the peripheral facility. The supplementary unit contains a kerosene stove and two pressure sterilizers, a small one for sterilizing 2 ml and 5 ml syringes, and a larger one for the small drums with dressing materials and the instrument sets.
Dilution and storage of liquids
The kit contains several plastic bottles and a few large disposable syringes which are needed to dilute and store liquids (e.g. benzyl benzoate, chlorhexidine and gentian violet solution).
Water supply
The kit contains several items to help provide for clean water at the health facility. Each basic unit contains a 20 litre foldable jerrycan and a plastic bucket. The supplementary unit contains a water filter with candles and 2.5 kg of chloramine powder to chlorinate the water.
Chapter 3: Composition of the New Emergency Health Kit
The New Emergency Health Kit consists of ten basic units and one supplementary unit.
10 basic units (for basic health workers) for a population of 10,000 persons for 3 months (1 basic unit for 1,000 persons for 3 months). The unit contains drugs, renewable supplies and basic equipment packed in one carton.
1 supplementary unit (for physicians and senior health workers), for a population of 10,000 people for 3 months. One supplementary unit contains:
- drugs (approximately 130 kg)
- essential infusions
(approximately 180 kg)
- renewable supplies (approximately 60 kg)
-
equipment (approximately 40 kg)
NB: The supplementary unit does not contain any drugs and medical supplies from the basic unit. To be operational, the supplementary unit should be used together with ten basic units
FIGURE
Basic unit (for 1,000 persons for 3 months)
Drugs
Acetylsalicylic acid, tab 300 mg. tab |
3,000 |
Aluminium hydroxyde, tab 500 mg tab |
1,000 |
Benzyl benzoate, lotion 25%. bottle 1 litre |
1 |
Chlorhexidine (5%). bottle 1 litre |
1 |
Chloroquine, tab 150 mg base. tab |
2,000 |
Ferrous Sulfate + Folic Acid, tab 200 + 0.25 mg. tab |
2,000 |
Gentian Violet, powder. 25 g |
4 |
Mebendazole, tab 100 mg. tab |
500 |
ORS (Oral Rehydration Salts).sachet for 1 litre |
200 |
Paracetamol, tab 100 mg. tab |
1,000 |
Sulfamethoxazole + Trimetoprim, tab 400 + 80mg (cotrimoxazole) tab |
2,000 |
Tetracycline eye ointment 1% tube 5 g |
50 |
Renewable supplies
Absorbent cotton wool. Kg |
1 |
Adhesive tape 2.5 cm x 5 m. roll |
30 |
Bar of soap (100-200 g). bar |
10 |
Elastic bandage (crepe) 7.5 cm x 10 m.unit |
20 |
Gauze bandage 7.5 cm x 10 m,. roll |
100 |
Gauze compress 10 x 10 cm, 12 ply, nonsterile.unit |
500 |
Ballpen, blue or black.unit |
10 |
Exercise book A4 unit |
4 |
Health card + plastic sachet. unit |
500 |
Small plastic bag for drugs. Unit |
2,000 |
Notepad A6. unit |
10 |
Thermometer (oral/rectal) Celsius / Fahrenheit unit |
6 |
Protective glove, nonsterile, disposable.unit |
100 |
Treatment guidelines for basic list.unit |
2 |
Equipment
Nail brush, plastic, autoclavable.unit |
2 |
Bucket, plastic, approx. 20 litres.unit |
1 |
Gallipot, stainless steel, 100 ml.unit |
1 |
Kidney dish, stainless steel, approx. 26 x 14 cm unit |
1 |
Dressing set (3 instruments + box). unit |
2 |
Dressing tray, stainless steel, approx. 30 x 15 x 3 cm.unit |
1 |
Drum for compresses approx. 15 cm H, 014 cm unit |
2 |
Foldable jerrycan, 20 litres.unit | |
Forceps Kocher, no teeth, 12-14 cm.unit |
2 |
Plastic bottle, 1 litre.unit |
3 |
Syringe Luer, disposable, 10 mlunit |
1 |
Plastic bottle, 125 ml.unit |
1 |
Scissors straight/blunt, 12-14 cm. Unit |
2 |
Supplementary unit (for 10,000 persons for 3 months)
Drugs
Anaesthesics
Ketamine, inj. 50 mg/ml.10 ml / vial |
25 |
Lidocaine, inj. 1%. 20 rnl / vial |
50 |
Analgesics
Pentazocine, inj. 30 mg/ml1 ml / ampoule |
50 |
Probenecid, tab 500 mg. tab |
500 |
Recall from basic unit:
Acetyl salicyclic acid, tab 300 mg.(10 x 3,000) |
30,000 |
Paracetamol, tab 100 mg. (10 x 1,000) |
10,000 |
Anti-allergics
Dexamethasone, inj. 4 mg/ml 1 ml / amp. |
50 |
Prednisolone, tab 5 mg. tab |
100 |
Epinephrine (adrenaline), see "respiratory tract"
Anti-epileptics
Diazepam, inj. 5 mg/ml.2 rnl / arnpoule |
200 |
Phenobarbital, tab 50 mg. tab |
1,000 |
Anti-infective drugs
Ampicillin, tab 250 mg tab |
2,000 |
Ampicillin, inj. 500 mg /vial. vial |
200 |
Benzathine benzylpenicillin, inj. 2.4 MIU / vial.vial |
50 |
Chloramphenicol, caps 250 mg. caps |
2,000 |
Chloramphenicol, inj. 1 g / vial. vial |
500 |
Metronidazole, tab 250 mg tab |
2,000 |
Nystatin, non-coated tablet.100,000 IU / tab |
2,000 |
Phenoxymethylpenicillin, tab 250 mg tab |
4,000 |
Procabenzylpenicillin, inj. 3-4 MU / vial.vial |
1,000 |
Quinine, inj. 300 mg/ml.2 ml / amp. |
100 |
Quinine sulfate, tab 300 mg tab |
3,000 |
Sulfadoxine + pyrimethamine, tab 500 mg + 25 mg tab |
300 |
Tetracycline, caps or tab 250 mg.caps or tab |
2,000 |
Recall from basic unit:
Mebendazole, tab 100 mg(10 x 500) |
5,000 |
Cotrimoxazole, tab 400 + 80 mg. (10 x 2,000) |
20,000 |
Chloroquine, tab 150 mg (10 x 2,000) |
20,000 |
Blood, drugs affecting the Folic acid, tab 1 mg. |
5,000 |
Recall from basic unit:
Ferrous sulfate + Folic acid, tab 200
+ 0.25 mg. (10 x 2,000) 20,000
Cardiovascular drugs
Methyldopa, tab 250 mg. tab |
500 |
Hydralazine, inj. 20 mg/ml.1 ml / amp. |
20 |
Dermatological
Polyvidone iodine 10%, sol., 500 ml bottle |
4 |
Zinc oxyde 10% ointment. kg |
2 |
Benzoic acid 6% + salicylic acid 3% ointment. kg |
1 |
Recall from basic unit:
Tetracycline eye ointment, 1% (10 x 50) |
500 |
Gentian violet, powder 25 g. (10 x 4) |
40 |
Benzyl benzoate, lotion 25%, litre. (10 x 1) |
10 |
Diuretics
Furosemide, inj. 10 mg/ml. 2 ml / amp. |
20 |
Furosemide, tab 40 mg.tab |
200 |
Gastro-intestinal drugs
Promethazine, tab 25 mg. tab |
500 |
Promethazine, inj. 25 mg/ml.2 ml / amp. |
50 |
Atropine, inj. 1 mg/ml.1 ml / amp. |
50 |
Recall from basic unit:
Aluminium hydroxyde, tab 500 mg (10 x 1,000) |
10,000 |
Oxtocics
Ergometrine maleate, inj. 0.2 mg/ml.1 ml / amp. |
200 |
Psychotherapeutic drugs
Chlorpromazine, inj. 25 mg/ml. 2 ml / amp. |
20 |
Respiratory tract, drugs acting on
Aminophylline, tab 100 mg. tab |
1,000 |
Aminophylline, inj. 25 mg/ml.10 ml / amp. |
50 |
Epinephrine (adrenaline), inj. 1 mg/ml.1 ml / amp. |
50 |
Solutions correcting water, electrolyte and acid-base disturbances
Compound solution of sodium lactate (Ringer's Lactate), inj. sol., with giving set and needle 500 ml / bag |
200 |
Glucose, inj. sol. 5%, with giving set and needle 500 ml / bag |
100 |
Glucose, inj. sol. 50%.50 ml / vial |
20 |
Water for injection.10 ml / plastic vial |
2,000 |
Recall from basic unit:
ORS (Oral Rehydration Salts).(10 x 200) |
2,000 |
Vitamins
Retinol (Vitamin A), caps 200,000 IU caps |
4,000 |
Ascorbic acid, tab 250 mg. tab |
4,000 |
Renewable supplies
Scalp vein infusion set, disposable, 25G (D 0.5 mm). Unit |
300 |
Scalp vein infusion set, disposable, 21G (D 0.8 mm).unit |
100 |
IV placement canula, disposable, 18G (D 1.7 mm). Unit |
15 |
IV placement canula, disposable, 22G (D 0.9 mm).unit |
15 |
Needle Luer IV, disposable, 19G (D 1.1 mm x 38 mm). unit |
1,000 |
Needle Luer IM, disposable, 21G (D 0.8 mm x 40 mm). unit |
2,000 |
Needle Luer SC, disposable, 25G (D 0.5 mm x 16 mm) unit |
100 |
Spinal needle, disposable, 20G (64 mm - D 0.9 mm). Unit |
30 |
Spinal needle, disposable, 23G (64 mm - D 0.7 mm). Unit |
30 |
Syringe Luer resterilisable, nylon, 2 ml. unit |
20 |
Syringe Luer resterilisable, nylon, 5 ml. unit |
100 |
Syringe Luer resterilisable, nylon, 10 ml.unit |
40 |
Syringe Luer, disposable, 2 ml. unit |
400 |
Syringe Luer, disposable, 5 ml.unit |
500 |
Syringe Luer, disposable, 10 ml.unit |
200 |
Syringe conic connector (for feeding), 60 ml unit |
20 |
Feeding tube, CH5 (premature baby), disposable. unit |
20 |
Feeding tube, CH8, disposable. Unit |
50 |
Feeding tube, CH16, disposable. unit |
10 |
Urinary catheter (Foley), n°12, disposable unit |
10 |
Urinary catheter (Foley), n°14, disposable unit |
5 |
Urinary catheter (Foley), n°18, disposable.unit |
5 |
Surgical gloves sterile and resterilisable n°6.5 pair |
50 |
Surgical gloves sterile and resterilisable n°7.5 pair |
150 |
Surgical gloves sterile and resterilisable n°8.5 pair |
50 |
Recall from basic unit:
Protective glove, non sterile, disposable. (100 units x 10) |
1,000 |
Sterilization test tape (for autoclave). roll |
2 |
Chloramine, tabs or powder kg |
2.5 |
Thermometer (oral/rectal) dual Celsius / Fahrenheit.unit |
10 |
Spare bulb for otoscope. Unit |
2 |
Batteries R6 alkaline AA size (for otoscope).unit |
6 |
Recall from basic unit:
Thermometer (oral/rectal) Celsius /Fahrenheit.(6 units x 10) |
60 |
Ballpen, blue or black (10 units x 10) |
100 |
Exercise book A4.(4 units x 10) |
40 |
Health card + plastic sachet. (500 units x 10) |
5,000 |
Small plastic bagfor drugs. (2,000 units x 10) |
20,000 |
Notepad A6 (10 units x 10) |
100 |
Urine collecting bag with valve, 2000 ml. unit |
10 |
Finger stall 2 fingers, disposable. Unit |
300 |
Suture, synthetic absorbable, braided, size DEC.2 (000) with cutting needle curved 3/8, 20 mm triangular unit |
24 |
Suture, synthetic absorbable, braided, size DEC.3 (00) with cutting needle curved 3/8, 30 mm triangular unit |
36 |
Surgical blade (surgical knives) n°22 for handle n°4. unit |
50 |
Razor blade.unit |
100 |
Tongue depressor (wooden), disposable unit |
100 |
Gauze roll 90 m x 0.90 m roll |
3 |
Gauze compress 10 x 10 cm, 12 ply, sterile unit |
1,000 |
Recall from basic unit:
Absorbent cotton wool.(1 kg x 10) |
10 |
Adhesive tape 2.5 cm x 5 m.(30 rolls x 10) |
300 |
Bar of soap (100-200 g/bar). (10 bars x 10) |
100 |
Elastic bandage (crepe) 7.5 cm x 10 m. (20 units x 10) |
200 |
Gauze bandage 7.5 cm x 10 m (100 rolls x 10) |
1,000 |
Gauze compress 10 x 10 cm, 12 ply, nonsterile. (500 units x 10) |
5,000 |
Equipment
Clinical stethoscope, dual cup. unit |
2 |
Obstetrical stethoscope (metal).unit |
1 |
Sphygmomanometer (adult). unit |
1 |
Razor non disposable. unit |
2 |
Scale for adult. unit |
1 |
Scale hanging 25 kg x 100 g (Salter type) + 3 trousers. unit |
3 |
Tape measure. unit |
5 |
Drum for compresses, h: 15 cm, D 14 cm.unit |
2 |
Recall from basic unit:
Drum for compresses, approx. h :15 cm, D 14 cm.(2 units x 10) |
20 |
Otoscope + disposable set of patric speculums. unit |
1 |
Tourniquet. Unit |
2 |
Dressing tray, stainless steel, approx. 30 x 15 x 3 cm unit |
1 |
Kidney dish, stainless steel, approx. 26 x 14 cm.unit |
1 |
Scissors straight/blunt, 12-14 cm. unit |
2 |
Forceps Kocher no teeth, 12-14 cm. Unit |
2 |
Recall from basic unit:
Kidney dish, stainless steel, approx. 26 x 14 cm. (1 unit x 10) |
10 |
Gallipot, stainless steel, 100 ml. (1 unit x 10) |
10 |
Dressing tray, stainless steel, approx. 30 x 15 x 3 cm (1 unit x 10) |
10 |
Scissors straight/blunt, 12-14 cm. (2 units x 10) |
20 |
Forceps Kocher, no teeth, 12-14 cm.(2 units x 10) |
20 |
Abcess/suture set (7 instruments + box).unit |
2 |
Dressing set (3 instruments + box). Unit |
5 |
Recall from basic unit:
Dressing set (3 instruments + box). (2 units x 10) |
20 |
Pressure sterilizer, 7.5 litres (type: Prestige 7506, double rack, ref. UNIPAC 01.571.00) unit |
1 |
Additional rack Public Health Care 2ml/5ml, ref.Prestige 7531 unit |
2 |
Pressure sterilizer, 20-40 litres with basket (type UNIPAC 01.560.00).unit |
1 |
Kerosene stove, single burner (t,vpe UNIPAC 01.700.00).unit |
2 |
Water filter with candles, 10-20 litres (type UNIPAC 56.199.02).unit |
3 |
Nail brush, plastic, autoclavable.unit |
2 |
Recall from basic unit:
Plastic bottle, 1 litre. (3 units x 10) |
30 |
Syringe Luer, disposable, 10 ml (1 unit x 10) |
10 |
Plastic bottle, 125 ml. (1 unit x 10) |
10 |
Nail brush, plastic autoclavable.(2 units x 10) |
20 |
Bucket, plastic, approx. 20 litres. (1 unit x 10) |
10 |
Foldable jerrycan, 20 litres.(1 unit x 10) |
10 |
Portable weight / height chart (UNICEF/SCF) (UNIPAC 01.455.70) unit |
1 |
Clinical guidelines - diagnostic and treatment manual. |
1 |
Guide clinique et thpeutique. |
1 |
Guia clinica y terapica |
1 |
Annex 1
Basic unit: treatment guidelines
These treatment guidelines are intended to give simple guidelines for the training of primary health care workers using the basic unit. In the dosage guidelines, five age groups have been distinguished. When dosage is shown as 1 tab. x 2, one tablet should be taken in the morning and one before bedtime. When dosage is shown as 2 tab. x 3, two tablets should be taken in the morning, two should be taken in the middle of the day and two before bedtime.
The treatment guidelines contain the following diagnosis/symptom groups:
· Anemia
· Pain
· Diarrhoea: see detailed
diagnosis and treatment schedules in Annex 2 a-c.
· Fever
·
Respiratory tract infections: see detailed diagnosis and treatment schedules in
Annex 3.
· Measles
· Eye
· Skin conditions
·
Urinary tract infections
· Sexually transmitted disease
·
Preventive care in pregnancy
· Worms
FIGURE
FIGURE
FIGURE
FIGURE
FIGURE
Annex 2
Evaluation and treatment of diarrhoea
Annex 2a
Assessment of diarrhoea patients for dehydration
FIGURE
Annex 2b
Treatment plan A to treat diarrhoea at home
Use this plan to teach the mother to:
· Continue to treat at home her child's current episode of
diarrhoea.
· Give early treatment for future episodes of diarrhoea.
Explain the three rules for treating diarrhoea at home
1. GIVE THE CHILD MORE FLUIDS THAN USUAL TO PREVENT DEHYDRATION:
· Use a recommended home fluid, such as a cereal gruel. If
this is not possible, give plain water.
· Use ORS solution for children
described in the box overleaf.
· Give as much of these fluids as the
child will take. Use the amounts shown below for ORS as a guide.
·
Continue giving these fluids until the diarrhoea stops.
2. GIVE THE CHILD PLENTY OF FOOD TO PREVENT UNDERNUTRITION:
· Continue to breast-feed frequently.
· If the
child is not breast-fed, give the usual milk. If the child is less than 6 months
old and not yet taking solid food, dilute milk of formula with an equal amount
of water for 2 days.
· If the child is 6 months or older, or already
taking solid food:
- Also give cereal or another starchy food mixed, if possible,
with pulses, vegetables, and meat of fish. Add 1 or 2 teaspoonfuls of vegetable
oil to each serving.
- Give fresh fruit juice or mashed banana to provide
potassium.
- Give freshly prepared foods. Cook and mash or grind food
well.
- Encourage the child to eat: offer food at least 6 times a day.
-
Give the same foods after diarrhoea stops, and give an extra meal each day for
two weeks.
3. TAKE THE CHILD TO THE HEALTH WORKER IF THE CHILD DOES NOT GET BETTER IN 3 DAYS OR DEVELOPS ANY OF THE FOLLOWING:
· Many watery stools
· Repeated vomiting
·
Marked thirst
· Eating or drinking poorly
· Fever
·
Blood in the stool
Children should be given ORS solutions at home, if:
· They have been on Treatment Plan B or C.
· They
cannot return to the health worker if the diarrhoea gets worse.
· It is
national policy to give ORS to all children who see a health worker for
diarrhoea.
IF THE CHILD WILL BE GIVEN ORS SOLUTION AT HOME, SHOW THE MOTHER HOW MUCH ORS TO GIVE AFTER EACH LOOSE STOOL AND GIVE HER ENOUGH PACKETS FOR 2 DAYS
FIGURE
· Describe and show the amount to be given after each stool using a local measure.
Show the mother how to mix ORS.
Show her how to give ORS:
· Give a teaspoonful every 1-2 minutes for a child under 2
years.
· Give frequent sips from a cup for an older child.
· If
the child vomits, wait 10 minutes. Then give the solution more slowly (for
example, a spoonful every 2-3 minutes).
· If diarrhoea continues after
the ORS packets are used up, tell the mother to give other fluids as described
in the first rule above or return for more ORS.
Annex 2 c
Treatment plan B to treat dehydration
APPROXIMATE AMOUNT OF ORS SOLUTION TO GIVE IN THE FIRST 4 HOURS
FIGURE
* Use the patient's age only when you do not know the weight. The approximate amount of ORS required (in ml) can also be calculated by multiplying the patient's weight (in grams) times 0.075.
· If the child wants more ORS than shown, give
more.
· Encourage the mother to continue breast-feeding.
· For
infants under 6 months who are not breast-fed, also give 100-200 ml clean water
during this period.
OBSERVE THE CHILD CAREFULLY AND HELP THE MOTHER GIVE ORS SOLUTION:
· Show her how much solution to give her child.
·
Show her how to give it - a teaspoonful every 1-2 minutes for a child under 2
years, frequent sips from a cup for an older child.
· Check from time to
time to see if there are problems.
· If the child vomits, wait 10
minutes and then continue giving ORS, but more slowly, for example, a spoonful
every 2-3 minutes.
· If the child's eyelids become puffy, stop ORS and
give plain water or breast milk. Give ORS according to Plan A when the puffiness
is gone.
AFTER 4 HOURS, REASSESS THE CHILD USING THE ASSESSMENT CHART. THEN SELECT PLAN A, B OR C TO CONTINUE TREATMENT.
· If there are no signs of dehydration, shift to Plan A.
When dehydration has been corrected, the child usually passes urine and may also
be tired and fall asleep.
· If signs indicating some dehydration are
still present, repeat Plan B, but start to offer food, milk and juice as
described in Plan A.
· If signs indicating severe dehydration have
appeared, shift to Plan C.
IF THE MOTHER MUST LEAVE BEFORE COMPLETING TREATMENT PLAN B:
· Show her how much ORS to give to finish the 4 hour
treatment at home.
· Give her enough ORS packets to complete rehydation,
and for 2 more days as shown in Plan A.
· Show her how to prepare ORS
solution.
· Explain to her the three rules in Plan A for treating her
child at home:
- to give ORS or other fluids until diarrhoea stops;
- to
feed the child;
- to bring the child back to the health worker, if necessary.
Annex 2d
Treatment plan C to treat severe dehydration quickly
Follow the arrows. If the answer is "yes", go across. If "no", go down.
FIGURE
Notes:
· If possible, observe the patient at least 6 hours after
rehydration to be sure the mother can maintain hydration giving ORS solution by
mouth.
· If the patient is above 2 years and there is cholera in your
area, give an appropriate oral antibiotic after the patient is alert.
Annex 3
Management of the child with cough or difficult breathing
· Assess the child
Ask:
- How old is the child?
- Is the child coughing? For how
long?
- Is the child able to drink? (for children age 2 months up to 5
years)
- Has the child stopped feeding well? (for children less than 2
months)
- Has the child had fever? For how long?
- Has the child had
convulsions?
Look and listen (the child must be calm):
- Count the breaths in one minute.
- Look for chest
indrawing.
- Look and listen for stridor.
- Look and listen for wheeze. Is
it recurrent?
- See if the child is abnormally sleepy, or difficult to
wake.
- Feel for fever, or low body temperature (or measure
temperature).
- Look for severe undernutrition.
· Decide how to treat the child
- The child aged less than two months |
see Annex 3a |
- The child aged two months up to five years | |
- who is not wheezing |
see Annex 3b |
- who is wheezing |
refer |
- Treatment instructions |
see Annex 3c |
- Give an antibiotic | |
- Advise mother to give home care | |
- Treatment of fever |
Annex 3a
The child aged less than two months
FIGURE
Annex 3b
The child aged two months to five years
FIGURE
Annex 3c
Treatment instructions
· Give an antibiotic
- Give first dose of antibiotic in clinic.
- Instruct mother
on how to give the antibiotic for five days at home (or to return to clinic for
daily procaine penicillin injection).
FIGURE
(1) Give oral antibiotic for five days at home only if referral
is not feasible.
(2) If the child is less than 1 month old, give 1/2
pediatric tablet or 1.25 ml syrup twice daily. Avoid cotrimoxazole in infants
less than one month of age who are premature or jaundiced.
(3) Not included
in kit but if available can be used as an alternative to ampicillin.
Advise mother to give home care
· Feed the child.
- Feed the child during illness.
- Increase feeding after
illness.
- Clear the nose if it interferes with feeding.
· Increase fluids.
- Offer the child extra to drink.
- Increase breastfeeding.
· Soothe the throat and relieve the cough with a safe
remedy.
· More important: in the child classified as having "No
pneumonia: cough or cold", watch for the following signs and return quickly if
they occur:
- Breathing becomes difficult.
- Breathing becomes fast.
-
Child is not able to drink.
- Child becomes sicker.
This child may have pneumonia
· Treat fever
FIGURE
Annex 4
Sample monthly activity report
FIGURE
Annex 5
Sample health card
FIGURE
Annex 6
Guidelines for suppliers
Quality
1. The quality of the drugs must comply with intemationally
recognized pharmaco-poeial standards.
2. At the time of shipment the product
shall have at least two thirds of its shelf life.
3. Tablets should
preferably be divisible and carry characteristic symbols for easy
identification.
4. Drugs should be procured only from those manufacturers
able to produce documents meeting the regulations of the WHO Certification
Scheme on the Quality of Pharmaceutical Products Moving in International
Commerce.
Labelling
1. Labelling should be in English and preferably one other
official language of WHO.
2. All labels should display at least the following
information:
· International nonproprietary name (INN) of the active
ingredient(s).
· Dosage form.
· Quantity of active ingredient(s)
in the dosage form (e.g. tablet, ampoule) and the number of units per
package.
· Batch number.
· Date of manufacture.
· Expiry
date (in clear language, not in code).
· Pharmacopoeial standard (e.g.
BP, USP.).
· Instructions for storage.
· Name and address of the
manufacturer.
3. A printed label on each ampoule should contain the
following:
· INN of the active ingredient(s).
· Quantity of
the active ingredient.
· Batch number.
· Name of the
manufacturer.
· Expiry date.
The full label should again appear on
the collective package.
4. Directions for use, warnings and precautions may
be given in leaflets (package inserts). However, such leaflets should be
considered as a supplement to labelling and not as an alternative.
5. For
articles requiring reconstitution prior to use (e.g. powders for injection) a
suitable beyond-use time for the constituted product should be indicated.
Packaging
1. Tablets and capsules should be packed in sealed waterproof
containers with replaceable lid, protecting the contents against light and
humidity.
2. Liquids should be packed in unbreakable leak-proof bottles or
containers.
3. Containers for all pharmaceutical preparations must conform to
the latest edition of internationally recognized pharmacopoeial standards.
4.
Ampoules must either have break-off necks, or sufficient files must be
provided.
5. Each Basic Unit should be packed in one carton. The
Supplementary Unit must be packed in cartons of max. 50 kg. The cartons should
preferably have two handles attached. Drugs, renewable supplies, infusions and
equipment should all be packed in separate cartons, with corresponding
labels.
6. Each carton must be marked with a green label (the international
colour code for medical supplies in emergency situations). The word "BASIC" must
be printed on each green label for the basic unit.
Packing list
Each consignment must be accompanied by a list of contents, stating the number of cartons and the type and quantity of drugs and other supplies in each carton.
Annex 7
Useful addresses
World Health Organization, Avenue Appia, CH-1211 Geneva-27, Switzerland. Telephone 41.22.7912111; telex 27821; telefax 41.22.7910746
United Nations High Commissioner for Refugees, Palais des Nations, CH-1211 Geneva-10, Switzerland. Telephone 41.22.7398111; telex 27492; telefax (general) 41.22.7319546; telefax (supplies) 7310776
UNICEF (UNIPAC), Arhusgade 129, Freeport, DK 2100, Copenhagen, Denmark. Telephone 45.31.262444; telex 19813; telefax 45.31.269421
OXFAM, 274 Branbury Road, Oxford OX2 7DZ, United Kingdom. Telephone 44.865.56777; telex 83610; telefax 44.865.57612
Mcins Sans Frontis, 8 Rue Saint-Sabin, 75011 Paris, France. Telephone 33.1.40212929; telex 214360; telefax 33.1.48066868
International Committee of the Red Cross, 17 Avenue de la Paix, CH-1202 Geneva, Switzerland. Telephone 41.22.7346001; telex 22269; telefax 41.22.7332057
League of Red Cross and Red Crescent Societies, P.O.Box 372, CH-1211 Geneva-19, Switzerland. Telephone 41.22.7345580; telex 22555; telefax 41.22.7330395
Christian Medical Commission of the World Council of Churches, P.O.Box 66, CH-1211 Geneva-20, Switzerland. Telephone 41.22.7916111; telex 23423; telefax 41.22.791.03.61
London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom. Telephone 44.1.6368636; telex 8953474; telefax 44.1.4365389
International Dispensary Association, P.O.Box 3098, 1003 AB Amsterdam, The Netherlands. Telephone 31.2903.3051; telex 13566; telefax 31.2903.1854
1. AFORCOPI
Antibiothpie
Editions Marketing, 1986
2. BERKOWITZ R.L., COUSTAN D.R., MOCHIZUKI T.K.
Mcaments
et grossesse
Editions Medsi, 1983
3. BIOFORCE
Mcaments essentiels
BIOFORCE, 1987
4. British Medical Association and The Pharmaceutical Society of
Great Britain
British national formulary
Editions BMA and The
Pharmaceutical Society of Great Britain, 1990
5. Centre Belge d'Information
Pharmaco-thpeutique
Rrtoire commentes mcaments
Minist de la
SantBelgium, 1989
6. Centre Hospitalier Villeneuve Saint-Georges
Formulaire de
mcaments essentiels pour les infirmiers et infirmis d'Afrique
Editions
GEEP, 1987
7. CHALEON J.
Pharmacie
Editions Maloine, 5th edition,
1988
8. Contact n°64
CMC, Geneva, 1983
9. DORNER G., ROEPNACK C.G., BURCHARDT R., BARRAL E.
Gestion
des achats, du stockage et de la distribution des mcaments
Editions
Cantor, 1985
10. DOROZ P.
a. Guide pratique des mcaments
b. Guide
pratique des interactions mcamenteuses
Editions Maloine, 3rd edition, 1989
11. ENENKEL S., STILLE W.
Antibiotics in the
tropics
Springer, Berlin, 1990
12. FATTORUSSO V., RITTER O.
Vademecum clinique du diagnostic
au traitement
Editions Masson, 12th edition, 1988
13. FERRIER Pierre E.
Prs de patrie
Editions Doin,
3rd edition, 1984
14. GENTILINI M., DUFLO B.
Mcine tropicale
Editions
Flammarion Mcine-Sciences, 4th edition, 1986
15. GOODMAN & GILMAN
The pharmacological basis of
therapeutics
Editions Pergamon, 8th edition, 1990
16. HALL Alan A., BOWES B.
The storage of drugs under
controlled temperature conditions
Editions South Tees Health Authority, 2nd
edition, 1985
17. IDA
Essential drug information sheets
IDA, Amsterdam,
1989
18. MANAGEMENT SCIENCES FOR HEALTH
Managing drug
supply
Drug Management Program, Boston, 1986
19. MARTINDALE
The extra pharmacopoeia
Editions The
Pharmaceutical Press, London, 29th edition, 1989
20. MEDECINS SANS FRONTIERES
Clinical guidelines - Diagnostic
and treatment manual
Editions Hatier, Paris, 2nd edition, 1990
21. MEDECINS SANS FRONTIERES / AEDES
Approvisionnement en
mcaments essentiels
Bruxelles, 1990
22. NEUMAN M.
Guide des interactions mcamenteuses et
rrtoire des mcaments par
classes thpeutiques
Editions Maloine,
1976
23. PERLEMUTER L., OBRASKA P., QUEVAUVILLIERS J.
Dictionnaire
pratique de thpeutique mcale
Editions Masson, 5th edition, 1990
24. PERLEMUTER L., TOUITOU Y.
Dictionnaire pratique de
pharmacologie clinique
Editions Masson, 1976
25. RESEAU MEDICAMENT - MINISTERE DE LA COOPERATION
Pour une
politique nationale du mcament
Minist de la Cooption, Paris, 1989
26. ROELANDTS D.
Formulaire thpeutique
Editions
Thpeutic, 13th edition, 1988-89
27. SAULNIER J.L.
Mcaments, grossesse et
allaitement
Editions Serendip, 1987
28. SCHELLING J.L.
Manuel de pharmaco-thpie
Editions
Roland Bettex, 1986
29. SERVIPHARM
Product information
Editions Servipharm
Ltd, 1986
30. TIGRETTI Thse
Les 40 mcaments du
district
Editions IUED, Geneva, 1988
31. TIGRETTI Thse
Les 120 mcaments de l'hal
secondaire
Editions IUED, Geneva, 1989
32. TOUITOU Y.
Pharmacie - thpeutique
mcamenteuse
Editions Masson, 6th edition, 1985
33. UNHCR
Essential drugs policy
UNHCR, Geneva, 1989
34. UPUNDA G., YUDKIN J., BROWN G.V.
Guidelines to drug
usage
Editions MacMillan, London, 1983
35. VIDAL
Dictionnaire Vidal
Editions Vidal, 1990
36. VIDAL
Guide national de prescription des
mcaments
Editions Vidal, 1988-89
37. W.H.O.
Accelerated stability studies of widely used
pharmaceutical substances under simulated tropical conditions
Unpublished
document
38. W.H.O. Basic tests for pharmaceutical substances
W.H.O.,
Geneva, 1987
39. W.H.O.
Drug information sheets for use of the community
health worker
W.H.O., Alexandria, 1983
40. W.H.O.
Essential drugs monitor
W.H.O., Geneva, free
periodical newsletter
41. W.H.O. Estimating drug requirements
W.H.O., Geneva, 1988
42. W.H.O.
Guidelines for developing national drug
policy
W.H.O., Geneva, 1988
43. W.H.O. The new emergency health kit
W.H.O., Geneva, 1991
44. W.H.O.
The rational use of drugs in the management of
acute diarrhoea in children
W.H.O., Geneva, 1990
45. W.H.O. The use of essential use (seventh list)
W.H.O.,
Geneva, 1992
46. W.H.O. The world drug situation
W.H.O.,
Geneva
Anaesthetics.
Analgesics, antipyretics, nonsteroidal
anti-inflammatory drugs, and drugs used to treat gout
Antiallergics and drugs
used in anaphylaxis
Antidotes and other substances used in
poisonings.
Antiepileptics
Anti-infective drugs
Antimigraine
drugs.
Antineoplastic and immunosuppressive drugs.
Antiparkinsonism
drugs
Blood, drugs affecting the
Blood products and plasma
substitutes.
Cardiovascular drugs.
Dermatological drugs
Diagnostic
agents.
Disinfectants and antiseptics
Diuretics
Gastrointestinal
drugs
Hormones, other endocrine drugs, and
contraceptives.
Immunologicals
Muscle relaxants (peripherally acting) and
cholinesterase inhibitors
Ophthalmological preparations
Oxytocics and
antioxytocics
Peritoneal dialysis solution.
Psychotherapeutic
drugs
Respiratory tract, drugs acting on the
Solutions correcting water,
electrolyte, and acid-base disturbances.
Vitamins and minerals.
Many drugs included in the list are preceded by a square symbol (*) to indicate that thney represent an example of a therapeutic group and that various drugs could serve as alternatives. It is imperative that this be understood when drugs are selected at national level, since choice is then influenced by the comparative cost and availability of equivalent products.
Numbers in parentheses after the drug names indicate:
(1) Drugs subject to international control under a) the Single
Convention on Narcotic Drugs, 1961,
b) the Convention on Psychotropic
Substances, 1971 or c) the Convention against Illicit Traffic in Narcotic Drugs
and Psychotropic Substances, 1988.
(2) Specific expertise, diagnostic
precision, or special equipment required for proper use.
(3) Greater potency
or efficacy.
(4) In renal insufficiency, contra-indicated or dosage
adjustments necessary.
(5) To improve compliance.
(6) Special
pharmacokinetic properties for purpose.
(7) Adverse effects diminish
benefit/risk ratio.
(8) Limited indications or narrow spectrum of
activity.
(9) For epidural anaesthesia.
Letters in parentheses after the drug names indicate the reasons for the inclusion of complementary drugs:
(A) When drugs in the main list cannot be made available.
(B)
When drugs in the main list are known to be ineffective or inappropriate for a
given individual.
(C) For use in rare disorders or in exceptional
circumstances.
1. Anaesthetics
1.1 GENERAL ANAESTHETICS AND OXYGEN
Diazepam (1b
2).
Ether, anaesthetic (2)
Halothane (2)
Ketamin (2)
Nitrous oxide
(2)
*Thiopental (2)
1.2 LOCAL ANAESTHETICS
Bupivacaine (2,9)
*Lidocaine.
1.3 PREOPERATIVE MEDICATION
Atropine
Chloral
hydrate
Diazeparn (1b)
*Morphine (1a)
Promethazine
2. Analgesics, antipyretics, nonsteroidal anti-inflammatory drugs and drugs used to treat gout
2.1 NON-OPIOIDS
Acetylsalicylic acid.
Allopurinol
(4)
Colchicine (7)
*Ibuprofen
*Indometacin.
Paracetamol
2.2 OPIOID ANALGESICS
*Codeine (1a)
*Morphine
(1a)
*Pethidine (A) (1a, 4)
3. Antiallergics and drugs used in anaphylaxis
*Chlorphenamine
*Dexamethasone
Epinephrine
Hydrocortisone.
*Prednisolone
4. Antidotes and otHer substances used in poisonings
4.1 GENERAL
*Charcoal, activated
Ipecacuanha
4.2 SPECIFIC
Atropine
Deferoxamine
Dimercaprol
(2)
*Methionine
Methylthioninium chloride (methylene
blue)
Naloxone
Penicillamine (2)
Potassium ferric
hexacyanoferrate
(II) - 2 H2O
(Prussian blue)
Sodium calcium edetate (2)
Sodium
nitrite
Sodium thiosulfate
5. Antiepileptics
Carbamazepine
*Diazepam (1b)
Ethosuximide
Phenobarbital
(1b)
Phenytoin
Valproic acid (7)
6. Anti-infective drugs
6.1 ANTHELMINTHIC DRUGS
6.1.1 Intestinal anthelminthics
Levamizole
(B)
*Mebendazole
Niclosamide
Piperazine
Praziquantel
Pyrantel
Thiabendazole.
6.1.2 Specific anthelminthics
Albendazole
6.1.3 Antifilarials
Diethylcarbamazine
Ivermectin
(D)
Suramin sodium (2, 7)
6.1.4
Antischistosomals
Metrifonate
Oxamniquine
Praziquantel
6.2 ANTIBACTERIALS
6.2.1 Penicillins
Amoxicillin (4)
Ampicillin
(4)
Benzathine benzyl penicillin
(5).
Benzylpenicillin
*Cloxacillin
Phenoxymethyl
penicillin
*Piperacillin
Procaine benzylpenicillin
6.2.2 Other antibacterial drugs
*Chloramphenicol
(7)
Ciprofloxacin (B)
Clindamycin (B)
Doxycycline (B) (5,
6)
*Erythromycin
*Gentamicin (2, 4, 7)
*Metronidazole
Nitrofurantoin
(B) (4, 7)
Spectinomycin (8)
*Sulfadimidine (4)
*Sulfamethoxazole +
trimethoprim (4)
*Tetracycline
Trimethoprim (B)
6.2.3 Antileprosy drugs
Clofazimine
Dapsone
Rifampicin
6.2.4 Antituberculosis drugs
Ethambutol
(4)
Isoniazid
Pyrazinamide
Rifampicin
Rifampicin +
isoniazide
Streptomycin (4)
Thioacetazone + isoniazide
6.3 ANTIFUNGAL DRUGS
Amphotericin B (4)
Flucytosine (B)
(4,8)
Griseofulvin
*Ketoconazole (2)
Nystatin
6.4 ANTIPROTOZOAL DRUGS
6.4.1 Antiamoebic and antisriardiasis drugs
Chloroquine
(B)
*Diloxanide
*Metronidazole.
6.4.2 Antileishmaniasis drugs
*Meglumine
antimoniate
Pentamidine (5)
6.4.3 Antimalarial drugs
a) For curative treatment
*Chloroquine
Mefloquine
(B)
Primaquine
Quinine
*Tetracycline (B)
*Sulfadoxine +
pyrimethamine (B)
b) For prophylaxis
Chloroquine
Proguanil
6.4.4 Antitrypanosomal drugs
a) African trypanosomiasis
Eflomithine (C)
Melarsoprol
(5)
Pentamidine (5)
Suramin sodium
b) American trypanosomiasis
Benznidazole (7)
Nifurtimox
(2, 8)
6.5 lNSECT REPELLENTS
Diethyltoluamide
7. Antimigraine drugs
7.1 FOR TREATMENT OF ACUTE ATTACK
Acetylsalicylic
acid
Ergotamine (7)
Paracetamol
7.2 PROPHYLAXIS
*Propranolol.
8. Antineoplastic and immunosuppressive drugs
8.1 IMMUNOSUPPRESSIVE DRUGS
*Azathioprine (2)
Ciclosporine
(2)
8.2 CYTOTOXIC DRUGS
Bleomycin (2)
Calcium folinate (C)
(2)
Cisplatin (2)
Cyclophosphamide (2)
Cytarabine (2)
Dacarbazine
(2)
Dactinomycin (2)
*Doxorubicin (2)
Etoposide (2)
Fluorouracil
(2)
Mercaptopurine (2)
Methotrexate (2)
Procarbazine
Vinblastine
(2)
Vincristine (2)
8.3 HORMONES AND
ANTIHORMONES
*Dexamethasone
*Ethinylestradiol
*Prednisolone
Tamoxifen
9. Antiparkinsonism drugs
*Biperiden
Levodopa + *Carbidopa
(5, 6)
10. Blood, drugs affecting the
10.1 ANTIANAEMIA DRUGS
Ferrous salt
Perrous salt + folic
acid.
10.1 ANTIANAEMIA DRUGS (SUITE)
Folic acid
(2)
Hydroxocobalamin (2)
*Iron-dextran (B) (5)
10.2 ANTICOAGULANTS AND ANTAGONISTS
Desmopressin
(8)
Heparin
Phytomenadione
Protamine sulfate
*Warfarin (2, 6)
11. Blood products and plasma substitutes
11.1 PLASMA SUBSTITUTES
*Dextran 70
*Polygeline
11.2 PLASMA FRACTIONS FOR SPECIFIC USES
Albumin, human (2,
8)
Factor IX complex (C) (2, 8)
Factor VIII concentrate (C) (2, 8)
12. Cardiovascular drugs
12.1 ANTIANGINALDRUGS
Glyceryl trinitrate
*Isosorbide
dinitrate
*Nifedipine
*Propranolol
12.2 ANTIDYSRHYTHMIC DRUGS
Atenolol
(B)
Lidocaine
*Procainamide (B)
*Propranolol
*Quinidine
(A)
Verapamil (8)
12.3 ANTIHYPERTENSIVE DRUGS
*Captopryl
(B)
*Hydralazine
*Hydrochlorothiazide
Methyldopa (B)
(7)
*Nifedipine
*Propranolol
*Reserpine (A)
*Sodium nitroprusside
(C) (2, 8)
12.4 CARDIAC GLYCOSIDES
Digitoxin (B) (6)
Digoxin (4)
12.5 DRUGS USED IN VASCULAR SHOCK
Dopamine
12.6 ANTITHROMBOTIC DRUGS
Acetylsalicylic
acid
Streptokinase (C)
13. Dermatological drugs
13.1 ANTIFUNGAL DRUGS (TOPICAL)
Benzoic acid + salicylic
acid.
*Miconazole
Nystatin
Selenium sulfide (C)
13.2 ANTI-INFECTIVE DRUGS
*Methylrosanilinium chloride
(gentian violet).
Mupirocin
*Neomycin + *Bacitracin
Silver sulfadiazine
13.3 ANTI-lNFLAMMATORY AND ANTIPRURITIC DRUGS
*Betamethasone
(3)
*Calamine lotion.
*Hydrocortisone.
13.4 ASTRINGENT DRUGS
Aluminium diacetate
13.5 KERATOPLASTIC AND KERATOLYTIC AGENTS
Benzoyl
peroxide
Coal tar Dithranol
Fluorouracil
*Podophyllum resin
(7)
Salicylic acid
13.6 SCABICIDES AND PEDICULICIDES
Benzyl
benzoate
Permethrin
13.7 SUN BLOCKING AGENTS
Aminobenzoic acid, sun protection
factor 15
*Benzophenones, sun protection factor 15
Zinc oxide (C)
14. Diagnostic agents
14.1 OPHTHALMIC DRUGS
Fluorescein
Tropicamide
14.2 RADIOCONTRAST MEDIA
*Amidotrizoate
Barium
sulfate
*Iopanoic acid
*Iotroxate (C)
*Propyliodone
15. Disinfectants and antiseptics
15. 1 ANTISEPTICS
*Chlorhexidine
*Iodine
Hydrogen
peroxide
12.2 DISINFECTANTS
Calcium hypochlorite
Glutaral,
activated
16. Diuretics
*Amiloride (4, 7,
8)
*Furosemide
*Hydrochlorothiazide
Mannitol (C)
Spironolactone (C)
17. Gastrointestinal drugs
17.1 ANTACIDS AND OTHER ANTIULCER DRUGS
Aluminium
hydroxide
*Cimetidine
Magnesium hydroxide
17.2 ANTIEMETIC DRUGS
Metoclopramide.
*Promethazine.
17.3 ANTIHAEMORRHOIDAL DRUGS
*Local anaesthetic, astringent,
and anti-inflammaroty drug
17.4 ANTI-INFLAMMATORY DRUGS
Hydrocortisone
Sulfasalazine
(2)
17.5 ANTISPASMODIC DRUGS
*Atropine
17.6 CATHARTIC DRUGS
*Senna
17.7 DIARRHOEA, DRUGS USED IN
17.7.1 Oral rehydration
Oral rehydration salts (for
glucose-elctrolyte solution)
Sodium chloride 3.5 g/l
Potassium chloride
1.5 g/l
Trisodium atrate dihydrate 2.9 g/l
Glucose 20.0 g/l
17.7.2 Antidiarrhoeal (symptomatic) drugs
*Codeine (la)
18. Hormones, other endocrine drugs, and contraceptives
18.1 ADRENAL HORMONES AND SYNTHETIC SUBSTITUTES
*Dexamethasone
Fludrocortisone
(C)
Hydrocortisone
*Prednisolone
18.2 ANDROGENS
Testosterone (C)
18.3 CONTRACEPTIVES
18.3.1 Hormonal contraceptives
Depot medroxyprogesterone
acetate (B) (7,8)
*Ethinylestradiol + *Levonorgestrel
*Ethinylestradiol +
*Norethisterone
*Norethisterone (B) (7,8)
Norethisterone enantate (B)
(7,8)
18.3.2 Intrauterine devices
Copper-containing device
18.3.3 Barrier methods
Condoms with or without spermicide
(nonoxinol)
Diaphragms wiht spermicide (nonoxinol)
18.4 ESTROGENS
*Ethinylestradiol
18.5 INSULINS AND OTHER ANTIDIABETIC AGENTS
Insulin injection
(soluble)
Intermediate-acting insulin
*Tolbutamide
18.6 OVULATION INDUCERS
*Clomifene (C) (2,8)
18.7 PROGESTOGENS
Norethisterone
18.8 THYROID HORMONES AND ANTITHYROID
DRUGS
Levothyroxine
Potassium iodide
*Propylthiouracil
19. Immunologicals
19.1 DIAGNOSTIC AGENTS
Tuberculin, purified protein
derivative (PPD)
19.2 SERA AND IMMUNOGLOBULINS
Anti-D immunoglobulin
(human)
Antirabies hyperimmune serum
Antiscorpion sera
Antitetanus
immunoglobulin (human)
Antivenom sera
Diphtheria
antitoxin
Immunoglobulin, human normal (2)
Tetanus antitoxin (equine)
19.3 VACCINES
19.3.1 For universal immunization
BCG vaccine
(dried)
Diphtheria-pertussis-tetanus vaccine
Diphtheria-tetanus
vaccine
Measles vaccine
Measles-mumps-rubella vaccine
Poliomyelitis
vaccine (inactivated)
Poliomyelitis vaccine (live attenuated)
Tetanus
vaccine
19.3.2 For specific groups of individuals
Hepatitis B
vaccine
Influenza vaccine
Meningococcal vaccine
Rabies
vaccine
Rubella vaccine
Typhoid vaccine
Yellow fever vaccine
20. Muscle relaxants (peripherally acting) ard cholinesterase
inhibitors
*Gallamine (2)
*Neostigmine
Pyridostigmine (B) (2,
8)
Suxamethonium (2)
Vecuronium (C)
21. Ophthalmological preparations
21.1 ANTIINFECTIVE
AGENTS
Gentamicin
*Idoxuridine
Silver nitrate
*Tetracycline.
21.2 ANTIINFLAMMATORY AGENTS
Prednisolone
21.3 LOCAL ANAESTHETICS
*Tacaine
21.4 MIOTICS AND ANTIGLAUCOMA
DRUGS
Acetazolamide
*Pilocarnine
*Timolol
21.5 MYDRIATICS
Atropine
Epinephrine (A)
22. Oxytocics and antioxytocics
22.1 OXYTOCICS
*Ergometrine
Oxytocin
22.2 ANTIOXYTOCICS
*Salbutamol (2)
23. Peritoneal dialysis solution
Intraperitoneal dialysis
solution (of appropriate composition)
24. Psychotherapeutic
drugs
*Amitriptyline
*Chlorpromazine
*Diazepam (1b)
*Fluphenazine
(5)
*Haloperidol
Lithium carbonate (2, 4)
25. Respiratory tract, drugs acting on the
25.1 ANTIASTHMATIC DRUGS
Aminophylline (2)
Beclometasone
25.1 ANTIASTHMATIC DRUGS (SUITE)
*Cromoglicic acid
(B)
Ephedrine (A)
Epinephrine
Salbutamol
25.2 ANTITUSSIVES
*Codeine (1a)
26. Solutions correcting water, electrolyte and acid-base disturbances
26.1 ORAL REHYDRATION
Oral rehydration salts (for
glucose-electrolyte solution).
Potassium chloride
26.2 PARENTERAL
*Compound solution of sodium
lactate
Glucose
Glucose with sodium chloride
Potassium chloride
(2)
Sodium bicarbonate
Sodium chloride
26.3 MISCELLANEOUS
Water for injection
27. Vitamins and minerals
Ascorbic acid (C)
Calcium
gluconate (C) (2, 8)
*Ergocalciferol
Iodine
(8)
*Nicotinamide
Pyridoxine
Retinol
Riboflavin
Sodium fluoride
(8)
Thiamine
The average price is included to give an indication as drug prices can vary widely depending on the costs of the raw materials, supply and demand on the international markets and currency rate.
Abfosan (R)
Acetaminophen, tab 100 mg (1,000 tab = 24
FF)
Acetaminophen, tab 500 mg (1,000 tab = 53 FF)
Acetyl salicylate
lysine, amp. 0.1 mg/ml, 5 ml (100 amp = 270 FF).
Acetyl salicylate lysine,
amp. 0.2 mg/ml, 5 ml (100 amp = 395 FF)
Acetyl salicylic acid (A.S.A.), tab
75 mg
Acetyl salicylic acid (A.S.A.), tab 100 mg
Acetyl salicylic acid
(A.S.A.), tab 300 mg (1,000 tab = 26 FF)
Acetyl salicylic acid (A.S.A.), tab
500 mg (1,000 tab = 32 FF)
Adrenaline, amp. 0.25 mg/ml, 1 ml
Adrenaline,
amp. 1 mg/ml, 1 ml (100 amp = 35 FF).
Albuterol, amp 0.5 mg/ml, 1
ml
Albuterol syrup 2 mg/5 ml
Albuterol, tab 2 mg.
Albuterol, tab 4
mg.
Alcoholic solutions.
Aldomet (R)
Aluminium hydroxide (+ magnesium)
tab 500 mg (1.000 tab = 46 FF)
Amfipen (R)
Aminophylline, amp. 25 mg/ml,
10 ml (100 amp = 48 FF)
Aminophylline, tab 100 mg (1,000 tab = 27
FF)
Aminophylline, tab 200 mg (1,000 tab = 44 FF)
Amoxicillin, syrup 125
mg/5 ml.
Amoxicillin, tab/cap 250 mg (1,000 tab = 226 FF)
Amoxicillin,
tab/cap 500 mg (1,000 tab = 385 FF)
Amoxicillin, vl 500 mg
Amoxicillin, vl
1 g (1 vial = 13.50 FF)
Amoxil (R)
Ampicillin, syrup 125 mg/5 ml (powder
for 100 ml = 4 FF)
Ampicillin, tab/cap 250 mg (1,000 tab = 190
FF)
Ampicillin, tab/cap 500 mg (1,000 tab = 294 FF)
Ampicillin, vl 500 mg
(100 vials = 147 FF)
Ampicillin, vl 1 g (100 vials = 190 FF)
Anausin
(R)
Aneurin tab 50 mg (1,000 tab = 30.50 FF).
Angilol (R)
Antepar
(R)
Antiamaril vaccine
Antimeningococcal vaccine A + C
Antitetanic
serum, amp. 1.500 IU/ml 1 ml (100 amp = 483 FF)
Apresoline (R)
Artosin
(R)
Artracin (R)
Ascorbic acid, tab 50 mg
Ascorbic acid tab 250 mg
(1,000 tab = 45 FF)
Aspegic (R)
Aspirin
Atropine sulphate, amp. 1
mg/ml, 1 ml (100 amp = 35 FF)
Atropine sulphate, tab 1 mg (1,000 tab = 25
FF)
Avlosulfon (R)
B Complex, syrup
B Complex, tab (1,000 tab = 13.40
FF)
Bactrim (R)
Banacide (R)
BBL (R)
BCG
vaccine
Benemide(R)
Benerva (R)
Benzathine penicillin G, vl 2.4 MIU
(100 vials = 228.50 FF)
Benzoic acid + Salicylic acid, 6% + 3%, ointment (1
kg = 68 FF)
Benzyl benzoate, concentrated emulsion of 90% (1 litre = 34.50
FF)
Benzyl benzoate, emulsion of 25% (1 bottle = 24.50 FF)
Benzyl
penicillin, vl 1 MIU (100 vials = 158.50 FF)
Benzyl Penicillin, vl 5 MIU (100
vials = 281.50 FF)
Betadine (R)
Bevitine (R)
Bicillin (R)
Bilarcil
(R)
Biltricide (R)
Bleach
Brufen (R)
Buscopan (R)
Butazolidin
(R)
Butylscopolamine = Butylhyoscine, amp. 20 mg/ml, 1 ml (100 amp = 47.50
FF)
Butylscopolamine = Butylhyoscine, tab 10 mg (1,000 tab = 73.50 FF)
Calamine lotion (1 litre = 17FF)
Calcium hypochlorite = HTH
(1 kg = 15.50 FF)
Cetavlon (R)
Cetrimide, concentrated solution of 20 or
40% (1 litre = 94FF)
Cetrimide, powder ;
Charcoal, tab 375 mg (1,000 tab =
52.50FF)
Chloramine T = Chloramine, powder/tab 250 mg
Chloramine T =
Chloramine, powder/tab 500 mg (1,000 tab = 59.50 FF)
Chloramine T =
Chloramine, powder/tab 1 g
Chloramine T = Chloramine, tab 12 mg (1,000 cp
=56.50 FF)
Chloramphenicol,syrup 125 mg/5 ml
Chloramphenicol, tab/cap 250
mg (1,000 tab = 169.50 FF)
Chloramphenicol, vl 1 g (100 vials =
256.50FF).
Chloramphenicol in oil, vl 250 mg/ml, 2 ml (100 vials = 888
FF)
Chlorhexidine, concentrated solution of 5% (1 litre = 134
FF)
Chlorhexidine 1.5% + Cetrimide 15%, concentrated solution (1 litre =
22FF)
Chlorinated lime
Chlorine (products that generate)
Chloromycetin
(R)
Chloroquine, amp. 40 mg base/ml, 2 ml
Chloroquine, amp. 40 mg base/ml,
5 ml (100 amp = 36FF)
Chloroquine, tab 100 mg base (1,000 tab = 44
FF)
Chloroquine, tab 150 mg base (1,000 tab = 79FF)
Chlorphenamine =
Chlorpheniramine, amp. 10 mg/ml, 1ml
Chlorphenamine = Chlorpheniramine, tab 4
mg (1,000 tab = 15.50 FF)
Chlorpromazine, amp. 25 mglml, 2 ml (100 amp =
35F)
Chlorpromazine, tab 25 mg (1,000 tab = 24FF)
Chlortetracycline 1 or
3%, eye ointment (5 g = 0.80 FF)
Cidomycin (R)
Cimetidine, tab 200 mg
(1,000 tab = 192 FF)
Cimetidine, tab 400 mg
Cimetidine, tab 800
mg
Clamoxyl (R)
Clofazimine, tab/cap 50 mg (1,000 tab = 299
FF)
Clofazimine, tab/cap 100 mg (1,000 tab = 760 FF)
Cloxacillin, cap 250
mg (1,000 cap = 215 FF)
Cloxacillin, cap 500 mg (1,000 cap = 500
FF)
Cloxacillin, vl 250 mg (100 vials = 141FF)
Cloxacillin, vl 500
mg
Cobalin (R)
Codelsol (R)
Combantrin (R)
Cotrimoxazole, syrup 240
mg/5 ml (1 vial 100 ml = 4 FF)
Cotrimoxazole, tab 480 mg (1,000 tab = 90.50
FF)
Cotrim (R)
Creolin (R)
Cresol, concentrated solution (1 litre =
8.20 FF)
Cresyl (R)
Crystal violet, powder
Crystal violet, solution of
0.5% ;
Crystapen (R)
Crystapen V (R)
Dakin (solution of)
Dapsone, tab 50 mg
Dapsone, tab 100 mg
(1,000 tab = 24 FF)
Decadron (R)
Decaserryl (R)
Decortisyl
(R)
Deltastab (R)
Dettol (R)
Dexamethasone, amp. 4 mg/ml, 1 ml (100 amp
= 53.30 FF)
Dexamethasone, tab 0.75 mg
Dextran, vl 500 ml (1 vial = 21
FF)
Dextrose, amp. 10 ml of 30% or 50% (100 amp = 60 FF)
Dextrose, vl 500
ml of 5% (1 vial = 6.50 FF)
Dextrose, vl 1 litre of 5% (1 vial = 7.50
FF)
Di-hydan (R)
Diazepam, amp. 5 mg/ml, 2 ml (100 amp = 37.50
FF)
Diazepam, tab 5 mg (1,000 tab = 18.50 FF)
Diethylcarbamazine, tab 50
mg (1,000 tab = 20 FF)
Diethylcarbamazine, tab 100 mg (1,000 tab = 36
FF)
Digoxin, amp. 0.25 mg/ml, 2 ml (100 amp = 46.50 FF)
Digoxin, tab 0.25
mg (1,000 tab = 22 FF)
Dihydralazine, amp. 20 mg/ml, 1 ml (100 amp = 570
FF)
Dihydralazine, tab 25 mg (1,000 tab = 45.20 FF)
Dihydralazine, tab 50
mg
Dilantin (R)
Dipyrone, amp. 500 mg/ml, 2 ml (100 amp = 44.50
FF)
Dipyrone, tab 500 mg
Docemine (R)
Dochlotride (R)
Dolipol
(R)
Doliprane (R)
Doxy 100 (R)
Doxycycline, tab/cap 100 mg (1,000 tab =
136 FF)
DPT vaccine
Econosone (R)
Efcortesol (R)
Epanutin (R)
Epinephrine,
amp. 0.25 mg/ml, 1 ml
Epinephrine, amp. 1 mg/ml, 1 ml (100 amp = 35
FF)
Ergometrine, amp. 0.2 mg/ml, 1 ml (100 amp = 175.50 FF)
Erythrocin
(R)
Erythromycin, tab 250 mg (1,000 tab = 294 FF)
Erythromycin, tab 500
mg
Esidrex (R)
Ethambutol, tab 100 mg
Ethambutol, tab 400 mg (1,000 tab
= 170 FF)
Ethanol, 70%
Ethyl alcohol, alcohol 95% (1 litre = 195
FF)
Euphyllin(R)
Eusaprim (R)
Fansidar (R
Fegal (R)
Fenbid
(R)
Ferrous sulphate + Folic acid, tab 200 + 0.25 mg (1,000 tab = 24
FF)
Ferrous sulphate, tab 200 mg (1,000 tab = 26 FF)
Flagyl (R)
Folic
acid, tab 5 mg (1,000 tab = 15 FF)
Fortal (R)
Frusid (R)
Fulcin
(R)
Furadantin (R)
Furosemide = Frusemide, amp. 10 mg/ml, 2 ml (100 amp =
38 FF)
Furosemide = Frusemide, tab 40 mg (1,000 tab = 48 FF)
Ganidan (R)
Garamycin (R)
Gardenal (R)
Gentallin
(R
Gentamicin, amp. 10 mg/ml, 1 ml
Gentamicin, amp. 40 mg/ml, 2 ml (100
amp = 76 FF)
Gentamicin, amp. 80 mg/ml, 2 ml
Gentian violet, powder (25 g
= 14 FF)
Gentian violet, solution of 0.5%
Glucose, amp. 10 ml of 30% or
50% (100 amp = 60 FF)
Glucose, vl 500 ml of 5% (1 vial = 6.50 FF)
Glucose,
vl 1 litre of 5% (1 vial = 7.50 FF)
Granudoxy (R)
Griseofulvin, tab 125 mg
(1,000 tab = 83 FF)
Griseofulvin, tab 500 mg (1,000 tab = 245
FF).
Grisovin (R)
HAC (R)
Halfan (R)
Hcel (R),
Half Strenght Darrow's
Solution, vl 500 ml (1 vial = 6.50 FF)
Half Strenght Darrow's Solution, vl 1
litre
Halofantrine, oral suspension
Halofantrine, tab 250 mg
Hetrazan
(R)
Hexacycline (R)
Hibitane (R)
HTH = Calcium hypochlorite (1 kg =
15.50 FF)
Hydralazine, amp. 20 mg/ml, 1 ml (100 amp = 570 FF)
Hydralazine
tab 25 mg (1,000 tab = 45.20 FF)
Hydralazine, tab 50
mg
Hydrochlorothiazide, tab 50 mg (1.000 tab = 20.80 FF)
Hydrocortisone,
vl 100 mg (1 vial = 2.70 FF)
HydroSaluric (R)
Hydroxocobalamin, amp. 1
mg/ml, 1 ml
Hyoscine butylbromide, amp. 20 mg/ml, 1 ml (100 amp = 47.50
FF)
Hyoscine butylbromide, tab 10 mg (1,000 tab = 73.50 FF)
Ibuprofen, tab 200 mg (1,000 tab = 52.50 FF).
Ibuprofen. tab
400 mg
Illotycin (R)
Imodium (R)
Inderal (R)
Indocid
(R)
Indometacin. tab 25 mg (1,000 tab = 17.50 FF)
Inosec
(R)
Iodine
Iodine tincture.
Iron salts, tab 200 mg (1,000 tab = 26
FF)
Isoniazid = INH, tab 100 mg (1,000 tab = 19.50 FF)
Isoniazid = INH,
tab 150 mg
Isoniazid = INH, tab 300 mg
Isoniazid + Thiacetazone, tab 100 +
50 mg (1,000 tab = 34 FF)
Isoniazid + Thiacetazone, tab 300 + 150 mg (1,000
tab = 90.50 FF)
Ivermectin, tab 6 mg
Javel solid (R)
Kanakion (R)
Ketalar (R)
Ketanest (R)
Ketamine, amp. 10
mg/ml, 20 ml (100 amp = 458 FF).
Ketamine, amp. 50 mg/ml, 10 ml (100 amp =
461 FF).
Lamprene (R)
Lanoxin (R)
Largactil (R)
Lariam
(R)
Lasix (R)
Levamisole, tab 40 mg (1,000 tab = 38 FF)
Levamisole, tab
150 mg
Levorenine, amp. 0.25 mg/ml, 1ml
Levorenine, amp. 1 mg/ml, 1 ml
(100 amp = 35 FF)
Lignocaine = Lidocaine, sol. 1% (10 mg/ml) (50 ml = 2.50
FF)
Lignocaine = Lidocaine, sol. 2% (20 mg/ml) (50 ml = 3 FF)
Lignocaine
hyperbaric, amp. 100 mg/2 ml (100 amp = 661 FF)
Loperamide, cap 2 mg (1,000
cap = 810 FF)
Luminal (R)
Lyorthol (R)
Lysol, concentrated solution (1
litre = 8.30 FF)
Macrodex (R)
Marnsil (R)
Maxolon (R)
Measles
vaccine
Mebendazole, tab 100 mg (1,000 tab = 47.50 FF)
Mectizan
(R)
Medomet (R)
Mefloquine, tab 50 mg
Mefloquine, tab 250
mg
Merbromine = Mercuresceine sodium
Mercurochrome (R)
Metamizol, amp.
500 mg/ml, 2 ml (100 amp = 44.50 FF)
Metamizol, tab 500 mg
Methergin
(R)
Methyldopa, tab 250 mg (1,000 tab = 159 FF)
Methylergometrine, amp.
0.2 mg/ml, 1 ml (100 amp = 175.50 FF)
Methylrosanilinium chloride,
powder
Methylrosanilinium chloride, solution of 0,5%
Metoclopramide, amp.
5 mg/ml, 2 ml (100 amp = 38 FF)
Metoclopramide, tab 10 mg
Metrifonate, tab
100 mg (1,000 tab = 221.50 FF)
Metrolyl (R)
Metronidazole, tab 250 mg
(1,000 tab = 68 FF)
Milton (R)
Mintezol (R)
Motrin
(R)
Multivitamins, syrup
Multivitamins, tab (1,000 tab = 27.50
FF)
Myambutol (R)
Mycostatin (R)
NaDCC, tab (1,000 tab = 226 FF)
Nepressol (R)
Niclosamide,
tab 500 mg (1,000 tab = 178 FF)
Nitrofurantoin, tab 50 mg
Nitrofurantoin,
tab 100 mg (1,000 tab = 29.50 FF)
Nivaquine (R)
Noramidopyrine, amp. 500
mg/ml, 2 ml (100 amp = 44.50 FF)
Noramidopyrine, tab 500 mg
Noscapine,
syrup 15 mg/5 ml
Noscapine, tab 15 mg (1,000 tab = 62.50 FF)
Nolotil
(R)
Notezine (R)
Novalgin (R)
Novaminsulfon (R)
Novobedouze
(R)
Nuelin (R)
Nystatin, tab oral/gynaecological 100,000 IU (1,000 tab =
152 FF)
Nystan (R)
O.R.S. = 0ral Rehydration Salt, sachet (100 sachets = 46.50
FF)
Oradexon (R)
Oral antipoliomyelitis vaccine
Oralit (R)
Orbenin
(R) Oxamniquine, tab 250 mg (1,000 tab = 8,450 FF)
Oxytetracycline 1 or 3%,
eye ointment (5 g = 0.80 FF)
Oxytetracycline, tab/cap 250 mg (1,000 tab =
61.50 FF)
Oxytocin, amp. 5 IU/ml, 1 ml
Oxytocin, amp. 10 IU/ml, 2 ml (100
amp = 67 FF)
Paludrine (R)
Panadol (R)
Paracetamol, tab 100 mg (1,000
tab = 24 FF),
Paracetamol, tab 500 mg (1,000 tab = 53 FF)
Penbritin
(R)
Penicillin G, vl 1 MIU (100 vials = 158.50 FF)
Penicillin G, vl 5 MIU
(100 vials = 281.50 FF)
Penicillin V, syrup 125 mg/5 ml
Penicillin V, tab
125 mg (1,000 tab = 70 FF)
Penicillin V, tab 250 mg (1,000 tab = 119
FF)
Penidural (R)
Pentazocine, amp. 30 mg/ml, 1 ml (100 amp = 182
FF)
Pentothal (R)
Pentobarbital sodium, vl 500 mg (100 vials = 559.50
FF)
Pentobarbital sodium, vl 1 g (100 vials = 407 FF)
Phenergan
(R)
Phenobarbitone = Phenobarbital, amp. 100 mg/ml, 2 ml (100 amp = 25
FF)
Phenobarbitone = Phenobarbital, tab 30 mg (1,000 tab = 16
FF)
Phenobarbitone = Phenobarbital, tab 50 mg (1,000 tab = 17
FF)
Phenobarbitone = Phenobarbital, tab 100 mg (1,000 tab = 33.50
FF)
Phenoxymethyl penicillin, syrup 125 mg/5 ml
Phenoxymethyl penicillin,
tab 125 mg (1,000 tab = 70 FF)
Phenoxvmethvl penicillin tab 250 mg (1 000 tab
= 119 FF)
Phenylbutazone, tab 200 mg
Phenytoin, tab 100 mg (1,000 tab =
37.50 FF).
Phytomenadione, amp. 1 mglml, 1 ml (100 amp = 53.50
FF)
Piperazine, syrup 750 mg/5 ml
Piperazine, tab 300 mg (1,000 tab =
29.50 FF)
Piperazine, tab 500 mg
Piriton (R)
Pitocin (R)
Polygeline,
vl 500 ml (1 vial = 29 FF)
Polyvidone iodine = PVI, concentrated solution of
10% (200 ml = 9.50 FF)
Potassium chloride, amp. 10 ml of 10% (100 amp = 64.50
FF)
Potassium chloride, amp. 20 ml of 10% (100 amp = 79 FF)
Potassium
chloride, tab 7,7 mmol (1,000 tab = 40 FF)
Potassium permanganate,
tab/crystal
PPF = Procaine Penicillin Forte, vl 3 + 1 MIU (100 vials =
213FF)
Praziquantel, tab 600 mg (1,000 tab = 3,138.50 FF)
Prednisollone or
Prednisone, tab 5 mg (1,000 tab = 59.50FF)
Primperan (R)
Pripsen
(R)
Probanthine (R)
Probenecid, tab 500 mg (1,000 tab = 204.50
FF)
Procaine benzyl penicillin + Benzyl penicillin, vl 3 + 1 MIU (100 vials =
213 FF)
Procaine benzyl penicillin, vl 3 MIU (100 vials = 182 FF)
Procaine
penicillin, vl 3 MIU (100 vials = 182 FF)
Proguanil, tab 100 mg (1,000 tab =
423.50 FF)
Promethazine, amp. 25 mg/ml, 2 ml (100 amp = 35
FF)
Promethazine, tab 25 mg (1,000 tab = 28 FF)
Propanthelin, tab 15 mg
(1,000 tab = 25.50 FF)
Propranolol, tab 10 mg
PVI = Polyvidone iodine,
concentrated solution of 10% (200 ml = 9.50 FF)
Pyrantel, tab 125 mg (1,000
tab = 159.50 FF)
Pyrazinamide, tab 500 mg (1,000 tab = 196 FF)
Pyridoxine,
tab 25 mg
Pyridoxine, tab 50 mg (1,000 tab = 37.50 FF)
Quinine salts, amp.
100 mg/ml, 2 ml
Quinine salts, amp. 150 mg/ml, 2 ml
Quinine salts, amp.
300 mg/ml, 2 ml (100 amp = 88.50 FF)
Quinine salts, tab 200 mg (1,000 tab =
158.50 FF)
Quinine salts, tab 300 mg (1,000 tab = 212.50 FF)
Rastinon (R)
Ranwiloid (R)
Redisol (R)
Redoxon
(R)
Reylan (R)
Reserpine, tab 0.10 mg
Reserpine, tab 0.25 mg (1,000 tab
= 15.50 FF)
Reserpine, tab 0.50 mg
Resochin (R)
Retinol, cap 50,000 IU
(1,000 cap = 58 FF)
Retinol, cap 200,000 IU (1,000 cap = 180
FF)
Rlheomacrodex (R)
Rifadin (R)
Rifampicin, tab/cap 150 mg (1,000 tab
= 289 FF)
Rifampicin, tab/cap 300 mg (1,000 tab = 520 FF)
Rimactane
(R)
Rimifon (R)
Ringer lactate (Hartmann), vl 500 ml (1 vial = 4.50
FF)
Ringer lactate (Hartmann), vl 1 litre (1 vial = 7.10 FF)
Ro-A-Vit (R)
Salbulin (R)
Salbutamol, amp. 0.5 mg/ml, 1 ml (100 amp = 20
FF)
Salbutamol, syrup 2 mg/5 ml
Salbutamol, tab 2 mg (1,000 tab = 27.50
FF)
Salbutamol, tab 4 mg (1,000 tab = 36 FF)
Salbutan (R)
Savlon
(R)
Sepfrim (R)
Serpasil (R)
SMX + TMP, syrup 200 + 40 mg/5 ml (100 ml
= 4 FF)
SMX + TMP, tab 400 + 80 mg (1,000 tab = 90.50 FF)
Sodium
bicarbonate, amp. 10 ml of 8.4% (100 amp = 55.50 FF)
Sodium bicarbonate, amp.
20 ml of 8.4% (100 amp = 108.50 FF)
Sodium bicarbonate, vl 500 ml of 1.4% (1
vial = 11.50 FF)
Sodium chloride = NaCl, amp. 10 ml of 10%
Sodium chloride
= NaCl, amp. 20 ml of 20%
Sodium chloride = NaCl, vl 500 ml of 0.9% (1 vial =
12 FF)
Sodium chloride = NaCl, vl 1 litre of 0.9% (1 vial = 6.90
FF)
Sodium dichloroisocyanurate (1,000 tab = 226 FF)
Solu-cortef
(R)
Spanor (R)
Stahillin V-K (R)
Streptomycin, vl 1 g (100 vials = 46
FF)
Streptomycin, vl 5 g (100 vials = 178 FF)
Sulfadimidine =
Sulphadimidine, tab 500 mg (1,000 tab = 37.50 FF)
Sulfadoxine +
Pyrimethamine, amp. 200 + 10 mg/ml, 2 ml (100 amp = 575 FF)
Sulfadoxine +
Pyrimethamine, tab 500 + 25 mg (1,000 tab = 265 FF)
Sulfaguanidine, tab 500
mg
Sulfamethoxazole + Trimethoprim, syrup 200 + 40 mg/5 ml (100 ml = 4
FF)
Sulfamethoxazole + Trimethoprim, tab 400 + 80 mg (1,000 tab = 90.50
FF)
Syntocinon(R)
Tagamet (R)
Teldvin (R)
Tensium (R)
Terramycine
(R).
Tetanus vaccine.
Tetracycline 1 or 3%, eye ointment (tube 5 g = 0.80
FF)
Tetracycline 3%, dermal ointment (tube 15 g = 2 FF)
Tetracycline,
tab/cap 250 mg (1,000 tab = 61.50 FF)
Tetramig (R)
Theodrox
(R)
Theophylline, amp. 25 mg/ml, 10 ml (100 amp = 48 FF)
Theophylline, tab
100 mg (1,000 tab = 27 FF)
Theophylline, tab 200 mg (1,000 tab = 44.50
FF)
Thiabendazole, tab 500 mg (1,000 tab = 216.50 FF)
Thiamine, tab 50 mg
(1,000 tab = 30.50 FF)
Thiazine (R)
Thiopentone sodium = Thiopental
sodium, vl 500 mg (100 vials = 140 FF)
Thiopentone sodium = Thiopental
sodium, vl 1 g (100 vials = 407 FF)
Tifomycine (R)
Tolbutamide, tab 500 mg
(1,000 tab = 69.50 FF)
Tosylchloramide sodium, powder/tab 250
mg
Tosylchloramide sodium, powder/tab 500 mg (1,000 tab = 59.50
FF)
Tosylchloramide sodium, powder/tab 1 g
Tosylchloramide sodium, tab 12
mg (1,000 tab = 56.50 FF)
Tramisol(R)
Tredemine(R)
Tylenol(R)
Urantoin(R)
Valium(R)
Vansil(R)
V-Cil-K(R)
Ventolin(R)
Vermox(R)
Vibramycin(R)
Videne(R)
Vitamin
A, cap 50,000 IU (1,000 cap = 58 FF)
Vitamin A, cap 200,000 IU (1,000 cap =
180 FF)
Vitamin B1, tab 50 mg (1,000 tab = 30.50 FF)
Vitamin B6, tab 25
mg
Vitamin B6, tab 50 mg (1,000 tab = 37.50 FF)
Vitamin B12, amp. 1 mg/ml,
1 ml
Vitamin C, tab 250 mg (1,000 tab = 45 FF)
Vitamin C, tab 50
mg
Vitamin K1, amp. 1 mg/ml, 1 ml (100 amp = 53.50 FF)
Vitamin B Complex
Whitfield's ointment (1 kg = 24 FF)
Xylocaine(R)
Xylocaine(R) 5%
Yellow fever vaccine
Yomesan(R)
Zadstat(R)
Zinamide(R)
Zinc oxide, ointment of vaseline
10% (1 tube = 7 FF)
Collection of practical guidelines Mcins Sans Frontis
Clinical guidelines - diagnostic and treatment manual 2nd
edition, 1990
Essential drugs - practical guidelines 1st edition, 1993
Minor surgical procedures in remote areas 1st edition, 1989
FRANCE
Mcins Sans Frontis
8 rue Saint-Sabin -
75544 Paris Cedex 11
Tel: (33) 1- 40.21.29.29 - Fax: (33) 1-
48.06.68.68
Telex: (042) 214360 MSF F
BELGIUM
Mcins Sans Frontis
Duprreet 94 - 1090
Bruxelles Jette
Tel: (32) 2- 474.74.74 - Fax: (32) 2- 474.75.75
Telex::
(046) 63607 MSF B
NETHERLANDS
Artsen Zonder Grenzen
Max Euweplein, 40 -
Postadres - Postbus 10014
1001 EA Amsterdam
Tel: (31) 20- 520.87.00 - Fax:
(31) 20- 620.51.70
Telex:: (044) 10773 MSF NL
SWITZERLAND
Mcins Sans Frontis
Rue du Lac 12 - Case
postale 6090 - 1211 Gen 6
Tel: (41) 22- 849.84.84 - Fax: (41) 22-
849.84.88
Telex: (045) 421927 MSF CH
SPAIN
Mcos Sin Fronteras
Nou de la Rambla 26 - 08001
Barcelone
Tel: (34) 3- 304.61.00 - Fax: (34) 3- 304.61.02
Telex: (052)
97309 MSF E
LUXEMBOURG
Mcins Sans Frontis
70 route de Luxembourg
- L-7240 Bereldange
Tel: (352) 33.25.15 - Fax: (352) 33.51.33
Telex::
(0402) 60811 MSF LU
In most Third World countries health needs are as immense as resources are limited.
In its 21 years of confronting this reality Mcins Sans Frontis has acquired highly valuable knowledge, knowledge that has been largely shaped by contact with the doctors, nurses and health agents of host countries.
Guides and manuals for Mcins Sans Frontis's field operations have been created thanks to this accumulated knowledge and the recommendations made by the great medical institutions.
This guide ESENTIAL DRUGS - PRACTICAL GUIDELINES, published
after Clinical Guidelines - diagnostic and treatment manual, Minor surgical
procedures in remote areas and Primary surgical procedures, is especially
intended for all those who administer daily medical care in impoverished
situations and will, we hope, facilitate their
work.